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Background: There is limited evidence concerning the effectiveness of enhanced recovery programmes
in hip and knee replacement surgery, particularly when applied nationwide across a health-care system.
Objectives: To determine the effect of hospital organisation, surgical factors and the enhanced
recovery after surgery pathway on patient outcomes and NHS costs of hip and knee replacement.
Design: (1) Statistical analysis of national linked data to explore geographical variations in patient
outcomes of surgery. (2) A natural experimental study to determine clinical effectiveness of enhanced
recovery after surgery. (3) A qualitative study to identify barriers to, and facilitators of, change. (4) Health
economics analysis to establish NHS costs and cost-effectiveness.
Setting: Data from the National Joint Registry, linked to English Hospital Episode Statistics and patient-
reported outcome measures in both the geographical variation and natural experiment studies, together
with the economic evaluation. The ethnographic study took place in four hospitals in a region of England.
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Participants: Qualitative study – 38 health professionals working in hip and knee replacement services
in secondary care and 37 patients receiving hip or knee replacement.
Interventions: Natural experiment – implementation of enhanced recovery after surgery at each
hospital between 2009 and 2011. Enhanced recovery after surgery is a complex intervention focusing
on several areas of patients’ care pathways through surgery: preoperatively (patient is in best possible
condition for surgery), perioperatively (patient has best possible management during and after
operation) and postoperatively (patient experiences best rehabilitation).
Main outcome measures: Patient-reported pain and function (Oxford Hip Score/Oxford Knee Score);
6-month complications; length of stay; bed-day costs; and revision surgery within 5 years.
Results: Geographical study – there are potentially unwarranted variations in patient outcomes of hip
and knee replacement surgery. This variation cannot be explained by differences in patients, case mix,
surgical or hospital organisational factors. Qualitative – successful implementation depends on empowering
patients to work towards their recovery, providing post-discharge support and promoting successful
multidisciplinary team working. Care processes were negotiated between patients and health-care
professionals. ‘Good care’ remains an aspiration, particularly in the post-discharge period. Natural
experiment – length of stay has declined substantially, pain and function have improved, revision rates are
in decline and complication rates remain stable. The introduction of a national enhanced recovery after
surgery programme maintained improvement, but did not alter the rate of change already under way.
Health economics – costs are high in the year of joint replacement and remain higher in the subsequent
year after surgery. There is a strong economic incentive to identify ways of reducing revisions and
complications following joint replacement. Published cost-effectiveness evidence supports enhanced
recovery pathways as a whole.
Limitations: Short duration of follow-up data prior to enhanced recovery after surgery implementation
and missing data, particularly for hospital organisation factors.
Conclusion: No evidence was found to show that enhanced recovery after surgery had a substantial
impact on longer-term downwards trends in costs and length of stay. Trends of improving outcomes
were seen across all age groups, in those with and without comorbidity, and had begun prior to the
formal enhanced recovery after surgery roll-out. Reductions in length of stay have been achieved
without adversely affecting patient outcomes, yet, substantial variation remains in outcomes between
hospital trusts.
Future work: There is still work to be done to reduce and understand unwarranted variations in
outcome between individual hospitals.
Study registration: This study is registered as PROSPERO CRD42017059473.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Services
and Delivery Research programme and will be published in full in Health Services and Delivery Research;
Vol. 8, No. 4. See the NIHR Journals Library website for further project information.
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Pharmacoeconomics and
Outcomes Research
LLSOA lower-layer super output area
LOS length of stay
MoM metal on metal
NIHR National Institute for Health
Research
NJR National Joint Registry
OHS Oxford Hip Score
OKS Oxford Knee Score
ONS Office for National Statistics
OPCS-4 Operating Procedure Codes
Classification of Interventions
and Procedures
OT occupational therapist
PEP-R Patient Experience Partnership
in Research
PROM patient-reported outcome
measure
QALY quality-adjusted life-year
S. aureus Staphylococcus aureus
SD standard deviation
THR total hip replacement
TKR total knee replacement
UKR unicompartmental knee
replacement
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Plain English summary
Osteoarthritis is a leading cause of pain and disability. Many people with severe hip or knee paincaused by osteoarthritis have an operation called joint replacement. This involves replacing the
painful hip or knee joint with an artificial joint. Over 200,000 hip and knee replacement operations
take place each year, funded by the NHS, and this number is expected to increase.
A new patient pathway for hip and knee replacement called ‘enhanced recovery’ has been introduced
in NHS and private hospitals. It is hoped that this will benefit patients through patient education
before and after surgery, and includes making changes around the home, exercises to strengthen the
joint and changes to diet, to help reduce the risk of complications and speed up a patient’s recovery.
Patients for whom it is suitable will benefit further by being able to return home earlier.
Over the past 10 years, there have been substantial reductions in pain and improvement in functionality
of the joint after surgery, fewer complications and reduced need for future reoperation. Large reductions
in length of stay and, in turn, hospital costs for the NHS have been achieved without an adverse impact
on patient outcomes. There has been an encouraging trend towards reduction in length of stay and
improved outcomes, but this started prior to the official launch of the enhanced recovery programme
and is likely to reflect early adoption of elements of enhanced recovery in some hospitals.
Although national trends towards improved patient outcomes are encouraging, there is still substantial
geographical variation in outcome between Clinical Commissioning Groups. This was not explained
by a hospital treating more complex or the most sick patients, nor by factors such as bed availability,
numbers of operating theatres and specialist surgeons, using new surgical techniques, or centralising
care into specialist high-volume hospitals.
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Scientific summary
Background
In England and Wales, there are around 200,000 total hip and knee replacement operations each year,
and this number is expected to increase as the result of an increasingly obese and elderly population.
Although the founding principle of the NHS is that it is free to all at the point of use, and based on clinical
need and not ability to pay, inequities in access to health care have been widely described across a range
of medical conditions. There is known discrepancy in access to common surgical procedures, and this has
been widely disseminated through The NHS Atlas of Variation in Healthcare (NHS England. The NHS Atlas of
Variation in Healthcare. Reducing Unwarranted Variation to Increase Value and Improve Quality. London: Public
Health England; 2010). Nevertheless, little is known about what happens after patients obtain access to
surgical procedures, in respect of potentially unwarranted geographical variations in the outcomes of
surgery. The NHS Act 2006 (Great Britain. National Health Service Act 2006. London: The Stationery
Office; 2006), as amended by the Health and Social Care Act 2012 (Great Britain. Health and Social Care
Act 2012. London: The Stationery Office; 2012), places duties on the NHS Commissioning Board to reduce
variations in access to, and outcomes from, health-care services for patients, and to assess and report on
how well they have fulfilled this duty. There is a commitment to address unwarranted variations in patient
outcomes in order to increase value from the health-care budget. Consequently, we first need to
understand and define any geographical variation in patient outcomes of joint replacement surgery.
Second, we need to determine the cause of the variation in patient outcomes.
The Department of Health and Social Care established an Enhanced Recovery Partnership Programme
between April 2009 and March 2011, with total knee and hip replacements being the focus of enhanced
recovery for musculoskeletal care. During this period, an enhanced recovery pathway was introduced
across all NHS hospitals. The enhanced recovery pathway is a complex intervention that focuses on key
areas of care across the pathway in order to improve patient care, preoperatively (for the patient to be in
the best possible condition for surgery), perioperatively (the patient has the best possible management
during and after their operation) and postoperatively (the patient experiences the best rehabilitation).
There has been limited evidence on the efficacy of a ‘national’ programme in which enhanced recovery
pathway has been implemented nationwide. Implementation may vary across diverse hospital settings,
and implementation may be adapted to local circumstances and interpretation of the enhanced recovery
pathway guidelines, reducing its effectiveness.
This report describes geographical variation in patient outcomes of total hip and knee replacement
surgeries, and how trends in patient outcomes have been changing over time. It assesses the clinical
effectiveness and cost-effectiveness of the national enhanced recovery pathway for total hip and knee
replacement surgeries. We describe the views of patients and health-care professionals to understand
the elements of health care that enable the pathway to be delivered, alongside patients’ experience of
care within the structure of the pathway and their preferences for care at key points in the pathway.
Objectives
1. Identification of hospital organisation, surgical factors and the enhanced recovery pathway as
determinants of geographical variation in patient outcomes and NHS costs.
2. Natural experiment to determine the clinical effectiveness and cost-effectiveness of the enhanced
recovery pathway.
3. Qualitative study (process evaluation) on implementation of the enhanced recovery pathway in four
hospital settings.
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Methods
Objective 1
Objective 1 involved statistical analysis of national linked data from the NHS Hospital and Community
Health Service (monthly workforce statistics), quarterly collection from all NHS organisations that operate
beds (KH03 – NHS England), the National Joint Registry, Hospital Episode Statistics and patient-reported
outcomes measures. Multilevel regression models are used to describe the association of patient case mix
and hospital organisational and surgical factors as potential determinants of geographical variations in
patient outcomes of surgery between 2014 and 2016, and the magnitude of this variation. Geographical
information systems are used to produce maps depicting geographical variation in outcomes across
Clinical Commissioning Groups and graphically display the influence that hospital process factors have on
explaining such variation in outcomes.
Objective 2
The project used a natural experimental study design to examine the impact that the new enhanced
recovery treatment pathway has had on length of stay, admissions costs, patient-reported outcome
measures, complications and revision surgery. We used the National Joint Registry, Hospital Episode
Statistics and patient-reported outcomes measures linked data sets from April 2008 to December 2016.
The intervention was defined as the period of national enhanced recovery after surgery (April 2009–
March 2011). Interrupted time series analysis assessed the impact on trends in outcomes before, during
and after the introduction of the new enhanced recovery pathway. There was a focus on the benefit of
the new enhanced recovery pathway to specific patient groups, such as frail older people with complex
comorbid conditions.
Data from the National Joint Registry for England,Wales, Northern Ireland and the Isle of Man, English
Hospital Episode Statistics, Office for National Statistics mortality and Clinical Practice Research
Datalink GOLD were used to estimate the hospital and non-hospital costs associated with primary total
hip and knee replacement, and posterior revisions within the year and subsequent years of occurrence.
A systematic search was performed to identify peer-reviewed studies between 2000 and 2017 that
described cost–utility analysis of enhanced recovery pathways, or components of one, compared with
usual care, in patients having total hip or knee replacement.
Objective 3
The process evaluation aimed to understand organisational processes that may help or hinder
the implementation of the enhanced recovery after surgery programmes for total hip and knee
replacement. This work used the Consolidated Framework for Implementation Research to inform
interpretation of results. It also aimed to characterise patients’ experiences of enhanced recovery
after surgery for total hip or knee replacement, using the ethnographer Mol’s work to explore how
care processes are negotiated between patients and health-care professionals. The qualitative research
used an ethnographic approach, which involved periods of ‘fieldwork’ in contexts. Ethnography aims
to achieve a deep understanding of practice and systems from the perspective of people in a context.
The qualitative study took place in four different hospitals within an area of England, and the settings
have been chosen as the primary contexts in which hip and knee replacements are currently performed
in UK health care. The four hospitals in the UK were a teaching hospital, a district general hospital,
a specialist orthopaedic hospital and an independent-sector treatment centre. The ethnographic study
used observations and interviews with staff involved in service delivery. Data were analysed using
a thematic analysis, followed by an abductive approach, whereby themes were mapped onto the 31
constructs and five domains of the Consolidated Framework for Implementation Research. Thirty-eight
staff participated, including orthopaedic surgeons, nurses and physiotherapists. In the study exploring
patients’ experiences of enhanced recovery after surgery, semistructured interviews were carried out
with 37 patients who had experienced a total hip or knee replacement. An inductive thematic analysis
was conducted to identify themes and subthemes in the responses.
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Results
Geographical variation
A total of 210,725 primary total knee replacements were identified, nested in 31,715 census areas
and 207 Clinical Commissioning Group areas (173,107 primary total hip replacements: 30,850 census
areas and 207 Clinical Commissioning Group areas). Almost 60% of patients were women and the
average age was ≈69 years. Although we identified a number of factors that predicted outcomes of
surgery (e.g. age, sex, comorbidity, deprivation, baseline hip/knee function, surgical volume, numbers of
orthopaedic surgeons, beds, operating theatres), these factors did not explain observed geographical
variation in outcomes of surgery across Clinical Commissioning Groups. The absolute change in Oxford
Knee Score varied from 11.2 to 19.1 points (Oxford Knee Score range 17.5–24.9 points), 6-month
complication rate of total knee replacement varied from 1.5% to 8.4% (total knee replacement range
2.0–8.6%), mean length of stay for total knee replacement varied from 2.7 to 6.6 days (total knee
replacement range 2.5–6.2 days) and hospitalisation cost varied from £4564 to £8901 (total hip
replacement range £4322–8566).
Qualitative (patient experiences)
Time to surgery varied, and cancellations were emotionally difficult. Patients valued preoperative education,
but timing of surgery meant that not all patients were offered educational classes. Participants wanted
more information on expected progress, along with emotional support. There were different experiences
of being offered a choice of anaesthesia. For some, this was explained comprehensively and before
admission; others were consulted on the day of surgery, which caused anxiety. Postoperative recovery
was often most challenging in the initial weeks, and some were unsure how to perform exercises or
worried about unfamiliar bodily sensations. They wanted more post-discharge input to provide ‘reassurance’.
Follow-up appointments were considered key in recovery.
Qualitative (ethnographic study)
The results showed that 17 Consolidated Framework for Implementation Research constructs, from
all five domains, influenced implementation. Within ‘intervention characteristics’, participants thought
that enhanced recovery after surgery afforded advantages over alternative solutions and guidance was
adaptable. In the ‘outer setting’, it was felt that enhanced recovery after surgery should be tailored
to patients, and education used to empower them in their recovery. However, there were concerns
about post-discharge support and tensions with primary care. Within the ‘inner setting’, effective
multidisciplinary collaboration was achieved by transferring knowledge about patients along the care
pathway and multidisciplinary working practices. Enhanced recovery after surgery was viewed as a
‘message’ that had to be communicated consistently. There were concerns about resources and high
volumes of patients. Staff access to information varied. At the domain ‘characteristics of individuals’,
knowledge and beliefs had an impact on implementation.
Natural experiment (interrupted time series)
A total of 438,921 primary total hip replacements and 525,088 primary total knee replacements were
identified. For total hip replacements, overall length of stay decreased from 5.6 days in April 2008
to 3.6 days in December 2016 (total knee replacement range 5.7–3.6 days). Although older patients
had a longer length of stay, the decreasing trend in length of stay was seen across all age groups
(e.g. 4.7–3.0 days in those aged < 60 years and 8.1–5.3 days in those aged ≥ 85 years). A decreasing
trend in length of stay was seen in patients with and without pre-existing comorbidity. For total knee
replacements, hospital admission costs decreased from £7573 in April 2008 to £5239 in December
2016 (total knee replacement range £7461–5158). Over the study period, there was an improvement
in patient-reported outcome measures, with an improvement in change in Oxford Hip Score 6 months
after surgery of 17.7 points in April 2008, with this change increasing to 22.9 points in December 2016
(total knee replacement Oxford Knee Score: from 15.0 to 17.1 points). The overall proportion of
complications was low and decreased from 4.1% in April 2008 to 1.7% in March 2016. For total hip
replacements, 5-year revision rates declined from 5.9 (95% confidence interval 4.8 to 7.2) per 1000 implant
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years at risk in April 2008 to 2.9 (95% confidence interval 2.2 to 3.9) per 1000 implant years at risk
in December 2011 (total knee replacement/unicompartmental knee replacement: from 6.6/1000 to
5.4/1000). Trends in length of stay, bed costs, patient-reported outcome measures, complications and
revision surgery were consistent with a continuation of a pre-existing secular trend, and were not
temporally related to implementation of the national enhanced recovery after surgery programme.
Health economics (costs)
We identified 854,866 individuals undergoing total hip or knee replacements in National Joint Registry
and Hospital Episode Statistics data. The mean censor-adjusted 1-year hospitalisation costs for total
hip and knee replacements were £7827 (95% confidence interval £7813 to £7842) and £7805
(95% confidence interval £7790 to £7818), respectively. The censor-adjusted 2-year costs were £9258
(95% confidence interval £9233 to £9280) and £9452 (95% confidence interval £9430 to £9475) for
total hip and knee replacements, respectively. Complications, revisions and death were the major predictors
of 1-year hospitalisation costs. Adding primary and outpatient care, total knee replacements cost £9483
in the year of surgery, compared with £9295 for total hip replacements.
Health economics (cost-effectiveness)
We identified two cost–utility analyses of entire enhanced recovery pathways and 11 analyses of
pathway components. Consistent results were found supporting enhanced recovery pathways as a
whole, prophylactic systemic antibiotics, antibiotic-impregnated cement and conventional ventilation
for infection prevention.
Conclusion
Our data show that outcomes of total hip and knee replacements have been gradually improving over
time, with a decrease in length of stay, reduction in inpatient bed-day cost, improvement in patient-
reported outcomes of pain and function, decrease in complications and reduction in 5-year revision risk.
These trends of improving outcomes were seen across all age groups, and in those with and without
comorbidity. However, trends of improving outcomes had begun prior to the introduction of the formal
NHS enhanced recovery after surgery roll-out out and therefore are not temporally associated with the
national enhanced recovery after surgery programme. These findings are positive, in highlighting that
reductions in length of stay have been achieved without adversely affecting patient outcomes.
Even though patient outcomes have been improving over time, analysis of the most recent years of
data identified potentially unwarranted variations in patient outcomes of total hip and knee replacements.
This variation cannot be explained by differences in patient case mix, surgical factors or hospital
organisational factors. This information is informative to commissioners in monitoring variations in
outcomes of surgery.
The qualitative study of patients’ experiences of the enhanced recovery pathway illustrates how
processes of care were negotiated between patients and health-care professionals, along with the
emotional and physical work that patients did as ‘active’ participants in their recovery. Interviews with
patients included discussion around preoperative educational needs, tensions between mobilising and
giving themselves time to ‘heal’ after surgery, and challenges post discharge. The study demonstrates
that ‘good care’ remains an aspiration, particularly in the post-discharge period.
The ethnographic study demonstrates that successful implementation of enhanced recovery after
surgery services for total hip and knee replacements depends on several aspects, such as the extent to
which services have been adapted to meet individual needs, effective communication between staff
and planning processes. Doing so provides information to health-care providers on how best to organise
and deliver these services in the future. The study may also be of use to clinicians and researchers in
helping to understand service delivery for enhanced recovery after surgery in other surgeries.
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Recommendations for research
l Although national trends towards improved patient outcome are encouraging, there is still
substantial variation in outcome between hospital trusts and Clinical Commissioning Groups,
so there is work to be done to understand why these potentially unwarranted variations in patient
outcome exist.
l Further research should explore patient experiences of referral from primary to secondary care
services to provide a more comprehensive account of experiences through the care pathway.
In addition, future research may consider general practitioners’ views and experiences of enhanced
recovery after surgery, particularly at the points of referral and discharge. This would provide a
‘system-wide’ understanding of the delivery of enhanced recovery after surgery.
Study registration
The study is registered as PROSPERO CRD42017059473.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Services and
Delivery Research programme and will be published in full in Health Services and Delivery Research;
Vol. 8, No. 4. See the NIHR Journals Library website for further project information.
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Chapter 1 Introduction
Hospital Episode Statistics1 and patient-reported outcome measures2 data were made available byNHS Digital, and re-used with the permission of NHS Digital. All rights reserved.
Background
Osteoarthritis presents an important health burden as the population becomes older and increasingly
obese.3 Almost half of those aged > 75 years seek medical care for osteoarthritis, with a large impact
on health-care costs and health-related quality of life.4 It is a leading cause of worldwide disability, with
an estimated annual loss of productivity cost of £3.2B in the UK,5 with pain being the primary symptom
that causes people to seek out pharmacological (e.g. prescription analgesia) and non-pharmacological
(e.g. exercise programmes supervised by physiotherapists) treatment and, in severe cases, joint replacement
surgery. Over 200,000 people with severe hip or knee pain caused by osteoarthritis have joint replacement
surgery each year in the NHS, and this number is expected to increase.6
A 2010 White Paper7 outlined the future of the NHS, making it more accountable to patients through
greater choice and information, with a strong focus on clinical outcomes. To shift decision-making as
close as possible to individual patients, the government has devolved power and responsibility for
commissioning services to general practitioners (GPs) and their practice teams working in consortia.
The NHS Act 2006,8 as amended by the Health and Social Care Act 2012,9 places duties on the NHS
Commissioning Board and Clinical Commissioning Groups (CCGs) to have regard to the need to reduce
variations in access to, and outcomes from, health-care services for patients, and to assess and report
on how well they have fulfilled this duty.
There are well-known geographical variations in the uptake of common surgical procedures, including
total hip replacement (THR) and total knee replacement (TKR),10,11 as publicised through The NHS Atlas
of Variation in Healthcare.12 A recent study found evidence of significant unexplained variation among
hospitals in both health outcomes and resource use following THR or TKR,13 but little is known about
factors that can explain why such variation exists. In the NHS, as part of the Patient Choice Agenda,14
patients can choose which hospital they want to have their surgery in. Information on the outcomes
of surgery between different hospitals would help patients in making their decision. Geographical
variation in outcomes of surgery may be explained by a hospital treating more complex, sick patients.
However, differences in patient outcomes could also be explained by how hospitals organise their
services,10 such as bed availability, numbers of operating theatres and specialist surgeons, using
new surgical techniques, such as minimally invasive surgery,10 or centralising care into specialist
high-volume hospitals.15,16
Between April 2009 and March 2011, the Department of Health and Social Care established an
Enhanced Recovery Partnership Programme17 to support the NHS to implement and realise the
benefits of enhanced recovery in colorectal, musculoskeletal, gynaecological and urological major
elective surgical pathways. Through this programme, a new ‘enhanced recovery’ patient pathway
for THR and TKR has now been introduced across all NHS hospitals.18 Enhanced recovery is a complex
intervention19,20 that focuses on key areas of care across the pathway: preoperatively (for the patient
to be in the best possible condition for surgery), perioperatively (the patient has the best possible
management during and after their operation) and postoperatively (the patient experiences the best
rehabilitation). It is hoped that this will benefit patients through patient education before and after
surgery, which includes making changes around the home, doing exercises to strengthen the joint and
changing diet to help reduce the risk of complications and speed up recovery. Patients for whom
it is suitable will benefit further by being able to return home earlier to continue their recuperation
at home with appropriate support. This in turn will benefit the hospital by freeing up space for other
DOI: 10.3310/hsdr08040 Health Services and Delivery Research 2020 Vol. 8 No. 4
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Judge et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
1
patients on the waiting list. A greater number of frail older people with complex comorbid conditions
now receive THR or TKR. The new enhanced recovery pathway (ERP) could specifically benefit these
patient groups.21
There is limited evidence concerning the clinical effectiveness and cost-effectiveness of enhanced recovery
programmes in TKR and THR.22 There is a need for information on what the core active ingredients are
and how they are exerting their effect.20 This is important because, when implemented nationwide in
diverse hospital settings, the intervention may be adapted to local circumstances that inhibit its
effectiveness.23 A recent synthesis of evidence about effectiveness and implementation of enhanced
recovery programmes highlights ‘barriers’ to and ‘facilitators’ of implementation.22 Barriers include
resistance to change, inadequate funding, lack of support from management, high staff turnover, poor
documentation and shortness of time. Facilitators include a dedicated enhanced recovery lead, the
presence of multidisciplinary team working, and ongoing education for staff and patients. Studies of
patients’ experiences of enhanced recovery following colorectal surgery have been carried out,24–26 but
we know little about experiences for TKR and THR, or the elements of pathway-driven care that patients
like most and least. Organisational processes and collaboration between professionals are crucial to
the delivery of safe and satisfactory care,27 but the organisational contexts that can support or inhibit
delivery of enhanced recovery have not been explored.
Aims
To determine the effect of hospital organisation, surgical factors and the ERP on patient outcomes and
NHS costs of hip and knee replacement.
Objectives
1. Identification of hospital organisation, surgical factors and the ERP as determinants of geographical
variation in patient outcomes and NHS costs.
2. Natural experiment to determine the clinical effectiveness and cost-effectiveness of the enhanced
recovery treatment pathway.
3. Qualitative study (process evaluation) on implementation of ERPs in four hospital settings.
Design and methodology
The project comprises a patient forum and two main work packages. The project began with a patient
forum to identify the outcomes that matter most to THR and TKR patients (patient-identified outcomes).
Findings from the forum inform the primary and secondary outcomes of the study.
Work package 1
Work package 1 aims to explore geographical variation in patient outcomes of surgery. Using Hospital
and Community Health Service (HCHS), KH03 and Supporting Facilities data sets linked to the National
Joint Registry (NJR), Hospital Episode Statistics (HES) and patient-reported outcome measures (PROMs),
we explore how hospital organisational factors (e.g. staff, beds, operating theatres) and surgical factors
(e.g. minimally invasive technique, surgeon volume, operative time, implant fixation, thromboprophylaxis)
explain geographical variation in patient outcomes, adjusting for patient case mix. The results are
displayed as maps, highlighting the level of variation in patient outcomes across CCGs.
Work package 2
Work package 2 focuses specifically on the enhanced recovery care pathway.
INTRODUCTION
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Process evaluation
Here we characterise the enhanced recovery intervention as used in practice in different hospital
settings (tertiary care centre of excellence, teaching hospital, district general hospital, private hospital)
and understand organisational processes that enable or impede implementation of the ERP. The
qualitative work uses an ethnographic approach.
Natural experiment
We evaluate the impact that the ERP has had on NHS costs and patient outcomes [PROMs, length of stay
(LOS), complications, revision]. We used interrupted time series analysis to examine changes in secular
trends in outcomes and NHS costs before and after the introduction of the new treatment pathway.
Economic evaluation
This describes the hospital and non-hospital NHS costs for THR and TKR, and the cost-effectiveness of
the ERP.
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Chapter 2 Data sources
National Joint Registry
Starting in 2003, the NJR6 has collected information on all hip and knee replacements performed each
year in both public and private hospitals in England, Wales and, since 2012, Northern Ireland. Data
are entered into the NJR using forms completed by surgeons at the time of surgery and revision
operations are linked using unique patient identifiers.
Hospital Episode Statistics
The HES database holds information on all patients admitted to NHS hospitals in England, including
diagnostic International Classification of Diseases codes, providing information about a patient’s illness or
condition, and Operating Procedure Codes Classification of Interventions and Procedures (OPCS-4)
procedural codes for surgery. It covers a smaller geographical area than the NJR and does not include
privately funded operations. Data for all-cause mortality are provided by the Office for National
Statistics (ONS) and linked to the HES database.
Patient-reported outcome measures
Since April 2009, PROM28 data have been collected on hip and knee replacements performed in
public hospitals in England. Preoperative and 6-month quality-of-life questionnaires [the EuroQol-5
Dimensions (EQ-5D)29] and joint-specific PROMs [the Oxford Hip Score (OHS)30 and Oxford Knee
Score (OKS)31] are collected.
Clinical Practice Research Datalink
The Clinical Practice Research Datalink (CPRD),32 formerly the General Practice Research Database,
was established in 1987 and contains anonymised individual patient data from electronic primary
health-care records from practices across the UK. Data cover clinical and referral events in primary
and secondary care, and comprehensive demographic information, medication prescription data, clinical
events, specialist referrals, hospital admissions and their major outcomes. As of June 2017, 693 general
practices contributed data to the CPRD. In total, data from an estimated 14.2 million patients are
available within the CPRD, of whom 2.8 million were active in 2017.
Hospital organisational characteristics
The NHS HCHS Workforce Statistics in England provide details on the workforce within NHS
organisations, including numbers of consultants and specialties (e.g. trauma and orthopaedic,
anaesthetists), registrars and other doctors in training. The NHS quarterly Bed Availability and
Occupancy data set has data on the number of available beds and occupied beds, whereas the
Supporting Facilities data set provides information on operating theatres and dedicated day-case
theatres. The data are published quarterly and can be linked to HES data through the hospital
provider code.10
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Data applications
National Joint Registry, Hospital Episode Statistics and patient-reported outcome measures
Approval for NJR data was received on 8 July 2016 (NJR internal reference RSC2016/11). Confidentiality
Advisory Group section 251 approval was received on 20 September 2016 (Confidentiality Advisory
Group reference 16/CAG/0111). A Data Access Request Service application was made to NHS Digital
for HES and PROMs data to be linked to data from the NJR. This was approved, with the data-sharing
agreement signed on 23 January 2016. Data from the NJR were received on 14 March 2017. HES and
PROM data were made available to download on 7 April 2017.
Clinical Practice Research Datalink, Hospital Episode Statistics and patient-reported
outcome measures
Independent Scientific Advisory Committee approval was received on 5 July 2016 (protocol number
11_050AMnA2R). The CPRD subsequently announced a new linkage to PROMs, so a further
Independent Scientific Advisory Committee amendment was submitted and approval was obtained on
10 January 2017 (protocol number 11_050 AMnA2RA2). CPRD data linked to inpatient and outpatient
HES were received on 9 May 2017 and linked PROMs data were received on 25 July 2017.
Data summary
Data were available on 746,822 primary THRs from the NJR (2003–17). HES data were obtained for
years 2008–17, of which 445,611 could be linked to NJR data. PROMs data (2009–16) were available
for 229,025 patients with complete preoperative and 6-month postoperative OHSs (Figure 1). There
were 841,139 primary TKRs and unicompartmental knee replacements (UKRs) in the NJR (2003–17),
with HES data (2008–17) linked for 531,790 patients and PROM data (2009–17) linked for 258,297
patients, with preoperative and 6-month postoperative OKSs (Figure 2).
In the CPRD data, we have 72,339 primary THRs and 64,071 primary TKRs from 1995 to 2017. Linked
HES data were available for 42,204 hips and 38,606 knees. PROM data from 2009 onwards were
linked to 5184 hips and 5352 knees.
Descriptive summary statistics of the variables available for analysis from the NJR (Table 1),
HES (Table 2), hospital organisational factor (Table 3) and PROMs (Table 4) linked data sets are
described below.
DATA SOURCES
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Patients with primary hip replacement
(n = 746,749)
Not matched with hospital inpatient record
[n = 301,194 ( 40.3%)]
Emergency admissions and other types
different from planned
[n = 2532 (0.3%)]
Surgery before April 2008
[n = 576 (0.1%)]
Surgery after December 2016
[n = 3556 (0.5%)]
Patients with primary hip replacement
(n = 438,921)
> 15 days of stay
[n = 6724 (1.5%)]
Patients in the analysis
of LOS
(n = 432,162)
LOS data missing or discharge
date prior to admission date
[n = 35 (< 0.1%)]
After 2011
[n = 278,297 (63.4%)]
Patients in the analysis of
5-year revision
(n = 160,624)
Revisions by 5 years
[n = 3577 (2.2%)]
No baseline OHS available
[n = 169,358 (38.6%)]
Baseline but not 6 months after
surgery OHS available
[n = 42,767 (9.7%)]
Patients in the analysis
of OHS change
(n = 226,796)
Patients in the analysis of complications
after surgery
(n = 385,201)
Patients with complications
[n = 6232 (1.6%)]
Complication date prior to
surgery date
[n = 9472 (2.2%)]
After June 2016 
[n = 29,520 (6.7%)]
Outliers: after March 2016
[n = 14,728 (3.4%)]
FIGURE 1 Flow diagram on selection of primary THR patients. Navy shows inclusion; light blue shows exclusion.
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Patients with primary TKR/UKR
(n = 850,639)
Not matched with hospital
inpatient record
[n = 313,292 (36.8%)]
Emergency admissions and other types
different to elective
[n = 946 (0.1%)]
Surgery before April 2008
[n = 629 (0.1%)]
Surgery after December 2016
[n = 4646 (0.6%)]
Patients with primary TKR/UKR
(n = 531,126)
> 15 days of stay
[n = 7290 (1.4%)]
Patients in the analysis of
LOS
(n = 523,798)
LOS data missing or discharge
date prior to admission date
[n = 38 (< 0.1%)]
After 2012
[n = 277,110 (52.2%)]
Patients in the analysis of
5-year revision
(n = 253,503)
Revisions by 5 years
[n = 6639 (2.6%)]
Death date prior to surgery date
[n = 513 (0.1%)]
After June 2016
[n = 36,581 (6.9%)]
Patients in the analysis of 6-month
complications
(n = 464,587)
Complications by 6 months
[n = 8101 (1.7%)]
Complication date prior to
surgery date
[n = 11,375 (2.1%)]
Death date prior to surgery date
[n = 477 (0.1%)]
Outliers: after March 2016
[n = 18,106 (2.1%)]
No baseline OKS available
[n = 224,846 (42.3%)]
Baseline but not 6 months after
surgery OKS available
[n = 49,840 (9.4%)]
Patients in the analysis of OKS
change
(n = 256,440)
FIGURE 2 Flow diagram on selection of primary TKR patients. Navy shows inclusion; light blue shows exclusion.
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TABLE 1 Descriptive statistics (NJR data set)
Category
Unilateral primary
hip replacements
Unilateral primary
knee replacements
Total (n) 440,640 531,524
Age (years) at operation
Mean (SD) 69.1 (10.8) 69.6 (9.5)
Range 18–117 18–102
Age categories (years), n (%)
< 50 21,045 (4.8) 12,205 (2.3)
50–59 57,333 (13.0) 65,771 (12.4)
60–69 131,691 (29.9) 175,354 (33.0)
70–79 158,015 (35.9) 197,931 (37.2)
80–84 48,300 (11.0) 55,868 (10.5)
≥ 85 24,256 (5.5) 24,395 (4.6)
Sex, n (%)
Female 263,961 (59.9) 302,295 (56.9)
Male 176,679 (40.1) 229,229 (43.1)
Side, n (%)
Right 196,585 (44.6) 252,958 (47.6)
Left 244,055 (55.4) 278,566 (52.4)
BMI (kg/m2)
Mean (SD) 28.9 (5.2) 31.0 (5.4)
Range 16–60 16–60
Missing, n (%) 124,706 (28.3) 150,496 (28.3)
ASA grade, n (%)
P1 59,934 (13.6) 52,158 (9.8)
P2 310,596 (70.5) 391,903 (73.7)
P3 68,326 (15.5) 85,949 (16.2)
P4 1769 (0.4) 1494 (0.3)
P5 15 (0.0) 20 (0.0)
Year of primary hip replacement, n (%)
2007 1 (0.0)
2008 29,070 (6.6) 34,130 (6.4)
2009 39,279 (8.9) 46,892 (8.8)
2010 44,717 (10.2) 53,130 (10.0)
2011 47,312 (10.7) 57,285 (10.8)
2012 50,793 (11.5) 60,679 (11.4)
2013 52,836 (12.0) 62,168 (11.7)
2014 57,156 (13.0) 69,600 (13.1)
2015 57,536 (13.1) 70,686 (13.3)
2016 58,416 (13.3) 72,350 (13.6)
2017 3525 (0.8) 4603 (0.9)
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TABLE 1 Descriptive statistics (NJR data set) (continued )
Category
Unilateral primary
hip replacements
Unilateral primary
knee replacements
Type of surgeon, n (%)
Other 84,646 (19.2) 110,724 (20.8)
Consultant 355,994 (80.8) 420,800 (79.2)
Type of approach, n (%)
Other 166,376 (37.8)
Posterior 274,264 (62.2)
Lateral parapatellar 4911 (0.9)
Medial parapatellar 495,866 (93.3)
Mid-vastus 16,015 (3.0)
Subvastus 6094 (1.2)
Other 8638 (1.6)
Primary indication, n (%)
Osteoarthritis 426,826 (96.9) 525,652 (98.9)
Osteoarthritis and other 13,814 (3.1) 5872 (1.1)
Primary thromboprophylaxis, n (%)
None 13,373 (3.0) 18,967 (3.6)
Aspirin only 21,716 (4.9) 28,905 (5.4)
LMWH (± other) 289,732 (65.8) 384,276 (72.3)
Other (no LMWH) 115,819 (26.3) 99,376 (18.7)
Primary mechanical prophylaxis, n (%)
None 26,306 (6.0) 29,036 (5.5)
Any 414,334 (94.0) 502,488 (94.5)
Primary graft femur, n (%)
None 437,943 (99.4) 526,675 (99.1)
Any 2697 (0.6) 4849 (0.9)
Primary graft tibia, n (%)
None 529,515 (99.6)
Any 2009 (0.4)
Primary complication, n (%)
None 433,428 (99.0) 528,917 (99.5)
One or more 4438 (1.0) 2607 (0.5)
Missing 2774 (0.6) 0 (0.0)
Primary cup fixation, n (%)
Uncemented cup 275,877 (63.3)
Cemented cup 160,131 (36.7)
Missing 4632 (1.1)
Primary fixation, n (%)
Cementless 22,865 (4.3)
Cemented 504,910 (95.1)
Hybrid 3359 (0.6)
Missing 390 (0.1)
DATA SOURCES
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TABLE 1 Descriptive statistics (NJR data set) (continued )
Category
Unilateral primary
hip replacements
Unilateral primary
knee replacements
Type of primary implant, n (%)
MoM resurfacing 7803 (1.8)
THR (any bearing) 423,499 (98.2)
Missing 9338 (2.1)
Type of resurfacing stem fix, n (%)
Cemented HR stem 7097 (91.0)
Uncemented HR stem 706 (9.1)
THR or missing 432,837 (98.2)
Femoral fixation, n (%)
Cementless 25,219 (4.8)
Cemented 499,559 (95.2)
Missing 6746 (1.3)
Tibial fixation, n (%)
Cementless 23,158 (4.4)
Cemented 498,538 (95.6)
Missing 9828 (1.8)
Type of primary stem fixation, n (%)
Uncemented THR stem 193,118 (45.4)
Cemented THR stem 232,520 (54.6)
Resurfacing or missing 15,002 (3.4)
Type of primary bearing, n (%)
MoM 16,175 (3.8)
Non-MoM 412,223 (96.2)
Missing 12,242 (2.8)
Details of primary bearing, n (%)
MoM 16,175 (3.8)
MoP 263,520 (61.5)
CoC 68,487 (16.0)
CoP 78,878 (18.4)
CoM 1245 (0.3)
MoC 93 (0.0)
Missing 12,242 (2.8)
Primary implant type, n (%)
MoM THR 8372 (2.0)
HR 7803 (1.8)
Non-MoM THR 412,223 (96.2)
Unicondylar/hinged/linked/custom/preassembled 40,471 (7.7)
Bicondylar 484,529 (92.3)
Missing 12,242 (2.8) 6524 (1.2)
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TABLE 1 Descriptive statistics (NJR data set) (continued )
Category
Unilateral primary
hip replacements
Unilateral primary
knee replacements
Primary head size (mm), n (%)
≤ 28 172,885 (40.1)
32 145,693 (33.8)
36–42 101,341 (23.5)
44–48 5346 (1.2)
50–52 4510 (1.1)
≥ 54 1527 (0.4)
Missing 9338 (2.1)
Minimally invasive, n (%)
Yes 17,911 (4.1) 27,999 (5.3)
No 422,729 (95.9) 503,525 (94.7)
Unit type, n (%)
Public hospital 336,285 (76.3) 403,302 (75.9)
Independent hospital 82,109 (18.6) 100,399 (18.9)
Independent treatment centre 22,246 (5.1) 27,823 (5.2)
Surgical volume per consultant
Mean (SD) 98.0 (80.5) 88.4 (60.4)
Range 1–693 1–434
Resurfacing volume per consultant
Mean (SD) 2.3 (8.7)
Range 0–160
Missing, n (%) 12,242 (2.8)
THR volume per consultant
Mean (SD) 94.7 (78.3)
Range 0–687
Missing, n (%) 12,242 (2.8)
TKR volume per consultant
Mean (SD) 79.3 (54.3)
Range 0–409
Missing, n (%) 0 (0.0)
UKR volume per consultant
Mean (SD) 8.0 (16.7)
Range 0–218
Missing, n (%) 0 (0.0)
PFJR volume per consultant
Mean (SD) 1.1 (2.7)
Range 0–56
Missing, n (%) 0 (0.0)
Surgical volume per unit
Mean (SD) 341.3 (253.0) 383.5 (266.2)
Range 1–1286 1–1633
DATA SOURCES
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TABLE 1 Descriptive statistics (NJR data set) (continued )
Category
Unilateral primary
hip replacements
Unilateral primary
knee replacements
Resurfacing surgical volume per unit
Mean (SD) 6.8 (17.9)
Range 0–192
Missing, n (%) 12,242 (2.8)
THR surgical volume per unit
Mean (SD) 328.0 (243.9)
Range 0–1272
Missing, n (%) 12,242 (2.8)
TKR surgical volume per unit
Mean (SD) 348.0 (243.0)
Range 0–1429
Missing, n (%) 0 (0.0)
UKR surgical volume per unit
Mean (SD) 30.9 (43.8)
Range 0–384
Missing, n (%) 0 (0.0)
PFJR surgical volume per unit
Mean (SD) 4.6 (6.1)
Range 0–67
Outcome, n (%)
Death 33,473 (7.6) 36,921 (7.0)
Revised 7600 (1.7) 10,293 (1.9)
Unrevised 399,179 (90.7) 484,308 (91.1)
Missing 388 (0.1) 2 (0.0)
Time to revision (years)
Mean (SD) 2.2 (2.2) 2.4 (1.7)
Range 0–9 0–9
Not revised or missing, n (%) 433,040 (98.3) 521,231 (98.1)
Time to death (years)
Mean (SD) 3.6 (2.1) 3.7 (2.1)
Range 0–9 0–9
Alive or missing, n (%) 406,535 (92.3) 494,603 (93.1)
ASA, American Society of Anesthesiologists; BMI, body mass index; CoC, ceramic on ceramic; CoM, ceramic on metal;
CoP, ceramic on polyethylene; HR, hip resurfacing; LMWH, low-molecular-weight heparin; MoC, metal on ceramic;
MoM, metal on metal; MoP, metal on polyethylene; PFJR, patellofemoral joint replacement; SD, standard deviation.
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TABLE 2 Descriptive statistics (HES data set)
Category
Unilateral primary
hip replacements
Unilateral primary
knee replacements
Total (n) 440,640 531,524
IMD quintiles at primary surgery, n (%)
Least deprived (20%) 106,613 (24.2) 115,670 (21.8)
Less deprived (20–40%) 108,818 (24.7) 122,769 (23.1)
Less deprived (40–60%) 79,678 (18.1) 101,703 (19.1)
More deprived (20–40%) 74,417 (16.9) 97,473 (18.3)
Most deprived (20%) 71,114 (16.1) 93,909 (17.7)
Rurality at primary surgery, n (%)
Urban ≥ 10,000 population 315,071 (71.5) 398,650 (75.0)
Town and fringe 56,321 (12.8) 62,623 (11.8)
Village/isolated 69,248 (15.7) 70,251 (13.2)
Ethnicity, n (%)
White 386,149 (97.3) 451,169 (93.4)
Non-white 10,806 (2.7) 32,103 (6.6)
Missing 43,685 (9.9) 48,252 (9.1)
Comorbidities at primary surgery, n (%)
None 326,661 (74.1) 374,092 (70.4)
Mild 80,211 (18.2) 113,913 (21.4)
Moderate 22,785 (5.2) 30,315 (5.7)
Severe 10,983 (2.5) 13,204 (2.5)
Charlson Comorbidity Index, n (%)
AIDS 0 (0.0) 0 (0.0)
Metastatic solid tumour 628 (0.1) 323 (0.1)
Severe liver disease 1072 (0.2) 1135 (0.2)
Lymphoma 389 (0.1) 384 (0.1)
Leukaemia 610 (0.1) 666 (0.1)
Non-metastatic tumour 4784 (1.1) 4979 (0.9)
Diabetes mellitus with end organ damage 1090 (0.3) 1711 (0.3)
Moderate–severe renal disease 18,249 (4.1) 22,028 (4.1)
Hemiplegia 505 (0.1) 709 (0.1)
Dementia 1380 (0.3) 1224 (0.2)
Chronic pulmonary disease 56,225 (12.8) 74,930 (14.1)
Mild diabetes mellitus (without end organ damage –
includes ketoacidosis and coma)
40,035 (9.1) 67,315 (12.7)
Mild liver disease 525 (0.1) 806 (0.2)
Peptic ulcer disease 610 (0.1) 872 (0.2)
Peripheral vascular disease 4048 (0.9) 4235 (0.8)
Stroke/cerebrovascular disease 1623 (0.4) 1926 (0.4)
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TABLE 2 Descriptive statistics (HES data set) (continued )
Category
Unilateral primary
hip replacements
Unilateral primary
knee replacements
Congestive heart failure 1643 (0.4) 1624 (0.3)
Myocardial infarction 481 (0.1) 375 (0.1)
Complication within 6 months, n (%)
Stroke 839 (0.2) 999 (0.2)
Respiratory infection 2977 (0.7) 3124 (0.6)
Acute myocardial infarction 941 (0.2) 1099 (0.2)
Pulmonary embolism/deep-vein thrombosis 1865 (0.4) 2193 (0.4)
Urinary tract infection 3258 (0.7) 3676 (0.7)
Wound disruption 786 (0.2) 1609 (0.3)
Surgical site infection 2028 (0.5) 3136 (0.6)
Fracture after implant 455 (0.1) 179 (0.0)
Complication of prosthesis 4590 (1.0) 4250 (0.8)
Neurovascular injury 70 (0.0) 128 (0.0)
Acute renal failure 2031 (0.5) 2537 (0.5)
Blood transfusion 526 (0.1) 414 (0.1)
Revision NJR+HES, n (%) 8622 (2.0) 13,626 (2.6)
Reoperations only, n (%) 1616 (0.4) 2722 (0.5)
LOS (days)
Mean (SD) 4.8 (3.8) 4.7 (3.6)
Range 0–378 0–737
Missing, n (%) 35 (0.0) 36 (0.0)
Readmission within 6 months, n (%) 87,675 (19.9) 120,034 (22.6)
AIDS, acquired immunodeficiency syndrome; IMD, Index of Multiple Deprivation; SD, standard deviation.
TABLE 3 Descriptive statistics (hospital organisational factors)
Category
Unilateral primary
hip replacements
Unilateral primary
knee replacements
FTE (n) 440,640 531,524
Specialty group
Trauma and orthopaedic surgery
Median (IQR) 41.1 (29.9–56.9) 40.9 (29.9–56.6)
Range 0.1–115.5 10.4–115.5
Missing, n (%) 167,434 (38.0) 202,251 (38.1)
Rehabilitation medicine
Median (IQR) 3.3 (1.5–6.7) 3.0 (1.0–6.6)
Range 0.2–21.0 0.2–21.0
Missing, n (%) 330,039 (74.9) 401,909 (75.6)
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TABLE 3 Descriptive statistics (hospital organisational factors) (continued )
Category
Unilateral primary
hip replacements
Unilateral primary
knee replacements
Grade
Consultant
Median (IQR) 34.5 (23.8–50.4) 34.9 (24.0–51.3)
Range 1.0–143.3 1.0–143.3
Missing, n (%) 167,916 (38.1) 202,682 (38.1)
Middle-grade doctor
Median (IQR) 20.8 (13.1–31.8) 21.1 (13.3–32.5)
Range 1.0–116.2 1.0–116.2
Missing, n (%) 173,421 (39.4) 208,469 (39.2)
Trainee doctor
Median (IQR) 9.0 (5.0–13.0) 9.0 (6.0–14.0)
Range 0.6–37.0 0.6–37.0
Missing, n (%) 200,001 (45.4) 237,983 (44.8)
Beds: specialty group
Trauma and orthopaedic surgery (overnight)
Median (IQR) 69.0 (50.5–91.9) 68.2 (50.4–92.2)
Range 0.0–167.2 0.0–167.2
Missing, n (%) 163,889 (37.2) 197,443 (37.1)
Rehabilitation (overnight)
Median (IQR) 0.0 (0.0–16.8) 0.0 (0.0–16.7)
Range 0.0–164.1 0.0–164.1
Missing, n (%) 163,889 (37.2) 197,443 (37.1)
Anaesthetics (overnight)
Median (IQR) 0.0 (0.0–16.8) 0.0 (0.0–16.7)
Range –0.1 to 40.1 –0.1 to 40.1
Missing, n (%) 163,889 (37.2) 197,443 (37.1)
Beds: total available
Overnight
Median (IQR) 764.2 (541.8–1024.9) 778.8 (557.6–1040.2)
Range 0.0–2195.8 0.0–2195.8
Missing, n (%) 147,090 (33.4) 177,083 (33.3)
Number of operating theatres
Median (IQR) 20 (14–29) 21 (14–30)
Range 2–63 2–63
Missing, n (%) 93,737 (21.3) 113,194 (21.3)
Number of dedicated day-case theatres
Median (IQR) 4 (2–6) 4 (2–6)
Range 0–17 0–17
Missing, n (%) 93,737 (21.3) 113,194 (21.3)
FTE, full-time equivalent; IQR, interquartile range.
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TABLE 4 Descriptive statistics (PROM data)
Category
Unilateral primary
hip replacements
Unilateral primary
knee replacements
Total (n) 440,640 531,524
OHS: follow-up at 6 months
Median (IQR) 42 (34–46)
Range 0–48
Missing, n (%) 214,080 (48.6)
OHS: preoperative
Median (IQR) 17 (11–23)
Range 0–48
Missing, n (%) 173,399 (39.4)
OKS: follow-up at 6 months
Median (IQR) 36 (28–42)
Range 0–48
Missing, n (%) 275,089 (51.8)
OKS: preoperative
Median (IQR) 18 (12–23)
Range 0–48
Missing, n (%) 227,822 (42.9)
EQ-5D: follow-up at 6 months
Median (IQR) 0.80 (0.69–1.00) 0.73 (0.62–0.88)
Range –0.59 to 1.00 –0.59 to 1.00
Missing, n (%) 214,787 (48.7) 274,554 (51.7)
EQ-5D: preoperative
Median (IQR) 0.26 (0.00–0.62) 0.52 (0.06–0.69)
Range –0.59 to 1.00 –0.59 to 1.00
Missing, n (%) 176,497 (40.1) 231,053 (43.5)
EQ-5D health scale change
Mean (SD) 8.9 (22.8) 3.4 (20.9)
Median (IQR) 6 (–5 to 20) 1 (–9 to 15)
Range –100 to 100 –100 to 100
Missing, n (%) 233,271 (52.9) 296,581 (55.8)
IQR, interquartile range; SD, standard deviation.
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Chapter 3 Patient forum
Introduction
Among the priorities identified through the work of the James Lind Alliance Priority Setting Partnership
for Hip/Knee Replacement was the need to involve patients to identify the outcomes that matter most
to them (patient-identified outcomes).33 We utilised the University of Bristol Musculoskeletal Research
Unit’s patient involvement group: the Patient Experience Partnership in Research (PEP-R).34 The PEP-R
comprises 12 patients with musculoskeletal conditions, most of whom have had joint replacement and
all of whom have experience of long-term pain.
Methodology
The session was organised and facilitated by Amanda Burston (patient and public involvement co-ordinator
based at the University of Bristol’s Musculoskeletal Research Unit). At the forum session, patients were
provided with a plain English description of the project and the outcome measures available in the data
sets, sent out in advance, along with information on patient and public involvement in research. In the
session, the patient and public involvement co-ordinator fostered discussion about the different outcome
variables and, using consensus techniques, captured patients’ views about the outcomes that matter most
to them.Views were linked to service users’ own individual experiences, which they were encouraged to
share with others.
At the end of the meeting, the group’s views were collated and drafted into a brief report that was sent
out to group members after the meeting. The meetings lasted around 2.5 hours, and included a comfort
break, refreshments and opportunity for discussion. Patients were reimbursed for their time and expenses.
Results
Prior to the meeting, the group was given a list of eight outcomes for consideration and discussion:
LOS, readmission, reoperation, revision surgery, complications, mortality, OHS and OKS on pain and
function, and EQ-5D quality-of-life scores. The meeting began by refreshing the group on what the
research project was about in relation to work package 1 (variation in patient outcomes of surgery)
and work package 2 (ERP). The group was then asked to evaluate which patient outcomes are most
important to them.
Top outcomes
Pain and function
It was suggested that when presenting geographic variation in outcomes of surgery, we should
consider stratifying according to preoperative pain and function. The group agreed that stability and
mobility are important.
Complications
Infection was the main issue. Everyone thought that infection was important. However, this was in the
context of hospital-acquired infection, such as meticillin-resistant Staphylococcus aureus (S. aureus) (MRSA),
rather than an infection in the hip or knee joint related to the operation itself. From earlier consultations
with surgeon co-applicants, it was found that surgeons worry about different complications to patients.
Surgeons are more worried about deep-vein thrombosis, rather than infection.
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Mid-outcomes
Length of stay
It was agreed that the right LOS was not one size fits all, as there is no point in being sent home early
if the support is not in place. The group agreed that LOS was an important outcome, but very dependent
on the level of support at home.
Revision/reoperation/readmission
The group felt that revision, reoperation and readmission should be evaluated as one outcome. It was
thought that if reoperation was 5 years later, rather than 10–20 years later, it would have a very
different sentiment for the patient.
Mortality
Rate of mortality was ranked low by the group but it was thought that patients’ families may rank the
outcome higher.
Other important outcomes and areas of discussion
l Choice of pain relief.
l Patient education on both pain relief and physiotherapy.
l Continuity of care.
l Length of time between discovery of problem and operation. This fed into the need to stratify
according to preoperative pain and function when looking at patient outcomes, as the time taken to
get to surgery can have an effect.
l Managing expectations. A group member explained that a friend who had recently had a knee
operation was disappointed with the results, as she expected to be able to go back to line dancing
club two or three times a week without pain or difficulty with her knee.
l The group agreed that patient satisfaction and overall outcomes are dependent on the patient’s
overall outlook and positivity. It was also thought that, if there is a long time between diagnosis and
surgery, then the patient becomes that much older, but the operation is not going to wind the
clock back.
The group felt that the maps describing geographical variation in outcome need to be clear to patients
about what hospitals include (e.g. some hospitals do not take more complex patients). Some group
members explained that they chose certain hospitals because of reputation and ‘word of mouth’. One
group member said that they found it difficult to find any information on outcomes when choosing a
hospital, but that they made a final choice of hospital on infection rate. It was explained to the group
that, for all outcomes, patient data will be adjusted for patient situation and comorbidities.
PATIENT FORUM
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Chapter 4 Identification of hospital
organisation and surgical factors as
determinants of geographical variation in
patient outcomes and NHS costs
Aims
Use the NJR, HES and PROMs linked data sets to identify patient, surgical and hospital organisational
factors that can explain geographical variation in patient outcomes.
Methodology
Data source and sample size
Hospital organisational factors from the HCHS Workforce Statistics, the Bed Availability and
Occupancy data set and the Supporting Facilities data set were linked to the NJR, HES and PROMs
data via the hospital provider code. Details of the NJR, HES and PROMs linked data have been
previously described in Chapter 2. For this analysis, we use the most recent 3 years of data, from 2014
to 2016.
Main outcome measures
The primary outcomes of interest are informed by the findings of the patient forum (as described in
Chapter 3). As a measure of patient-reported pain and function, we used the absolute change in OHSs
and OKSs.30,31 Each question is scored between 0 (meaning worse symptoms) and 4 (denoting least
symptoms). Scores from these 12 questions are added, getting a total score spanning from 0 (the worst
possible score) to 48 (the best possible score). We calculated the difference between the total scores
6 months after the operation and at baseline to obtain a measure of change associated with
the surgery.
Further outcomes included the proportion of complications at 6 months after surgery. For a list of the
International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10),35
codes used to identify complications of surgery, see Report Supplementary Material 1. We defined
complications as one or more from the following list: stroke (excluding transient ischaemic attack),
respiratory infection, acute myocardial infarction, pulmonary embolism/deep-vein thrombosis, urinary
tract infection, wound disruption, surgical site infection, fracture after implant, complication of
prosthesis, neurovascular injury, acute renal failure and blood transfusion. For a list of the OPCS-4
codes used to identify blood transfusion complication, see Report Supplementary Material 2. LOS was
calculated as the number of days between the hospital admission and discharge date. We estimated
the inpatient cost relating to the index episode using NHS Reference Costs from 2015–16.36 We
estimated the mean cost per bed-day based on the health-care resource use [Healthcare Resource
Group (HRG)] for each patient and their LOS. For methods to support the estimation of bed-day cost,
see Report Supplementary Material 3.
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Predictor variables
Patient-level characteristics (case mix)
Age, sex, body mass index (BMI), area deprivation, rurality, ethnicity, Charlson Comorbidity Index,
American Society of Anesthesiologists (ASA) grade, baseline OHS/OKS, baseline EQ-5D, calendar year
of primary THR/TKR, primary indication.
Surgical factors
Whether or not a minimally invasive technique was used, annual surgeon volume/caseload, grade of
operating surgeon, surgical approach, patient position, implant fixation, type of mechanical or chemical
thromboprophylaxis, anaesthetic type, type of bone graft if used.
Hospital organisational factors
Unit type (public, private, independent-sector treatment centre). As a measure of centralisation of
services, we calculated the annual volume of procedures performed in each hospital trust. From the
quarterly hospital surveys, we have information on hospital staffing according to the full-time
equivalent (FTE) of specialty groups (trauma and orthopaedic surgery, rehabilitation medicine) and staff
grades (consultants, middle-grade doctors, trainee doctors). Data on bed availability within specialty
groups (trauma and orthopaedics, rehabilitation). We further obtained data on numbers of available
operating theatres, including the number of dedicated day-case theatres.
Exclusion criteria
We included only patients receiving planned surgery (Figure 3) between 2014 and 2016. We excluded
patients without information for the 2001 census lower-layer super output area. Patients with missing
data for LOS were also excluded. We excluded patients without information on baseline and/or
6-month follow-up OHS/OKS scores for the analysis of change in OHS and OKS.
Patients with primary hip replacement
(n = 746,749)
Not matched with lower-layer super
output area
[n = 306,418 (41.0%)]
Surgery before 2014 or after 2016
[n = 267,532 (35.8%)]
Patients with primary hip replacement used
in the analysis of LOS, bed-day costs,
complications and revisions
(n = 173,107)
Missing data for LOS 
[n = 1 (< 0.1%)]
Missing data for OHS change
[n = 89,606 (51.8%)]
Patients in the analysis of OHS change
(n = 83,501)
Patients with primary total knee replacement
or primary UKR
(n = 841,296)
Not matched with lower-layer super
output area
[n = 315,239 (37.5%)]
Surgery before 2014 or after 2016
[n = 315,332 (37.5%)]
Patients with primary total knee replacement or
primary UKR used in the analysis of LOS,
bed-day costs, complications and revisions
(n = 210,725)
Missing data for OKS change
[n = 115,113 (54.6%)] 
Patients in the analysis of OKS change
(n = 95,612)
FIGURE 3 Flow diagram showing selection of patients for inclusion in this study (navy shows inclusion and light blue
shows exclusion). Reproduced from Garriga et al.37 © 2019 Garriga C et al. This is an Open Access article distributed
in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to
distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited.
See: http://creativecommons.org/licenses/by/4.0/.
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Sample size
To account for clustering within the data (patients nested within CCGs), we need to inflate the
required sample size by the design effect [1 + (n – 1)p], where p is the intracluster correlation and
n the mean cluster size. From our previous work, the intracluster correlation was 0.0135 for hip and
0.014 for knee replacement.38 There are 207 CCGs in England and the CCG is the cluster. If we expect
to have 100 patients from each CCG group, the design effect is (1 + 99 × 0.014) = 2.4.
For OHS and OKS outcomes, the minimally important difference between groups39,40 has been
estimated to be 5, with a standard deviation (SD) of 10. Using a two-sided, two-sample t-test, with
90% power, at a 5% level of significance, to detect a difference in mean OHS and OKS of 5 requires a
sample size of 85 in each exposure group. Assuming a 50% response rate to the 6-month follow-up
OHS and OKS questionnaires inflates the sample size to 170 per exposure group. The required sample
size per exposure group adjusted for clustering is 2.4 × 170 = 408. Several exposure variables will be
considered in the model. Including up to 50 degrees of freedom would require a sample size of around
20,000 patients, assuming equal-sized exposure groups. Hence, this is more than adequately powered.
We note that this does not account for multiple testing.
For the other binary outcomes, for complications of both THR and TKR, within 6 months of operation,
rates of stroke and myocardial infarction were < 0.5%, and of anaemia, urinary tract infection, wound
infection and pulmonary embolism/deep-vein thrombosis were < 3%.41 The NJR annual report shows
90-day mortality of 0.5% and 1-year mortality of 1.5%. Rates of revision are around 5% at 10 years and
rates of revision/reoperation are higher, at up to 20%.42 For the rarest outcomes, to detect a difference
in proportions of 0.5% compared with 1%, using a two-sided, two-sample chi-squared test, with 90%
power at a 5% level of significance, requires 6650 patients per exposure group. As HES encompasses
elective admissions to all English hospitals, we expect no loss to follow-up, as this information would be
captured. For the design effect of 2.4 (for which we assume the same intracluster correlation as above),
the sample size increases to 15,960 per degree of freedom. Hence, even for these rarest outcomes,
with an actual sample size of > 350,000, we can still include over 20 degrees of freedom in the model.
Geographical variables
Within our HES data set, the smallest level of geography available to us is the lower-layer super output
area (LLSOA) that a patient lives in. LLSOAs have a population between 1000 and 3000, and between
400 and 1200 households. There are 32,482 LLSOAs in England as of 2001. For the multilevel analysis,
we use this as an intermediate level between the patient level and the CCG level. From the ONS Open
Geography Portal, we obtained a polygon shapefile for the 2017 CCG areas in England. Maps were
produced using these boundaries.
We start by looking at the structure of the geographical data (CCG areas) for a hospital that a patient is
treated in. To do this, we use the ArcGIS 10.5 software (ESRI, Redlands, CA, USA) to do a point-in-polygon
overlay, providing a spatial join of the hospital points with the CCG areas. This shows us that there are
CCG areas that do not have any hospitals within them. For knee replacement, there are 173 CCGs that
have a hospital contained within their boundary (175 CCGs for hips). Hence, out of the 207 CCG areas,
there are 34 that do not have a hospital in their boundary for hips and 32 for knees. For this analysis,
we want a ‘nested data set’; currently, if our data structure is to have patients within hospitals within
CCGs, it does not work as there are CCG areas with no hospitals, which, therefore, would appear blank
on a CCG map of England when displaying outcomes of surgery.
To have a nested data structure, we instead will base this on the CCG area for a LLSOA that a patient
lives in. By doing a spatial join of the LLSOA points with the 2017 CCG polygon file, this provides us
with a nested data set of patients (level 1) within LLSOA (level 2) within CCG (level 3) (Table 5).
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However, with this structure to the data, we now need to allocate a hospital organisational
characteristic according to the LLSOA areas. This is done by using a spatial join based on the distance
between two points (hospital and LLSOA). For each LLSOA, we can then identify the nearest hospital
and attribute the hospital’s characteristics to that LLSOA area.
Statistical analysis
The hierarchical structure of the data consists of patients (level 1), nested within LLSOA (level 2),
within CCGs (level 3). Multilevel regression models are used to describe the association of patient,
hospital organisation and surgical factors and patient outcomes of surgery. This controls for evidence
of clustering in the data, by allowing outcomes to vary across LLSOAs and CCGs. Failure to control
for evidence of clustering can lead to estimates of standard errors that are spuriously precise and a
potential source of bias. Analyses are conducted separately for THR and TKR.
The general form of the multilevel model is given as:
Yijk = β0CONS + βX
T
ijk + Uj + Vk + eijk, (1)
where Yijk is the outcome variable in patient i, in LLSOA j, in CCG k. CONS is the constant term,
the vector of explanatory variables, Uj is the LLSOA residual error term distributed N(0, σ2j ), Vk is the
CCG residual error term distributed N(0, σ2k ), and eijk is the individual-level residual error distributed
N(0, σ2e ).
It is assumed that the set of random effects explains the clustering in the data, such that different
observations in the same cluster are independent. We examine continuous outcomes (e.g. LOS,
OHS, OKS) using linear regression, and binary outcomes (complications at 6 months) using logistic
regression. Normal distributional assumptions are assumed for both linear and logistic multilevel
regression models. We use normal probability plots that plot the ranked residuals against corresponding
points on a normal distribution curve, to assess our assumption that level 2 and 3 residuals are normally
distributed.
In order to generate the predicted outcomes across the 207 CCGs, we first estimate the linear
predictor, which is the sum of the betas for each patient i in the data set. The overall predicted
outcome in each CCG is then just the mean of the linear predictor for each CCG:
Linear.predi = β0CONSi + β1ASA2i + β2ASA3i + β3ASA4i + β4Charlson1i + +β5Charlson2i
+ β6Sexi + β7Agei.
(2)
TABLE 5 Nested structure of the data set (2014–16) for multilevel modelling
Classification number Classification
Number of units
TKR/UKR THR
3 NHS CCGs 207 207
2 2001 Census LLSOA code for England 31,715 30,850
1 Patients 210,725 173,107
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To incorporate evidence of clustering, the multilevel regression model has an estimate of the residual
CCG variation. This is additional CCG-level variation in outcomes that is not explained by the variables
in the regression model. So, for each of the 207 CCGs, k, we add the mean of the linear predictor to
the CCG-level residual:
pred:CCGk =mean:linear:pred:CCGk + vk . (3)
We fit the following models: (1) null model of the actual observed outcomes; (2) model that adjusts for
patient case-mix variables; (3) model further adjusting for surgical variable; and (4) model adjusting for
hospital organisational variables. Analyses were conducted using Stata version 15.1 statistical software
(StataCorp LP, College Station, TX, USA). Multilevel analyses were imported to Stata from MLwiN
version 3.00 (MLwiN Centre for Multilevel Modelling, Bristol, UK), using the Stata command runmlwin.
Results
Between 2014 and 2016, there were 173,107 primary THRs and 210,275 TKRs (see Figure 3). Almost
60% of patients were women and the average age was ≈69 years. The mean BMI at primary surgery
was in the obese range (≈30 kg/m2). The ASA grade of 83% of patients was ‘mild’ or ‘fit’. Additional
patient, surgical and hospital organisation factors are summarised for hip replacement and TKRs/UKRs
in Appendix 1, Table 25.
Predictive variables
Length of stay
Patients aged ≥ 80 years, in ASA grades 3 and 4, and with two or more comorbidities had longer LOS
(see Appendix 1, Tables 26 and 27). Shorter LOS was seen in private hospitals or private treatment
centres and with better quality-of-life scores (EQ-5D). Hospitals with ≥ 100 beds available overnight
for trauma and orthopaedics had longer LOS for THR than hospitals with < 35 beds. Knee implants
other than bicondylar (unicondylar, hinged, linked, custom or preassembled) were associated with
shorter LOS for patients undergoing knee surgery.
Oxford Hip Score and Oxford Knee Score change
Greater absolute change in OHS and OKS was associated with better preoperative EQ-5D score
(see Appendix 1, Tables 28 and 29). Greater change in OHS was associated with bigger femoral head
size (≥ 44 mm) and less deprived areas. Patients aged ≥ 60 years had greater change in OKS. Smaller
improvements were associated with worse condition for operation (ASA grades 3 and 4), and patients
with comorbidities for both OHS and OKS outcomes.
Complications at 6 months
Older patients (aged 80–84 or ≥ 85 years) with comorbidities and worse ASA grades had higher
probabilities of developing a complication in the following 6 months (see Appendix 1, Tables 30 and 31).
Thromboprophylaxis based on aspirin and < 200 hip replacements per year in the hospital were also
related to complications at 6 months. Fewer complications were associated with minimally invasive hip
replacement surgery. For TKR, private treatment centres and unicondylar, hinged, linked, custom or
preassembled implants had a lower percentage of complications at 6 months.
Variation in outcomes
Length of stay
The observed mean LOS by CCG ranged between 2.5 and 6.2 days for THRs, and between 2.7 and
6.6 days for TKRs. Variability across CCGs was high, with 54 out of 207 CCGs having significantly
shorter mean LOS and 58 CCGs having longer mean LOS for THR (Figure 4). Variability between CCGs
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was even more marked for patients undergoing TKR, with 72 CCGs with significantly shorter mean LOS
and 62 CCGs with longer mean LOS (Figure 5). Table 6 shows the five CCGs with the lowest estimates
of mean LOS (≈3 days) and the five CCGs with the highest mean estimates (≈6–7 days) for THR
and TKR patients, respectively. Maps of England with CCG boundaries show that the London region
had longer mean LOS, whereas North England and the East Coast have shorter mean LOS for both
THR and TKR (Figures 6 and 7). The mean bed-day costs ranged between £4727 (SD £1026) in the
NHS Scarborough and Ryedale CCG (within Yorkshire and the Humber region) and £8800 (SD £1572)
in the NHS Hillingdon CCG (within London region) for THR. The mean bed-day costs for TKR oscillated
between £4758 (SD £1096) in the NHS Scarborough and Ryedale CCG and £8692 (SD £1507) in the
NHS Central London CCG.
Oxford Hip Score and Oxford Knee Score change
Observed mean OHS change by CCG ranged between 17.5 and 24.9 points, and mean OKS change ranged
between 11.2 and 19.1 points. The estimated percentage of variation in OHS and OKS scores lying between
CCGs was 1.0% and 1.3%, respectively. In turn, 4.0% and 5.7% of the variation in OHS and OKS scores,
respectively, was attributed to differences at the level of LLSOAs. Caterpillar plots exploring the variability
for OHS change (see Figure 4) and OKS change (see Figure 5) show little variability between CCGs.
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FIGURE 4 Caterpillar plots showing variation in outcomes across CCGs (THR). (a) LOS (54/207 CCGs have significantly
shorter LOS than average, whereas 54 CCGs have longer LOS); (b) bed-day costs (56/207 CCGs have significantly lower
costs than average, whereas 53 have higher costs); (c) OHS change at 6 months (13/207 CCGs have significantly less
change at 6 months, whereas 11 have more change); and (d) complications at 6 months (4/207 CCGs have significantly
higher percentages of complications at 6 months than average).
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However, they presented wide confidence intervals (CIs), representing high variability within each CCG.
The mean OHS improvement ranged between 24.6 points (SD 5.3 points) in the Mid Essex CCG (within
East England) and 18.7 points (SD 6.2 points) in NHS Brent CCG (within London region). The mean OKS
improvement oscillated between 18.8 points (SD 4.2 points) in NHS Ipswich and East Suffolk CCG (within
East England) and 13.1 points (SD 4.3 points) in NHS City and Hackney CCG (within London region).
Complications at 6 months
Observed complications at 6 months by CCG ranged between 2.0% and 8.6% for THR, and between
1.5% to 8.4% for TKR. Complications at 6 months showed low variability between CCGs for patients
undergoing THR (see Figure 4) and TKR (see Figure 5). Complications at 6 months ranged between
3% and 5–6% for patients with THR and patients with TKR. CCG maps show that the London region
was associated with a higher percentage of complications.
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FIGURE 5 Caterpillar plots showing variation in outcomes across CCGs (TKR). (a) LOS (72/207 CCGs have significantly
shorter LOS than average, whereas 62 have longer LOS); (b) bed-day costs (65/207 CCGs have significantly lower costs
than average, whereas 56 have higher costs); (c) OKS change at 6 months (25/207 CCGs have significantly less change
at 6 months, whereas 26 have more change); and (d) complications at 6 months (7/207 CCGs have significantly lower
percentages of complications at 6 months than average, whereas eight have higher percentages).
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TABLE 6 Descriptive statistics of variables included in the hip and knee models (data from 2014 to 2016)
THRs TKRs/UKRs
Five lowest Five highest Five lowest Five highest
CCG Predicted (SD) CCG Predicted (SD) CCG Predicted (SD) CCG Predicted (SD)
Mean LOS (days)
Scarborough and Ryedale 2.7 (1.0) Hillingdon 6.1 (1.8) Scarborough
and Ryedale
2.9 (1.0) West London 6.6 (1.7)
Hastings and Rother 2.9 (1.0) Harrow 6.1 (2.1) Northumberland 3.2 (0.7) Hammersmith
and Fulham
6.6 (1.8)
Hambleton, Richmondshire and Whitby 3.1 (0.8) Camden 6.1 (1.9) Bassetlaw 3.3 (1.4) Camden 6.5 (1.8)
Northumberland 3.1 (0.9) Barnet 5.8 (2.0) Hastings and
Rother
3.4 (1.0) Central London
(Westminster)
6.1 (1.6)
High Weald Lewes Havens 3.3 (1.4) Central London
(Westminster)
5.7 (2.0) Salford 3.4 (1.0) Barnet 6.1 (1.6)
Mean bed-day cost (£)
Scarborough and Ryedale 4727 (1026) Hillingdon 8800 (1572) Scarborough
and Ryedale
4758 (1096) Central London
(Westminster)
8692 (1507)
Hastings and Rother 4880 (1051) Harrow 8647 (1881) Northumberland 4930 (720) City and
Hackney
8686 (1247)
Northumberland 4998 (867) Camden 8250 (1561) Bassetlaw 4960 (1329) Lewisham 8676 (1585)
Hambleton, Richmondshire and Whitby 5187 (908) Barnet 8132 (1788) Hastings and
Rother
5294 (1050) West London 8639 (1438)
High Weald Lewes Havens 5219 (1305) Waltham Forest 8060 (1710) Salford 5344 (1008) Camden 8600 (1493)
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THRs TKRs/UKRs
Five lowest Five highest Five lowest Five highest
CCG Predicted (SD) CCG Predicted (SD) CCG Predicted (SD) CCG Predicted (SD)
Mean OHS change (points) Mean OKS change (points)
Mid Essex 24.6 (5.3) Brent 18.7 (6.2) Ipswich and East
Suffolk
18.8 (4.2) City and
Hackney
13.1 (4.3)
Ipswich and East Suffolk 24.1 (4.9) Islington 19.1 (6.4) Eastern
Cheshire
18.5 (4.2) Newham 13.4 (4.3)
Stoke on Trent 24.1 (5.0) Harrow 19.2 (6.6) Castle Point and
Rochford
18.5 (4.0) Islington 13.6 (5.4)
Scarborough and Ryedale 23.7 (5.4) Kingston 19.4 (6.6) Warrington 18.5 (4.2) Brighton and
Hove
13.7 (4.5)
Nene 23.6 (5.3) Croydon 19.4 (5.9) Nene 18.5 (4.2) Barnet 13.8 (4.7)
Mean complications at 6 months (%)
High Weald Lewes Havens 3.0 (2.4) Tower Hamlets 5.4 (4.1) Hull 2.9 (1.4) Herts Valleys 5.8 (2.7)
Leeds West 3.1 (1.9) Newham 5.3 (3.2) Dartford,
Gravesham and
Swanley
2.9 (1.4) South Devon
and Torbay
5.7 (3.1)
Solihull 3.2 (2.0) Camden 5.2 (3.4) Calderdale 2.9 (1.5) Tower Hamlets 5.5 (2.4)
Herefordshire 3.2 (2.0) Enfield 5.1 (3.0) Hambleton,
Richmondshire
and Whitby
3.1 (1.4) Camden 5.4 (2.8)
West Leicestershire 3.2 (2.1) Hillingdon 5.0 (3.3) Erewash 3.1 (1.6) Newham 5.4 (2.7)
Reproduced from Garriga et al.37 © 2019 Garriga C et al. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0)
license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/.
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FIGURE 6 Map of patient outcomes across 2017 CCGs (THR). (a) LOS (days); (b) bed-day costs (£); (c) complications at
6 months (%); and (d) OHS change at 6 months (points). Ultrageneralised clipped boundaries in England V4. Reproduced
with permission.43 Source: Office for National Statistics licensed under the Open Government Licence v.3.0. Contains OS
data © Crown copyright and database right 2019.
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FIGURE 7 Map of patient outcomes across 2017 CCGs (TKR). (a) LOS (days); (b) bed-day costs (£); (c) complications at
6 months (%); and (d) OHS change at 6 months (points). Ultrageneralised clipped boundaries in England V4. Reproduced
with permission.43 Source: Office for National Statistics licensed under the Open Government Licence v.3.0. Contains OS
data © Crown copyright and database right 2019. (continued )
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Discussion
Main findings
There is substantial variation in patient outcomes of THR and TKR across CCG areas. This variation
remained after adjusting for patient case mix and surgical factors. Hospital organisational factors had
little to no influence on explaining this variation.
Strengths/limitations
Strengths of the study include use of the NJR data set, which, to the best of our knowledge, is the
largest arthroplasty data set in the world, allowing us to generalise the results to the UK. The NJR
has near complete coverage of all operations, particularly in the most recent years of data. Linkage to
HES allowed us to examine a wide range of confounding factors and enabled us to link in hospital
organisational factors; however, the limitation of this is that analysis was restricted to England only
and private operations are not included in the HES data set. The large sample size has allowed us to
explore geographical variation in rare complications. The main limitation of the study is missing data,
which was particularly prevalent for the hospital organisation factors. To overcome this, we used
multiple imputation methods, but only single imputation was possible given the complexity of the
multilevel regression models fitted.
What is already known
A large number of studies within the literature have identified factors predictive of patient outcomes
of THR and TKR. In respect of patient case-mix variables, it has been shown that baseline levels of pain
and functional disease severity,44–51 age,46,49,52,53 sex,46,48,54 obesity,48,52,55 comorbidities46,48,51 and social
deprivation50 are all related to patient-reported outcomes of pain and function. Less is known about
predictors of complications of surgery, although we have previously shown that such complications are
rare, with obesity associated with small but clinically insignificant effects.41 Predictors of LOS are less
commonly studied, with literature mostly relating to enhanced recovery interventions, although our
work in Chapter 5 shows that age and comorbidity are associated with longer LOS. Much of this work
on predictors of outcomes of THR and TKR is formally synthesised within large systematic reviews56
and in the published National Institute for Health Research (NIHR) Programme Grants for Applied Research
report [Clinical Outcomes in Arthroplasty study (COASt)57].
(c)
(2.8, 5)
(5, 4)
(4, 5.8)
(d)
(13, 14)
(14, 16)
(16, 17)
(17, 18)
(18, 19)
FIGURE 7 Map of patient outcomes across 2017 CCGs (TKR). (a) LOS (days); (b) bed-day costs (£); (c) complications at
6 months (%); and (d) OHS change at 6 months (points). Ultrageneralised clipped boundaries in England V4. Reproduced
with permission.43 Source: Office for National Statistics licensed under the Open Government Licence v.3.0. Contains OS
data © Crown copyright and database right 2019.
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We have previously demonstrated evidence of geographical variation and inequity in access to THR
and TKR for patients operated on in 2002 (between 12 and 14 years before the patients in our study
were operated on).10 However, in those patients who navigate through the care pathway and obtain
access to joint replacement surgery, there has been little research exploring geographical variations
in outcomes of surgery. A previous NIHR Health Services and Delivery Research study by Street et al.13
used HES data to explore variation in PROMs for THR and TKR across hospitals in England. Using
multilevel regression modelling, they looked at whether or not patient factors (age, sex, comorbidity,
deprivation) and hospital factors (volume, teaching hospital) predicted (1) health outcomes (EQ-5D,
OHS, OKS) or (2) resource use (LOS, hospital costs). The key findings were significant unexplained
variation among hospitals in both health outcomes and resource use. This is consistent with the findings
of our study; however, our research takes this forward by looking at variation in other relevant outcomes
(complications, LOS) and looking at a broader range of patient, surgical and hospital organisational factors
as predictors of geographical variation in outcomes. Our findings suggest that such factors do not
explain this variation. Hence, there are probably other unmeasured historical organisational factors and
processes specific to individual local hospitals that may explain why such variation exists. Specifically,
we have shown that it cannot be explained by ‘our population is different’, as we have well accounted
for patient case-mix factors.
Conclusions
We have identified potentially unwarranted variations in patient outcomes of THR and TKR. This
variation cannot be explained by differences in patient case mix, surgical factors or hospital
organisational factors. This information is informative to patients in deciding where to have their
surgery and to commissioners in monitoring variations in outcomes of surgery.
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Chapter 5 Natural experiment to determine
the clinical effectiveness and cost-effectiveness
of the enhanced recovery treatment pathway
Aims
To assess whether or not implementation of the UK Department of Health and Social Care national
enhanced recovery after surgery (ERAS) programme in THR and TKR has had an impact on trends in
LOS, bed-day costs, PROMs, complications and revision surgery.
Methodology
Data sources
The NJR, HES and PROMs linked data sets (see Chapter 2).
Outcomes
Length of stay, cost per bed-day, absolute change in OHS and OKS, and complications at 6 months
after surgery (see Chapter 4 for details). The rate of revision up to 5 years after primary THR and TKR
was also evaluated. This included revisions declared to the NJR by the surgeons and revisions reported
to HES. We specified our analysis time in years, reporting the rate as number of revisions per 1000
implant-years. For a list of the OPCS-4 codes used to identify hip revision, see Report Supplementary
Material 4; for knee revision, see Report Supplementary Material 5.
Intervention
The primary exposure (‘intervention’) is the period when the new ERP was introduced (between April 2009
and March 2011).
There is likely to be variation in the dates when individual hospitals introduced ERAS and variation in
the type of ERAS service a hospital has adopted. Hence, in addition to looking at the national picture,
we have looked at individual trusts in a region of England. In this region, adoption of enhanced recovery
in orthopaedics was monitored by the Musculoskeletal Clinical Leaders Network when the pathway was
being introduced to hospitals in 2009 and 2010. For this reason, information is available on the dates
when individual hospitals in the region introduced their programmes. As outcomes of revision surgery
and complications are rare, we focus just on outcomes of LOS and PROMs for the analysis of
individual hospitals.
Potential modifiers
We evaluated whether or not trends in LOS and OHS and OKS over time differed by age (18–59,
60–69, 70–79, 80–84, ≥ 85 years) and evaluated the presence of comorbidities (yes/no). For a list of
the ICD-1035 codes used to identify comorbidities, see Report Supplementary Material 6.
Statistical analysis
We used a natural experimental study design.58 We evaluated the ERAS impact on trends before,
during and after the implementation of the intervention.59,60 The timing of implementation of ERP varied
by trust and was assumed to span the 2 years of the implementation period (April 2009–March 2011).
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To do so, we described the trends by calculating monthly outcomes, being means (LOS, bed costs,
OHS, OKS), proportions (complications) and rates (revision), together with their 95% CIs. We estimated
a fractional polynomial over the study period and plotted the resulting curve along with the CI.
In interrupted times series studies, sample size calculations are related to the estimation of the number
of observations or time points at which data will be collected.61 According to the quality criteria of
Ramsey et al.,62 at least 10 pre and 10 post data points would be needed to reach at least 80% power
to detect a change (if the autocorrelation is > 0.4). Our outcomes will be estimated at monthly
intervals and, as autocorrelation is unknown, we will allow at least 2 years either side of the date of
interest (24 pre and 24 post data points).
We used an interrupted time series approach to estimate changes in outcomes during and immediately
following the intervention period, while controlling for baseline levels and trends. We modelled
aggregated data points of each outcome of interest by month using segmented linear regression:59
Yt = β0 + (β1× time t) + (β2× ERAS0) + (β3× time after ERAS0) + (β4× ERASend)
+ (β5× time after ERASend) + et.
(4)
The equation used on trusts in the South Central region excluded the intervention period because this
was assumed to be a date point:
Yt = β0 + (β1× time t) + (β4× ERASend) + (β5× time after ERASend) + et. (5)
Here, Yt is the mean LOS, mean OHS/OKS change, mean proportion of 6-month complications and
mean 5-year revision rate (taking place in month t). ‘Time’ is a continuous variable representing number
of months from the start of observation period (i.e. April 2008) at time t. β0 estimates the baseline
level of the outcome at the beginning of the time series (i.e. April 2008). β1 estimates the trend before
ERAS implementation. β2 is the change in level immediately following the intervention. β3 estimates the
change in the trend in the monthly mean after ERAS started (i.e. ERAS implementation trend). β4 is
the change in level immediately following the end of the intervention. β5 estimates the change in the
trend in the mean monthly number or rate (depending of outcome) after ERAS ended (i.e. ERAS
post-implementation trend). We checked the autocorrelation with the previous month, 2 months, etc.,
until the previous 12 months, using Durbin’s alternative test.63 Autocorrelation would invalidate the
interpretation of the model. For this reason, we estimated the linear regression models with Newey–West
standard errors.64 Parsimonious models were generated using the variables selected through backward
regression.
Separate models are fitted for THR and TKR. All analyses were conducted using Stata.
National results
Length of stay
For THR, the mean LOS decreased from 5.6 days in April 2008 to 3.6 days in December 2016 (Figure 8),
For TKR, the mean LOS decreased from 5.7 days in April 2008 to 3.6 days in December 2016 (Figure 9).
Prior to ERAS, LOS was already decreasing significantly (Table 7). The rate of reduction in mean
LOS was higher during the implementation period (April 2009–March 2011), and slowed afterwards
(April 2011–December 2016).
Although older patients had a longer LOS, the secular trends in decreasing LOS were observed across
all age groups (e.g. for THR, 4.7 days to 3.0 days in those aged 18–59 years; and 8.1 days to 5.3 days
in those aged ≥ 85) (Figures 10 and 11). Secular trends also decreased in patients with and without
pre-existing comorbidity (Figures 12 and 13).
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FIGURE 8 Trends in outcomes following primary hip replacement in England, 2008–16, by month. (a) LOS (days); (b) OHS
6 months –OHS baseline; (c) primary hip replacements with a complication in the following 6 months; and (d) primary hip
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Oxford Hip Score and Oxford Knee Score change
Over the study period, there was an improvement in PROMs, with an increment in OHS 6 months after
surgery of 17.7 points in April 2008 to 22.9 points in December 2016 for THR (see Figure 8). For TKR,
there was an increment in OHS 6 months after surgery of 15.0 points in April 2008 to 17.1 points in
December 2016 (see Figure 9). This secular trend was seen in patients with and without comorbidities,
and in all age groups except in those aged ≥ 85 years, for whom the change in OHS and OKS was
stable over the time period (Figures 14–17).
TABLE 7 Temporal trends in patients undergoing planned primary hip replacement from April 2008 to December 2016
Parameter Coefficient 95% CI p-value
LOS
Intercept 5.674 5.655 to 5.693 < 0.001
Monthly trend –0.020 –0.023 to –0.017 < 0.001
Level change ERAS0 0.176 0.120 to 0.232 < 0.001
Trend change after ERAS0 –0.013 –0.017 to –0.009 < 0.001
Level change ERASend –0.102 –0.203 to –0.001 0.049
Trend change after ERASend 0.019 0.015 to 0.022 < 0.001
OHS 6 months –OHS baseline
Intercept 17.063 16.896 to 17.230 < 0.001
Monthly trend 0.158 0.130 to 0.186 < 0.001
Level change ERAS0 0.772 0.538 to 1.006 < 0.001
Trend change after ERAS0 –0.131 –0.161 to –0.101 < 0.001
Level change ERASend 0.564 0.208 to 0.920 0.002
Trend change after ERASend –0.013 –0.025 to –0.001 0.039
Complication by 6 months
Intercept 4.044 3.465 to 4.624 < 0.001
Monthly trend –0.078 –0.096 to –0.061 < 0.001
Level change ERAS0 – – –
Trend change after ERAS0 – – –
Level change ERASend – – –
Trend change after ERASend 0.078 0.056 to 0.100 < 0.001
Revision rates by 5 years
Intercept 5.940 5.820 to 6.060 < 0.001
Monthly trend – – –
Level change ERAS0 – – –
Trend change after ERAS0 –0.098 –0.105 to –0.090 < 0.001
Level change ERASend – – –
Trend change after ERASend 0.103 0.068 to 0.139 < 0.001
–, p ≥ 0.05; ERAS0, start point of ERAS intervention in April 2009; ERASend, end point of ERAS intervention in March 2011.
Note
Parsimonious models with Newey–West standard errors.
Reproduced from Garriga et al.65 © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published
by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported
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FIGURE 10 Trends of LOS at hospital following primary hip replacement according to age categories in England,
2008–16, by month. (a) All ages; (b) 18–59 years; (c) 60–69 years; (d) 70–79 years; (e) 80–84 years; and (f) ≥ 85 years.
ERP implemented in England from April 2009 to March 2011. Reproduced from Garriga et al.65 © Author(s) (or their
employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in
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redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a
link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Minor changes have been made to the formatting. (continued )
ENHANCED RECOVERY TREATMENT PATHWAY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
40
9(c)
8
6
7
5
4
3M
ea
n
 L
O
S 
(d
ay
s)
2
1
0
Ap
ril
 20
08
De
ce
m
be
r 2
00
8
De
ce
m
be
r 2
00
9
De
ce
m
be
r 2
01
0
De
ce
m
be
r 2
01
1
De
ce
m
be
r 2
01
2
Month and year of primary hip replacement 
De
ce
m
be
r 2
01
3
De
ce
m
be
r 2
01
4
De
ce
m
be
r 2
01
5
De
ce
m
be
r 2
01
6
ER
AS
 st
ar
t
ER
AS
 en
d
9
(d)
8
6
7
5
4
3M
ea
n
 L
O
S 
(d
ay
s)
2
1
0
Ap
ril
 20
08
De
ce
m
be
r 2
00
8
De
ce
m
be
r 2
00
9
De
ce
m
be
r 2
01
0
De
ce
m
be
r 2
01
1
De
ce
m
be
r 2
01
2
Month and year of primary hip replacement 
De
ce
m
be
r 2
01
3
De
ce
m
be
r 2
01
4
De
ce
m
be
r 2
01
5
De
ce
m
be
r 2
01
6
ER
AS
 st
ar
t
ER
AS
 en
d
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2008–16, by month. (a) All ages; (b) 18–59 years; (c) 60–69 years; (d) 70–79 years; (e) 80–84 years; and (f) ≥ 85 years.
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2008–16, by month. (a) All ages; (b) 18–59 years; (c) 60–69 years; (d) 70–79 years; (e) 80–84 years; and (f) ≥ 85 years.
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FIGURE 11 Trends of LOS at hospital after primary TKR/UKR according to age categories in England, 2008–16.
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FIGURE 11 Trends of LOS at hospital after primary TKR/UKR according to age categories in England, 2008–16.
(a) All ages; (b) 18–59 years; (c) 60–69 years; (d) 70–79 years; (e) 80–84 years; and (f) ≥ 85 years. ERAS programme
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FIGURE 12 Trends of LOS at hospital following primary hip replacement by patients with/without comorbidities in
England, 2008–16, by month. (a) Without comorbidities; and (b) one or more comorbidities. ERP implemented in England
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FIGURE 13 Trends of LOS at hospital after primary TKR/UKR by patients with/without comorbidities in England, 2008–16.
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FIGURE 14 Trends of OHS change following primary hip replacement according to age categories in England, 2008–16,
by month. (a) All ages; (b) 18–59 years; (c) 60–69 years; (d) 70–79 years; (e) 80–84 years; and (f) ≥ 85 years. Reproduced
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FIGURE 14 Trends of OHS change following primary hip replacement according to age categories in England, 2008–16,
by month. (a) All ages; (b) 18–59 years; (c) 60–69 years; (d) 70–79 years; (e) 80–84 years; and (f) ≥ 85 years. Reproduced
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FIGURE 15 Trends of OKS change (OKS 6 months –OKS baseline) after primary TKR/UKR according to age categories in
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FIGURE 15 Trends of OKS change (OKS 6 months –OKS baseline) after primary TKR/UKR according to age categories in
England, 2008–16. (a) All ages; (b) 18–59 years; (c) 60–69 years; (d) 70–79 years; (e) 80–84 years; and (f) ≥ 85 years.
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FIGURE 16 Trends of OHS change following primary hip replacement by patients with/without comorbidities in England,
2008–16, by month. (a) Without comorbidities; and (b) one or more comorbidities. Reproduced from Garriga et al.65
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FIGURE 17 Trends of OKS change (OKS 6 months –OKS baseline) after primary TKR/UKR by patients with/without
comorbidities in England, 2008–16. (a) Without comorbidities; and (b) one or more comorbidities. Reproduced from
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The interrupted time series model shows that, prior to ERAS, OHS change significantly increased, by
0.158%, every month (see Table 7). During the ERAS implementation (April 2009–March 2011), the
secular trend slowed down and continued to increase by just 0.027%. The subsequent period after the
ERAS implementation (April 2011–December 2016) remained stable. For the OKS model, there is no
impact of the intervention in the secular trend of OKS change (Table 8), although post-intervention
trends improved in the 60–69 years and the 70–79 years age groups, by 0.025% and 0.024%,
respectively.
TABLE 8 Temporal trends in patients undergoing planned primary knee replacement from April 2008 to December 2016
Parameter Coefficient 95% CI p-value
LOS
Intercept 5.713 5.688 to 5.738 < 0.001
Monthly trend –0.029 –0.031 to –0.026 < 0.001
Level change ERAS0 0.151 0.100 to 0.202 < 0.001
Trend change after ERAS0 – – –
Level change ERASend –0.088 –0.160 to –0.016 0.017
Trend change after ERASend 0.015 0.012 to 0.017 < 0.001
OKS 6 months –OKS baseline
Intercept 14.004 13.842 to 14.166 < 0.001
Monthly trend 0.029 0.024 to 0.034 < 0.001
Level change ERAS0 0.301 0.029 to 0.573 0.030
Trend change after ERAS0 – – –
Level change ERASend – – –
Trend change after ERASend – – –
Complication by 6 months
Intercept 3.928 3.727 to 4.128 < 0.001
Monthly trend –0.056 –0.084 to –0.029 < 0.001
Level change ERAS0 –0.766 –1.345 to –0.187 0.010
Trend change after ERAS0 – – –
Level change ERASend 0.293 0.003 to 0.584 0.048
Trend change after ERASend 0.054 0.026 to 0.082 < 0.001
Revision rates by 5 years
Intercept 5.986 5.908 to 6.063 < 0.001
Monthly trend – – –
Level change ERAS0 – – –
Trend change after ERAS0 –0.038 –0.045 to –0.030 < 0.001
Level change ERASend – – –
Trend change after ERASend 0.050 0.022 to 0.079 0.001
–, p ≥ 0.20; ERAS0, start point of ERP intervention in April 2009; ERASend, end point of ERAS intervention in March 2011.
Note
Parsimonious models with Newey–West standard errors.
Reproduced from Garriga et al.66 © The Author(s). This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) license, which permits others to share this work,
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A total of 6232 (1.6%) THR patients between April 2008 and March 2016 had one or more
complication in the following 6 months. The proportion of complications at 6 months decreased from
4.1% to 1.7% (see Figure 8). The interrupted time series model shows that prior to ERAS, complication
proportions decreased by 0.078% every month (see Table 7). During the ERAS, the secular trend
increased by just 0.078%. The period after the ERAS intervention was stable.
For TKR patients, the proportion of complications at 6 months decreased between the first and the
last month of the study period, from 4.1% in April 2008 to 1.7% in May 2016. The trend significantly
declined before intervention (April 2008–March 2009), by 0.056% (see Table 8). The trend of 6-month
complications slightly increased after the ERAS implementation (April 2011–December 2016),
by 0.054%.
Five-year revision rates
A total of 3392 (2.1%) THR patients between April 2008 and December 2011 had a hip revision
in the following 5 years. Rates of 5-year hip revision per 1000 implant-years decreased from 5.9
in April 2008 to 2.9 in December 2011 (see Figure 8). The 5-year hip revision rates show a significant
downwards trend of –0.098 per 1000 implant-years during ERAS implementation (April 2009–March 2011).
The trend changed direction by increasing during the post-intervention period (April 2011–December 2016)
by 0.103 per 1000 implant-years.
A total of 4964 (2.6%) patients with a primary TKR between April 2008 and December 2012 had a knee
revision in the following 5 years. Rates of 5-year knee revision per 1000 implant-years slightly decreased,
from 6.6 in April 2008 to 5.4 in December 2011 (see Figure 8). There was a significant downwards trend of
–0.038 per 1000 implant-years during ERP implementation (April 2009–March 2011). However, the trend
significantly increased during the post-intervention period by 0.050 per 1000 implant-years.
Results for individual hospitals in the South Central region
Information was available from the Musculoskeletal Clinical Leaders Network on the dates of ERAS
implementation for the trusts listed in Table 9. These trusts were identified in the HES data set through
the hospital provider code.
TABLE 9 Hospitals in the South Central region available for analysis
Trust
Frequency
Date of ERASTHR TKR
Hampshire Hospitals NHS Foundation Trust 4186 5134 2009
University Hospital Southampton NHS Foundation Trust 2022 2445 September 2010
Oxford University Hospitals NHS Foundation Trust 5770 5616 October 2011
Royal Berkshire NHS Foundation Trust 2910 2977 August 2010
Buckinghamshire Hospitals NHS Trust 2450 3094 June 2011
Heatherwood and Wexham Park Foundation Trust 5671 7243 September 2010
Portsmouth Hospitals NHS Trust 4133 4950 October 2010
Isle of Wight NHS Primary Care Trust 1845 2151 2011
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Length of stay
Reductions in LOS were observed across all the individual hospitals for both THR and TKR (Figures 18 and 19).
However, there was notable variation between the individual trusts. For example, at the start of the
study period in April 2008, LOS was higher in some trusts than in others. For example, Southampton had
a mean LOS of around 7 days, compared with 5 days in Buckinghamshire, reflecting that these hospitals
may have already implemented ERAS-type pathways ahead of the national programme. The greatest
impact of ERAS was seen at Southampton and the Isle of Wight, where, prior to implementing ERAS,
LOS was stable and not changing, and after ERAS implementation LOS declined substantially. In many
hospitals, formalising ERAS implementation resulted in no improvements in LOS, predominantly as mean
LOS had already been declining, with little further reductions in LOS once ERAS was formally implemented.
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FIGURE 18 Length of stay after primary THR for hospitals in the South Central region. (a) Hampshire Hospitals NHS
Foundation Trust; (b) University Hospital Southampton NHS Foundation Trust; (c) Oxford University Hospitals NHS
Foundation Trust; (d) Royal Berkshire NHS Foundation Trust; (e) Buckinghamshire Hospitals NHS Trust; (f) Heatherwood
and Wexham Park Hospitals NHS Foundation Trust; (g) Portsmouth Hospitals NHS Trust; and (h) Isle of Wight NHS
Primary Care Trust. (continued )
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Oxford Hip Score and Oxford Knee Score outcomes
There does not seem to be any ecological correlation between hospitals’ trends in LOS and PROM
outcomes (Figures 20 and 21). The overall trends tend to mirror that of the national picture.
Discussion
Outcomes of primary THR and TKR have been gradually improving over time, with a decrease in
LOS, improvement in patient-reported outcomes of pain and function, decrease in complications and
reduction in 5-year revision risk. These trends of improving outcomes were seen across all age groups,
and in those with and without comorbidity, and had begun prior to the start of the formal NHS ERAS
roll-out. These findings are positive, in highlighting that reductions in LOS have been achieved without
an adverse impact on patient outcomes.
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We hypothesised that implementation of the national ERAS intervention would improve outcomes of
primary THR and TKR by changing secular trends during and after its implementation. Our hypothesis
was not confirmed, as implementation of ERAS did not influence these pre-existing secular trends.
However, as we had data for only a relatively short period prior to the ERAS implementation
(April 2008–March 2009), it is unclear how outcome trends varied over a longer pre-intervention period.
Our assumptions for this ‘natural experiment’ of the implementation of ERAS were that this large-scale
intervention was implemented homogeneously across all England NHS trusts spanning this 2-year
period. Our data suggest that there was already an encouraging trend towards reduction in LOS and
improved outcomes that had begun prior to the official ERAS programme. This is likely to reflect early
adoption of elements of ERAS methods in some trusts prior to the start of the Department of Health
and Social Care-led programme in 2009. Not all hospitals had implemented the ERAS at the end of the
planned period (March 2011).17 The survey on the spread and adoption of the ERAS carried out close
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to the end of the implementation (February 2011) by the Department of Health Social Care reported
full implementation in 81 consultant teams, whereas about 20 had partially implemented ERAS and
about 30 still planned to implement ERAS. A limitation is the variation in interpretation and adoption
across centres, because what constitutes ERAS was not clearly established after the expected
identification of best practices in the first year of the ERAS programme.67
Our results show trends in outcomes that have been achieved in the context of an increasing strain on
NHS funding and hospital budgets. NHS funding growth is much slower than the historical long-term
trend.68 For THR, there are fewer hospital beds, and wards have been closed. For example, the average
daily number of occupied beds open overnight for trauma and orthopaedics for England between April
and June 2010 was 10,015, whereas in October–December 2016 it was 8770. Conversely, the number
of primary THRs increased from 67,128 in 2008 to 87,733 in 2016 in England. It has been estimated
that 97,516 THRs will take place to the year 2035.69 Therefore, efficiencies need to be made to meet
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FIGURE 21 Change in OKS at 6 months after primary THR for hospitals in the South Central region. (a) Hampshire
Hospitals NHS Foundation Trust; (b) University Hospital Southampton NHS Foundation Trust; (c) Oxford University
Hospitals NHS Foundation Trust; (d) Royal Berkshire NHS Foundation Trust; (e) Buckinghamshire Hospitals NHS Trust;
(f) Heatherwood and Wexham Park Hospitals NHS Foundation Trust; (g) Portsmouth Hospitals NHS Trust; and (h) Isle of
Wight NHS Primary Care Trust.
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this demand within existing or lower capacity. An important issue is the large variation in services and
practices across hospitals in England. The Getting It Right First Time (GIRFT) programme aims to
reduce discrepancies between hospitals showing diversity in activity volumes, implant choice and
guidelines follow-up.70 The first GIRFT report was published in 2012, whereas the improving trends in
outcomes in our study are detected since 2008. Although our results of a positive national trend are
encouraging, there remains substantial variation in outcomes between hospital trusts. In 2016, mean
LOS varied between a low of 2.5 days and a high of 11.6 days, and OHS between 12.0 and 23.5 points.
Hence, although the national picture has improved for patients as a whole, there is still work to be
done to reduce and understand unwarranted variations in outcome between individual hospitals.
Many studies supporting the implementation of ERAS pathways have been set in single institutions or
are small trials.71 Thus, they may not be generalisable to the wider population. Nevertheless, reductions
in LOS prior to the official implementation of ERAS may reflect a commitment to improving the
cost-effectiveness of this surgery, which represents an important expenditure for the NHS.72–74 Reduction
in LOS has been reported in systematic reviews and randomised clinical trials comparing patients following
an ERAS programme for colorectal and other planned surgeries, against those under conventional care.22
This reduction in days in hospital has been also observed for joint replacement surgeries in several studies.
The type of ERAS for hip replacement differed among studies: physical therapy on the day of surgery in the
recovery room;75 preoperative patient education; postoperative multimodal analgesia with periarticular
injections; early physiotherapy and rehabilitation; discharge home with an outpatient rehabilitation
programme;76,77 patient and staff education on ‘enhanced recovery’ principles; pre-admission medication;
perioperative urinary catheterisation; low-dose spinal anaesthesia; aim for same-day mobilisation;78
perioperative care (information, pain relief, nausea control, nutrition, mobilisation and elimination);79
preoperative patient seminar; treatment of pain (spinal anaesthesia) and early mobilisation; standardised
programme in the operating theatre (tranexamic acid and no drains); 1–2 hours of multimodal fast-track
rehabilitation regime; daily physiotherapy within the first 24 hours; multimodal oral opioid-sparing
analgesia;80 and perioperative analgesic blocking peripheral nerve.81 These studies involved too few
patients (170,75 57,76 1256,77 630,78 28,79 98,80 1581) to allow us to make generalisations at a nationwide
level. In addition, these studies were limited to a single hospital or trust. Moreover, they were focused
on the comparison of the intervention with traditional management. Our study investigates whether or
not the ERAS pathway has been successfully implemented by comparing outcomes with a previous period
without ERAS, as has been done in other studies,76–78 but also, and for the first time, comparing with the
post-intervention period. Importantly, our study included all of the hospitals of a whole country.
Oxford Hip Score change increased across the study period, resulting in better scores (less pain and
better function after the surgery) for patients in 2016 than in 2008. A review of ERAS in THR shows
that better improvement in pain and function scores could be related to making patients active
participants in their recovery and helping them to manage their expectations.73
A Cochrane review of preoperative education for THR and TKR did not find additional benefits over
usual care.82 However, non-significant reduction in pain and better function were reported to be
associated with preoperative education.
Six-month complications were decreasing until the implementation took place. Subsequently, the trend
remained steady during the ERAS period and slightly increased following the intervention. A meta-
analysis in colorectal surgery on several ERAS programmes did not find evidence of increased surgical
complications83 (i.e. surgical site infections and anastomotic leakage), whereas medical complications
were reduced in colorectal ERAS patients (cardiovascular, pulmonary and infectious complications).
In patients with diabetes mellitus undergoing hip and knee replacement under ERAS protocols,
the additional risk or complications otherwise associated with operating on patients with diabetes
is reduced.84
ENHANCED RECOVERY TREATMENT PATHWAY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
70
Five-year revision surgery rates diminished across the study. Surveillance of revisions, using joint
registries, have long been the main measure of primary surgical success or failure. Revision rates could
have declined as a consequence of the recommendation of the UK National Institute for Health and
Care Excellence guidelines, which state that only implants with a revision rate of ≤ 5% at 10 years
should be used in order to avoid surgeries using low-quality prostheses.72
Conclusions
Our study shows that outcomes of THR and TKR are currently better than they were 10 years ago.
LOS has declined substantially over the study period, consistent across all age groups and in people
with and without comorbidity. Reductions in LOS have been achieved without adversely affecting
patient outcomes. Patient-reported outcomes in respect of pain and function have improved, revision
rates are in decline and complication rates remain stable. The introduction of a national ERAS programme
maintained improvement, but did not alter the rate of change already under way.
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Chapter 6 Enhanced recovery after surgery
implementation in practice: an ethnographic
study of services for hip and knee replacement
Introduction
In this chapter, we present the qualitative component of the study. The qualitative research had two
aims: (1) to understand the organisational processes that help or hinder the implementation of ERAS
programmes for hip and knee replacement [this work was informed by concepts from the Consolidated
Framework for Implementation Research (CFIR)]; and (2) to explore patients’ experiences of ERAS for
hip and knee replacement (this work used the ethnographer Mol’s work, which explores how care
processes are negotiated between health-care professionals and patients).
This chapter provides a brief background to this component of the study, describes the methods and
presents the findings. The chapter ends with a discussion of how the qualitative findings relate to
current literature. Findings and discussion will be presented in two parts. Part 1 describes findings that
explore organisational processes that help or hinder the implementation of ERAS programmes for hip
and knee replacement. Part 2 characterises patients’ experiences of ERAS for hip and knee replacement.
Background
As described in the previous chapters, there is substantial variation in how ERAS programmes for
hip and knee replacement are delivered,20 along with variation in health outcomes.13 The qualitative
research worked towards an understanding of ERAS in practice. This provides detail of the processes
that enable ERAS to be embedded in health care and how patients experience ERAS in the care that
they receive.
To provide structure and theoretical grounding for our research into health-care practice and delivery of
ERAS, we conceptualised ERAS as a ‘complex intervention’,20 in which there are a number of interacting
components. We then used implementation science85 as a way of understanding and interrogating the
implementation of ERAS as a complex intervention, as implementation science focuses on delivery and
what enables interventions to become embedded in practice. Within implementation science, the CFIR
is one framework that outlines 31 constructs that have an impact on processes of implementation,
grouped into five domains. These domains are (1) intervention characteristics that relate to the attributes
of an intervention; (2) outer setting or external influences; (3) inner setting or factors within an
organisation; (4) characteristics of individuals, that are the behaviours of individuals tasked with enacting
the intervention; and (5) process, that is the planning and delivery of an intervention.84
Health-care services should meet the needs of patients, which includes treating patients as individuals
and enabling them to be involved in choices about treatment. As ERAS involves a close collaboration
between health-care professionals and patients, meeting these needs may help patients invest in
their care and, in this way, improve outcomes after surgery. To explore this in detail, we made use of
Mol’s work, which focuses on how ‘good care’ is negotiated in practice. Meeting patients’ needs is not
straightforward because patients may make choices that do not accord with clinical definitions of
‘good care’. The value of Mol’s work is the focus on a concept of ‘good care’,86 in which patients are
not necessarily provided with unfettered choice, but in which care is negotiated between patients and
health-care professionals. The role of health-care professionals, then, is to offer advice and encouragement
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and adapt care when possible to meet patient preferences and needs. Mol shows us that tensions emerge
when the actions and expectations of health-care professionals and patients are not aligned.86
A recent systematic review of existing qualitative studies exploring staff experiences of delivering
ERAS for a range of conditions identified a number of factors that had an impact on successful
implementation. These included communication and collaboration between staff, attitudes to change,
the use of clinical protocols to standardise care, expectations around the intervention and the
embedding of ERAS into everyday practice.87 In addition, a previous qualitative review synthesised
patient experiences of ERAS for a range of conditions, including colonic and colorectal surgery.
Findings highlighted the need for comprehensive preoperative education and post-discharge support.88
However, no studies have explored factors that have an impact on the implementation of ERAS
programmes for hip and knee replacements or patients’ experiences of these programmes. As ERAS
programmes for hip and knee replacement involve a considerable recovery period after discharge from
hospital, patient experiences are likely to be different.
Aims
l To understand organisational processes that may help or hinder the implementation of ERAS
programmes for hip and knee replacement. This work used the CFIR to inform interpretation
of results.
l To characterise patients’ experiences of ERAS for hip and knee replacement using the ethnographer
Mol’s work to explore how care processes are negotiated between patients and health-care
professionals.
Understanding these issues will provide information to health-care professionals about how best to
organise and deliver these services to provide effective patient care.
Methodology
The qualitative research used an ethnographic approach, which involved periods of ‘fieldwork’ in
contexts.89 Ethnography typically includes a range of methods to provide a well-rounded account of the
issues under study. Ethnography aims to achieve a deep understanding of practice and systems from
the perspective of people in a context. For this reason, it provides an ideal means of exploring how a
service (ERAS) is implemented and experienced.90
Hospital sites
Maximum variation sampling was used to identify four hospitals from England with a range of
characteristics:91,92 (1) a teaching hospital, (2) a district general hospital, (3) a specialist orthopaedic
hospital and (4) an independent-sector treatment centre. This aimed to provide a range of
different experiences.
Part 1: exploring organisational processes that help or hinder the implementation
of enhanced recovery after surgery programmes for hip and knee replacement
This component of the study used observations of clinical practice and semistructured interviews with
health-care professionals to understand the implementation of ERAS programmes.
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Observation sessions and job shadowing
Potential participants were identified by a staff member working in the orthopaedic department, or
equivalent, of the individual hospital sites. Potential participants were then sent a study information
pack that included information about the study, an invitation letter and a reply slip to return if they
were interested in participating. Snowball sampling was also used, in which participants recommended
other potential participants.93
Using an observation checklist, observation sessions were conducted at each study site. Information
was recorded in writing, as is standard in ethnographic research. The checklist was developed by the
study team and provided structure for the researcher to collect information in a systematic manner so
that field notes described the clinical setting, activities taking place, treatment protocols and factors
that may have an impact on implementation. Informal interviews were also used. Initial notes were
written up into full ethnographic ‘field notes’ during each day of data collection, or as soon as possible
thereafter. To inform further data collection, memos or reflective notes were used to record emerging
thematic ideas. A total of 19 staff agreed to be shadowed and approximately 160 hours of fieldwork
was conducted (5 days of approximately 8 hours at each study site).
Semistructured interviews
Face-to-face semistructured interviews were undertaken with health-care professionals involved in service
delivery. Interviews ranged from around 30 to 60 minutes in duration. Thirty-one health-care professionals
participated in interviews, of whom 12 had also participated in observations. A ‘topic guide’ or list of
themes to explore in the interviews was devised based on data collected during observation sessions.
Interviews focused on participants’ views and experiences of delivering ERAS and factors having an
impact on implementation. To ensure that the experiences of participants were not ‘forced’ into predefined
concepts, data were not structured around implementation science theory. The topic guide was flexible
to enable follow-up on issues raised. Interviews were audio-recorded, transcribed and anonymised.
Analysis
Analysis was iterative and ongoing and informed further data collection. Analysis was carried out in two
phases, an interim and a final phase.Written field notes and transcripts of interviews were anonymised
and imported into NVivo software for analysis (QSR International,Warrington, UK). Interview transcripts
and field notes were analysed using an inductive thematic approach85 to identify themes and subthemes in
the data. On account of the variation in service delivery between sites, data from each hospital site were
analysed as a discrete data set. Twenty per cent of transcripts were double coded by another member
of the research team (RG-H). Codes were then discussed and refined to reach a single code list. As part
of the interim analyses, the CFIR was used to structure further analysis. This theory was identified as,
unlike most other approaches, it suggests that successful implementation is dependent on how well the
intervention meets patient needs, which accords with our findings. Using the CFIR as part of the analysis
involved transposing themes that had been coded inductively onto the 31 constructs of the framework,
grouped into the five domains: (1) ‘intervention characteristics’; (2) ‘outer setting’; (3) ‘inner setting’;
(4) ‘characteristics of individuals’; and (5) ‘process’. This was an ‘abductive’ approach to analysis as
described by Tavory and Timmermans.94 Interpretive accounts of the data were then generated.
Part 2: exploring patients’ experiences of enhanced recovery after surgery for hip
and knee replacement
We used qualitative semistructured interviews to explore patients’ experiences.
Recruitment
Potential participants were patients who had undergone THR or TKR at one of the four study
hospitals. Study information packs were distributed by local hospital health-care professionals.
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Packs included an invitation letter, a booklet with study information and a reply slip. Reply slips were
returned to a contact at each hospital. Potential participants were then either approached by the lead
researcher while in hospital or contacted by telephone after discharge.
Semistructured interviews
Interviews ranged from around 30 to 60 minutes in duration. Thirty-seven patients participated in
interviews, with the final sample size determined by data saturation. Interviews with patients 1 or 2 days
postoperatively were conducted face to face in an inpatient setting. Those with patients who had been
discharged took place by telephone owing to logistical challenges. A topic guide divided into themes was
used to explore patients’ views and experiences of having a joint replacement throughout the care pathway.
Data analysis
Interviews were audio-recorded, transcribed, anonymised and imported into NVivo qualitative analysis
software. An inductive thematic analysis was conducted, such that themes and subthemes were
identified in the responses.85 Memos were used to record emerging ideas and themes throughout the
process of data collection and analysis. Ten per cent of interviews were independently double coded by
a member of the study team and themes compared and contrasted to reach a single code list. Descriptive
accounts of the data were then generated.
Ethics approval
Ethics approval was provided by the South-West Exeter Research Ethics Committee (reference
16/SW/0214). Participants provided their written consent before interview to confirm that they
understood the aims and objectives of the research, that their participation was voluntary and that
they were willing to let the study include anonymous quotations from them in reports of the study.
Each NHS trust involved provided research and development approval.
Results
Characteristics of ERAS services for hip and knee replacement are displayed in Table 10. These present
summarised information only to preserve the anonymity of sites.
TABLE 10 Characteristics of ERAS services for hip and knee replacement at four study sites
Study site (year ERAS first
introduced) Key features
Towerton (2011) l ERAS nurse champion as central co-ordinator
l Patients provided with five separate leaflets, including information about
anaesthetic, monitoring wounds and blood clots
l Patients attend hip or knee school for further information
l Pre-assessment includes medical history and consideration of social history and
current living arrangements
l Physiotherapists see patients a minimum of 1 day after surgery
l Links with other locality services for post-discharge support put in place before
admission. ‘Step-down’ ward used for patients who are not well enough to go home
l Postoperative follow-up appointments conducted at 6 weeks, 6 months and
12 months
l Hip and knee patients follow same care pathway
l Only patients who have attended a hip or knee school are classed as
‘ERAS patients’
Shinebury (2000) l No central co-ordinator
l Patients provided with leaflets and DVDs for information. DVD includes
information about surgery, with previous patients talking about their experiences
l Patients attend hip or knee school, including demonstration of
rehabilitation exercises
l Preassessment involves full medical checks. Patients see OTs and complete
questionnaires about their home environments to assess level of support needed
post discharge
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Part 1: exploring organisational processes that help or hinder the implementation
of enhanced recovery after surgery programmes for hip and knee replacement
Sample characteristics
The 38 participants comprised 10 physiotherapists or occupational therapists (OTs), 18 nurses, five
orthopaedic surgeons, one anaesthetist, one matron, two therapy technician assistants and one theatre
manager. Twelve staff participated in interviews and observations, 19 took part in interviews only and
seven took part in observations only. Between 4 and 14 participants took part from each study site.
Participants’ characteristics are displayed in Table 11, which presents summarised information by study
site to avoid the potential for identification of individual participants. We use pseudonyms for study
sites and, in this part of the report, when we use the term ‘participant’ we are referring to hospital staff.
TABLE 10 Characteristics of ERAS services for hip and knee replacement at four study sites (continued )
Study site (year ERAS first
introduced) Key features
l Patients seen by physiotherapists and mobilised on day 1 after surgery
l Limited organisational support available for patients post discharge and formal
care packages are difficult to put in place
l Postoperative follow-up appointments conducted at 2 weeks, 6 weeks and 1 year,
run by the lead physiotherapist, OTs and specialised orthopaedic nurses. Follow-up
also takes place in fracture clinics at 5 and 10 years
l Hip and knee patients follow same care pathway
l All patients are included in the ERAS care pathway
Lastmere (2014/15) l No designated co-ordinator but, informally, physiotherapists act as key points
of contact
l Patients provided with one comprehensive hip or knee ‘joint guide’ booklet with
information about hospital, surgical procedures and rehabilitation, including safety
and exercise
l Patients attend hip or knee school that includes information on exercises, practice
with mobility aids and advice on likely LOS
l Preoperatively, patients complete questionnaires about their home environments
so that their rehabilitation needs can be assessed
l Patients are seen by physiotherapists postoperatively, preferably on the day of
surgery or postoperative day 1 at the latest. Patients are seen twice a day
l Postoperative follow-up appointments conducted at 6 weeks by consultants.
Patients also seen by physiotherapy team at least three or four times during the
first 6 weeks, either by attending rehabilitation classes or in one-to-one
appointments. All patients are seen within the first 2 weeks after surgery
l Hip and knee patients follow same care pathway
Woodland (around 2010) l No central co-ordinator
l Referrals from primary care are through a musculoskeletal ‘hub’, a triage system
run by consultants, to ensure that patients receive the correct treatment
l Patients having hip surgery attend a ‘school’. No school exists for those undergoing
knee replacement
l There is a same-day assessment clinic, a ‘one-stop shop’ that involves a full
preoperative assessment, including full observations and occupational therapy
assessment. Only hip school patients see physiotherapists
l All discharge planning is done by physiotherapists
l Postoperative follow-up appointments conducted at 6 weeks by consultants
l Hip and knee patients do not follow the same care pathway
l Not all patients are assigned to the ERAS care pathway for hip surgery and this is
done at the discretion of consultants. Those considered to be frailer or to have
more complex needs are less likely to be included in ERAS
DVD, digital versatile disc; OT, occupational therapist.
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Seventeen CFIR constructs were found to influence processes of implementation for ERAS
programmes in all five domains of the framework. A summary of the themes identified in the data and
their relationship to these constructs and domains is given in Table 12.
TABLE 11 Participant characteristics (aggregated to ensure anonymity)
Site pseudonym Profession (n) Sex (n)
Time spent in role
at site
Shinebury: district general
hospital
Physiotherapist (2) Male (1); female (1) 5–14 years
Staff nurse/sister (7) Female (7) 2 weeks–11 years
Consultant orthopaedic surgeon (3) Male (3) 4–21 years
Consultant anaesthetist (1) Male (1) 22 years
Elmfield: specialist orthopaedic
hospital
Physiotherapist (2) Female (2) 3–15 years
OT (3) Female (3) 18 months–12 years
Staff nurse/sister/nurse specialist (6) Female (6) 1 month–1 year
Matron (1) Female (1) 1 month
Consultant orthopaedic surgeon (1) Male (1) 10 years
Towerton: teaching hospital Physiotherapist (1) Male (1) 10 years
Therapy technician assistant (2) Female (2) 1–2 years
Staff nurse/sister/nurse specialist (4) Female (4) 3 months–7 years
Orthopaedic surgeon (1) Male (1) 3 years
Lastmere: independent-sector
treatment centre
Physiotherapist (2) Male (1); female (1) 2–4 years
Staff nurse (1) Female (1) 4 years
Theatre manager (1) Male (1) 3 years
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TABLE 12 Themes identified and their relation to the five domains of the CFIR and CFIR constructs
Domain (CFIR) Construct Description Related theme
Intervention
characteristics
Relative advantage Perceived advantages of
implementing the intervention
Understanding of advantages
Trade-off between reducing LOS
and increasing readmissions
Intervention source Views on whether the
intervention had been internally
or externally developed
Support for care pathway
internally developed
Adaptability Adaptability of the intervention to
meet the specific needs of the
organisation
Adaptability of ERAS to hospital
sites
Outer setting Patients’ needs and
resources
The extent to which the
intervention meets patient needs,
including barriers to access
Adaptability of ERAS to individual
needs
Importance of education to
empower patients
ERAS as a ‘message’ to be
communicated to patients
Concerns about post-discharge
support
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TABLE 12 Themes identified and their relation to the five domains of the CFIR and CFIR constructs (continued )
Domain (CFIR) Construct Description Related theme
Cosmopolitanism How effectively the organisation
networks with external
organisations to deliver the
intervention
Challenges in referral from
primary care
Tensions between primary and
secondary care on discharge
Inadequate post-discharge
documentation
Inner setting Networks and
communication
How effectively individuals within
an organisation network and
communicate with each other
Transferral of knowledge about
patients along care pathway
Multidisciplinary team meetings
Informal communication
Multidisciplinary paperwork
Understanding of ERAS as a
‘message’ to be communicated
across multidisciplinary team
Implementation climate Receptiveness of individuals within
an organisation to implementing
the intervention and how well
this is supported, rewarded and
expected by the organisation
ERAS champions to generate
support
Involvement in development of
ERAS
Compatibility Compatibility of the intervention
with individuals’ norms and values,
along with how well it fits within
existing workflows
Variation in perceived compatibility
of ERAS with existing roles
Goals and feedback The communication of goals and
how they are acted on and fed
back to staff
Formal and informal targets used
to inform service delivery
Available resources Availability of resources for
implementing the intervention,
including physical resources,
training and time
Concerns about costs to maintain
ERAS
Shortage of available staff and
high staff turnover
High volumes of patients
Access to knowledge
and information
Access to information about the
intervention
Varying levels of information and
training
Educational sessions
Formal multidisciplinary team
meetings
Learning on the job
Characteristics of
individuals
Knowledge and beliefs
about the intervention
Individuals’ attitudes and support
for the intervention
Belief in relative advantages of ERAS
Resistance where ERAS seen as
incompatible with professional
judgement
Process Planning Advanced planning of tasks to
support the delivery of the
intervention
Use of protocols to streamline
components of care
Adaptability of protocols to meet
individual needs
continued
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We now explore factors that have an impact on the implementation of ERAS services. These are
structured with the five domains of CFIR.
Intervention characteristics
Intervention characteristics illustrative quotations are displayed in Box 1.
TABLE 12 Themes identified and their relation to the five domains of the CFIR and CFIR constructs (continued )
Domain (CFIR) Construct Description Related theme
Engaging Attracting and engaging
relevant individuals involved in
implementing the intervention
through education and other
similar strategies
‘Top-down’ encouragement and
monitoring
Multidisciplinary team meetings to
cascade information
Opinion leaders Influential individuals who are
able to help generate support for
the intervention
Value of involving strong opinion
leaders in development
Champions Individuals responsible for
supporting and facilitating the
delivery of the intervention
Champions as a central point of
contact and expertise
Role in engendering enthusiasm
Reflecting and
evaluating
Feedback about the progress
of implementation, including
feedback to individuals involved
in its delivery
Reviewing outcomes data
Informal communication to discuss
development
Informal and formal feedback
through questionnaires from
patients
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BOX 1 Intervention characteristics illustrative quotations
[ERAS was] revolutionary . . . especially for the older nurses who had been there 20 years.
Senior sister, Towerton
When you’ve seen a patient with enhanced recovery protocols, you never want to go back to how you did
things before . . . [seeing how quickly patients recover] was just an amazing transformation.
Consultant surgeon, Towerton
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Staff expressed enthusiasm for the relative advantages of ERAS, as shortened LOS had resource and
cost-saving implications. There was a sense of a ‘trade-off’ between reducing LOS and not increasing
readmission and complication rates. At Shinebury, care pathways were developed internally by consultant
surgeons who piloted ERAS and communicated findings to staff. This helped generate internal support.
By contrast, a nurse sister at Elmfield described how ERAS practices had been ‘introduced on us’ and
suggested that having someone to lead its development would have inspired enthusiasm.
Participants saw ERAS as adaptable, and this was key to it working in individual hospital contexts. None
of those interviewed had seen any formal policies issued by the Department of Health and Social Care,
although many were aware that ERAS was a government initiative. There were various views about which
patients should be included in the pathway. At Shinebury, all patients were included in ERAS, whereas at
Elmfield patients were selected only if it was felt that they were healthy enough for rapid discharge.
Outer setting
Outer setting illustrative quotations are displayed in Box 2.
As ERAS was viewed as a ‘partnership’ between members of staff and patients, participants thought
that meeting patients’ needs would enable ERAS to work effectively. A number of patients could not
be discharged because they were medically unfit, but some patients were also thought by staff to be
somewhat resistant to ‘rapid’ discharge after their operation. A nurse at Elmfield thought that, to
address these issues, it was crucial to adapt approaches to suit individual needs, adopting a recovery
time that was manageable. Another emphasised the importance of education as a way of ‘breaking
down’ attitudes that acted as a barrier to discharge.
Patient information was distributed in a range of formats. Written information helped to reinforce
information provided at consultation and gave patients a source to refer back to. Sites operated hip
and knee schools, regular classes designed to educate patients about their treatment, and participants
thought that the ‘group dynamic’ created a safe space for asking questions and sharing experiences.
Face-to-face contact was seen as an opportunity to clarify information. Participants thought that patient
education had multiple aims, the most important of which was helping patients to have ownership of
their recovery. Professionals thought that such education made it easier for them to provide postoperative
support because patients had more knowledge about what to expect during recovery.
BOX 2 Outer setting illustrative quotations
You’ve got to bring the patient on board too. You’ve got to persuade them to go with the flow.
Consultant surgeon, Shinebury
You’re the one who’s going to make [the joint] work, so let’s get you working it. This is yours. It doesn’t belong
to the NHS. It doesn’t belong to the surgeon. This is yours. [It’s about giving] them the ownership and
the responsibility.
Deputy sister, Elmfield
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Participants conceptualised ERAS as a ‘message’, which had to be consistently communicated so that
patients understood and adhered to recommendations. If the message and its consistency was ‘diluted’,
then understanding and adherence could be reduced. Participants thought that new staff who were not
familiar with ERAS and those who were ‘not buying into the process’might provide inaccurate information.
Participants from all sites were concerned about post-discharge support. According to a nurse at
Elmfield, this was important as patients ‘panicked’ without it. There was variation in post-discharge
services provided by the sites. One participant felt that providing a telephone number as a point of
contact was ‘the absolute minimum’. Staff thought that this made patients feel more ‘secure’.
Co-operation with external agencies was important, notably because the smoothness of connection with
primary care at the point of referral and discharge had an impact on the successful implementation of ERAS.
Staff suggested that GPs did not always understand the practicalities of ERAS, and referrals might be
inappropriate or patients might receive information about recovery that may not accord with the
information provided from within the hospital.
Participants highlighted some gaps in communication between primary and secondary care after
patients’ discharge. One felt that GPs sometimes questioned patients’ readiness to return home;
another felt that they got ‘cross’ when they thought that patients had been discharged by the hospital
without sufficient pain relief. Participants at Shinebury and Elmfield were worried that patients had no
point of contact in secondary care if they were experiencing difficulties before their follow-up review.
This meant that such patients had to return to primary care first, which was seen as overly complex
and placing an unnecessary burden on services. Furthermore, there were concerns that GPs were not
provided with adequate post-discharge documentation. According to a nurse at Elmfield, there was a
need to engage more closely with GPs and community services.
One of the key elements of success was effective networking and communication between staff.
Multidisciplinary team members tended to operate in ‘silos’ with responsibility for delivering different
components of care. To communicate patient information, knowledge had to be transferred along the
care pathway as part of a ‘logical progression’. However, a nurse at Towerton was concerned that
those undertaking pre-assessment were not consistently transferring information, meaning that
potentially important details were missed.
Regular multidisciplinary team meetings to discuss ERAS were advocated, although these were
challenging to organise. Informal communication was seen as being important and the location of
staff in close proximity was seen to facilitate this. Nurses, physiotherapists and OTs at Shinebury
and Lastmere ran ‘joint clinics’ together, and doing so encouraged collaboration. Multidisciplinary
documentation was also valued, although the quality and consistency of this varied. For instance, at
Elmfield, paperwork did not identify whether or not patients had been assigned to the ERAS pathway.
A physiotherapist at Lastmere viewed documentation as a ‘back-up’, as staff were in ‘constant
communication’ with one another.
A number of participants characterised ERAS as a ‘message’ that needed to be communicated across
the multidisciplinary team to ensure that its components were being consistently delivered. However,
this was not always achieved. For instance, at Elmfield, surgeons did not always agree with one another
about which patients were eligible for ERAS. ERAS champions helped to ensure that the ‘message’ was
successfully communicated and that staff were delivering components of care consistently.
Regarding the implementation climate, participants described the importance of a collective ethos and
‘belief’ in ERAS. ERAS champions helped to garner support from the multidisciplinary team. However,
at Elmfield, there seemed to be no clear leadership. Furthermore, not all team members were invited
to meetings to discuss ERAS development, and this made them feel less engaged.
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There was variation in how compatible ERAS was seen to be with existing roles. A number of
participants thought that ERAS involved expanding on existing working practices, making it easy for
them to do the necessary work. However, some anaesthetists were reportedly resistant as they
preferred using their own professional judgement over following protocols. Similarly, a participant at
Towerton had found it difficult to change nursing practice, as colleagues were uncomfortable about
encouraging patients to be so independent and were reluctant to send them home.
Targets and goals for LOS were established formally by the hospital or trusts and informally by ERAS
services. Performance against formal and informal targets was fed back to staff and used as a basis to
collaboratively improve service delivery. Failure to meet formal LOS targets led to fines, meaning that
staff felt under substantial pressure to meet these goals.
The financial cost of maintaining ERAS was a concern, although the extent and nature of this varied.
Elmfield staff were particularly worried about lack of current funding, which meant that they were not
able to acquire sufficient staff or facilities, such as beds. Staff at Lastmere thought that funding cuts
may prevent them from providing patient information booklets, which they saw as being central to
effective rehabilitation.
A shortage of available staff and high staff turnover were seen as creating difficulties, as they meant
that colleagues had to do additional work and struggled to find time to deliver care. At Shinebury, staff
explained how time constraints made it challenging to arrange formal care packages after discharge
and this had an impact on the quality of postoperative follow-up. A deputy nurse sister at Elmfield
thought that follow-up reviews should be undertaken by nurses or physiotherapists, as they were
at Shinebury, to relieve the ‘pressure’ on consultants. Patient numbers at Shinebury and Towerton
were also seen to place pressures on services. Alongside this, operations could be cancelled at short
notice when operating theatre space was needed for trauma surgery.
Staff at the four sites had received varying levels of access to knowledge and information about ERAS.
Towerton appeared to have the most comprehensive training and education, and staff spent time with
the nurse champion, who ran educational sessions and incorporated information on ERAS into ongoing
orthopaedic training. Staff at Shinebury were also expected to attend joint school to help them educate
patients more effectively. By contrast, a participant at Elmfield explained how the intervention had
been introduced without any formal education and that this had not been effective. Multidisciplinary
team meetings were used as a way of communicating information about changes in working practice,
along with ‘learning on the job’.
Inner setting, characteristics of individuals and process
Participants emphasised the importance of individual commitment from staff. A strong belief in the
relative advantages of ERAS meant that most staff were committed to delivering the service. Resistance
to change existed where ERAS practices were seen as being incompatible with professional judgement.
Inner setting, characteristics of individuals and process illustrative quotations are provided in Box 3.
To plan processes of care, protocols were used to ‘streamline’ services and ensure that patients
received key elements of care, although these were not always formally described. However,
participants stressed that these should be sufficiently flexible to meet individual needs.
A consultant surgeon at Shinebury emphasised the importance of sustaining multidisciplinary
commitment and advocated ‘top-down’ encouragement and close monitoring to do so. To facilitate this,
staff at Shinebury held multidisciplinary meetings to ensure that key members of the team were
cascading information to colleagues ‘to keep that momentum going’. However, a nurse at Elmfield
explained that not all team members were invited to meetings to discuss ERAS development, and this
made them feel less engaged.
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BOX 3 Inner setting characteristics of individuals and process illustrative quotations
Inner setting
We [the physiotherapists] can actually gather information to save going through things . . . [the OT] might have
gathered something that perhaps I might take an hour to get out of somebody.
Physiotherapist, Shinebury
The other thing that will sometimes get in the way is if the [ERAS] message has been diluted at some point.
Consultant surgeon, Shinebury
I think there are other people that have the same beliefs as my beliefs . . . the bond, the desire [to implement
ERAS] is uniform from top to bottom.
Consultant surgeon, Towerton
The sadness we have is we did have a fabulous all singing and dancing booklet but it was funded by a
particular company [who is no longer providing support] . . . the funding for that isn’t possible [any more].
Physiotherapist, Elmfield
Giving [patients] enough time to ask questions I think is important so it’s about having an appropriate length
of clinic appointments which obviously [presents] a conflict between seeing a number of patients that the trust
wants you to but giving patients enough time to do that.
Consultant surgeon, Elmfield
Having enough capacities for the key professionals to interact with the patient at the right time, from pre-op
to post-op [is difficult].
Consultant surgeon, Towerton
Characteristics of individuals
Every anaesthetist was just doing his own individual recipe and it was very difficult . . . [it] took quite a lot of
engagement to get the anaesthetists to really champion it and get their colleagues to embrace that.
OT, Elmfield
Process
The idea [of the meetings] was to keep reviewing the figures and make sure there was an emphasis that
everybody cascades to their own colleagues about how we were doing and whether we [were] dropping off on
our rapid recovery . . . it’s been a challenge to keep that momentum going.
Consultant surgeon, Shinebury
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Involving strong opinion leaders in the development of ERAS helped to generate internal support,
whereas a lack of this at Elmfield was a barrier to engagement. The importance of having a recognised
ERAS champion to ‘drive through’ changes was highlighted. Towerton had a designated nurse specialist
who acted as the central point of contact. As a result, other members of the multidisciplinary team
did not need to be familiar with all aspects of the protocol. Similarly, consultants at Shinebury were
identified as a source of expertise. Clinical champions also helped to engender enthusiasm.
The ERAS programme had to be (re)activated on a continuous basis through reflection, evaluation and
modification. To reconfigure care, staff at Shinebury used multidisciplinary meetings to review outcomes
data and ‘brainstorm’ ways of improving services. Informal communication between team members,
for instance in hip and knee schools, provided another opportunity for this. Patient feedback was used
to shape patient education materials and joint schools. Feedback was collected informally or through
patient satisfaction questionnaires. On account of these processes, ERAS was seen as having been
improved or ‘refined’ at three study sites. ERAS at Shinebury was described as having a ‘core element’,
which has grown outwards as the service has ‘tried to add bits on to try and improve the situation’.
By contrast, staff at Elmfield talked about how ERAS was gradually being ‘nibbled at the edges’.
Part 2: exploring patients’ experiences of enhanced recovery after surgery for hip
and knee replacement
Sample characteristics
The 37 participants were 15 men and 22 women. Between 6 and 16 participants took part from each
study site; 14 had undergone TKR and 23 had undergone THR. Twenty-two participants were interviewed
in an inpatient setting and 15 were interviewed once they had been discharged. Of those who had been
discharged, five were interviewed 2–4 weeks postoperatively and 10 were interviewed 5–13 weeks
postoperatively. Participants’ characteristics are displayed in Table 13. In this section, we use the term
‘participants’ to refer to patients.
TABLE 13 Participant characteristics
Site pseudonym
Participant
pseudonym Sex
Age
(years)
Hip or knee
replacement
Length of time
since operation
Shinebury (district general
hospital)
Rebecca Female 76 Hip Inpatient
Matthew Male 77 Knee Inpatient
Susan Female 77 Knee Inpatient
Jennifer Male 77 Hip Inpatient
Bethan Female 70 Hip Inpatient
Sarah Female 53 Hip Inpatient
Stewart Male 68 Knee Inpatient
Craig Male 59 Hip Inpatient
Zoe Female 72 Knee Inpatient
Andrew Male 63 Knee Inpatient
Beth Female 71 Hip Inpatient
Cathy Female 59 Hip Inpatient
Dave Male 46 Hip Inpatient
Elizabeth Female 85 Hip Inpatient
continued
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Referral process
Around half of the patients who were interviewed said that they had been given the chance to choose
which hospital they would be seen at. Most participants made their choice of hospital based on
previous experiences and ease or convenience. A smaller number of participants made their choices
based on hospital performance. Others were guided by GPs in their decision-making, particularly those
who had additional health-care needs. However, for most, choice of hospital was not a priority
compared with the need to progress towards surgery.
Participants held varying views about waiting times for surgery. Some were surprised by the short
period between referral, appointment and operation date, and others experienced delays.
Participants attributed delays to funding constraints and administrative difficulties, particularly at the
interface between primary and secondary care. Several described how their operations had been
cancelled and, although some were sympathetic to the pressures on the health-care system, for others
this was emotionally difficult. The difficulty led to feelings of helplessness and frustration.
TABLE 13 Participant characteristics (continued )
Site pseudonym
Participant
pseudonym Sex
Age
(years)
Hip or knee
replacement
Length of time
since operation
Fiona Female 54 Hip Inpatient
Kevin Male 69 Hip 13 weeks
Elmfield (specialist orthopaedic
hospital)
Adam Male 76 Knee Inpatient
Geoff Male 48 Hip Inpatient
Robert Male 77 Knee Inpatient
Henrietta Female 85 Knee Inpatient
Linda Female 63 Knee 5 weeks
Owen Male 71 Hip 4 weeks
Towerton (teaching hospital) Amanda Female 74 Hip Inpatient
Jayne Female 68 Hip Inpatient
Ian Male 58 Knee Inpatient
Martin Male 67 Hip 4 weeks
Penny Female 36 Hip 9 weeks
Steven Male 56 Knee 7 weeks
Tom Male 72 Hip 12 weeks
Ursula Female 90 Knee 10 weeks
Veeda Female 77 Hip 8 weeks
Lastmere (independent-sector
treatment centre)
Harold Female 72 Knee 2 weeks
Irene Female 65 Hip 6 weeks
Jackie Female 55 Hip 5 weeks
Noura Female 57 Hip 4 weeks
Rachel Female 72 Hip 10 weeks
Quinn Male 42 Hip 3 weeks
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Preoperative education
Preoperative experiences illustrative quotations are displayed in Box 4.
Patients were referred from primary care (GPs) to secondary care and most participants were satisfied
with the verbal information that they had received in secondary care. The verbal information was
augmented by written information, and they thought that written information about postoperative
exercises was particularly useful, as they kept it until after discharge.
Participants valued the opportunity to attend classes for patients who were about to have hip or knee
surgery, called hip or knee ‘schools’. Patients felt that the classes helped prepare them for surgery and
gave them ‘confidence’ in the care they would receive. Classes helped make them feel enthusiastic
about the potential for early discharge and invested in their recovery, preparing them to take on the
role of ‘active’ participants in their own care. Guidance about how to use crutches and perform
exercises was considered particularly useful. Most thought that it was useful to practise exercises to
prepare them for standing and walking after their surgery, although some said that they had not
practised consistently.
BOX 4 Preoperative experiences illustrative quotations
I had every confidence in the hospital because of my other cancer operation, my life basically was in their
hands and I never had any doubt about it.
Kevin
What happened is [the hospital] gave me a date [for the operation], which is what you look forward to, and
then they cancelled, which drove me potty because I’ve never been depressed in my life but you’d be rest
assured I was depressed then. I’m always upbeat. I’m Gemini so I’m normally a very happy person. Apparently,
I was turning snappy, easily upset, generally fed up, which is like a mild form of depression, if you will, which
is just not me.
Tom
I met the whole team . . . The nurses, the anaesthetist, the surgeons. You know, they really made you feel that
they were going to look after you. I think one of the surgeons, actually that was his words, ‘We will look
after you’.
Owen
[The health-care professionals] were upbeat about [the surgery], not like it used to be, not staying in bed, not
being treated as though you’re 101 and getting you back up on your feet as soon as possible.
Cathy
[The health-care professionals] showed you how to use crutches properly and how to walk if you can; different
things like that. So you’re already halfway set before you got here, which was very helpful.
Andrew
I can’t remember [when the hip school was] because of the delay. That’s really why I’ve forgotten some of the
exercises really.
Amanda
Everybody will say you’re young to be having a hip replacement, I am young to be having a hip replacement
but [the consultant] said I need to have a hip replacement and so I kind of try to Google [Google Inc.,
Mountain View, CA, USA] in the experiences of somebody young to get information.
Jackie
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Classes were also a source of emotional support, as they were an opportunity to meet patients ‘in the
same boat’. Those undergoing their first replacement found it useful to talk with and listen to patients
who had undergone previous surgery: they used the classes as a time to ask others questions about
their experiences. An understanding of the roles of both patients and health-care professionals meant
that expectations of care were aligned prior to surgery.
The timing of these classes was sometimes problematic. Those who had received a rapid referral owing
to a cancellation missed out on this component of care. Others felt that they had attended too far in
advance of their operation, meaning that they could not remember the information on admission.
These challenges potentially undermined patients’ ability to participate fully in their care.
Participants wanted health-care professionals to provide them and their families with more information
about their recovery and their expected progress to help them take care of themselves. Some also felt
that they would have liked more emotional support. A small number of younger participants wanted
more information about joint replacements in younger people, with a focus on any differences in their
likely recovery after surgery.
Participants also sought information from family and friends who had undergone surgery, and from the
internet. Nevertheless, one participant raised concerns about the availability of conflicting information
and thought that hospitals should guide them to reliable sources.
Preoperative preparation
All participants found the preoperative assessment straightforward and comprehensive. They reported
that they were able to do everything that was required of them before surgery (see Box 4).
Waiting for operation
A number of participants described that they had to wait several hours from the point of admission to
hospital until their operation. They found this hard because they were not permitted to eat or drink
while waiting. Patients said that they would have valued more information about the reason for their
wait and about the precise time of their operation, and that absence of this information made them
feel more anxious.
Anaesthesia
Inpatient experiences illustrative quotations are provided in Box 5.
BOX 5 Inpatient experiences illustrative quotations
You get there for about 7.30 in the morning, or whatever it was. I was told we were second in the queue for
operation under [the consultant] so saw the first person depart, whenever that was, 8.30-ish, and I thought – and
I still didn’t go in until the afternoon. So therefore, there was that little bit of where that waiting you’re thinking,
‘What’s gone wrong? Am I going to get operated on?’ because unfortunately there was no communication.
Steven
I was recommended to have the spinal block and sedation, I asked for the sedation, I had no wish to sit there
listening to the bone grinding with a saw and hammer . . . I liked having the choice, yes that was nice. They
were lovely and they explained it all.
Cathy
It might surprise that I opted not for a general anaesthetic, which rather threw the cat amongst the pigeons
[laughs]. At my pre-op I said to the nurse, ‘By the way, I don’t want a general anaesthetic’, I’d obviously
committed a cardinal sin by saying that and she went, ‘Why don’t you want it?’, I said, ‘I don’t, that’s my
choice, I’ve never had a general, I don’t want a general’. I caused a flurry apparently and when my surgeon
happened to be there, went past and said, ‘Don’t worry, we’ll sort something out’, so I was obviously, they
weren’t expecting that although in the NICE guidelines that is an option.
Rachel
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Most participants were presented with the option of local or general anaesthesia, although they had
different experiences of this. Although some were given this option during hip or knee schools or their
preoperative assessment, others were asked on the day of surgery. These patients reported that it had
made them feel ‘surprised’ and ‘alarmed’ and worried about ‘being awake’ during surgery. They also felt
that receipt of information on the day of surgery meant they had not felt able to make an informed
choice. Several explained that anaesthetists also expressed a clear preference for localised anaesthesia,
which influenced their decision. Contrary to ERAS guidelines, one participant reported that she had not
been offered localised anaesthesia, but had insisted on it against the advice of her anaesthetist.
Pain management
Patients were generally satisfied with how their pain was managed and felt that nurses were attentive
to their needs (see Box 5). However, some patients at Shinebury felt under pressure to take their pain
medicines, although they thought that the medicines provided were ‘excessive’ and made them feel
‘out of it’. Others wanted more information about the pain medicines that they had been prescribed.
One patient expressed frustration and thought that nurses were reluctant to share this information,
which meant that she was not able to make a fully informed choice about her pain medicines.
When I said to the nurse, ‘do I really have to take codeine?’, she said ‘no, you can decide not to if you don’t
want to’. I was pleased about that.
Noura
They gave us sticks [at the hip school] and said you’ll be discharged on sticks. They were quite adamant on
that and yet the physios came along on the second morning and presented me with two crutches and I said
‘oh, crutches not sticks’. I thought communication has broken down slightly here somewhere, you get one
message at hip school and a slightly different message as soon as you’ve had the operation.
Noura
This morning, they were coming round and they said, ‘We’ll start the exercise and whatever this morning’ . . .
I was able to move and I could actually move my legs, move them up and down with no pain. I was like
someone else. Just a lovely ache. An ache that – that was heaven, that was, absolutely.
Cathy
The day after the operation they got me up straightaway and with the help of them, try and get my feet
walking again. It was all slowly done. There was no rush, a steady pace and eventually the day after that they
had me try and walk up the stairs successfully. I walked up and back down again, and it was a success.
Kevin
The night nursing staff were, ‘Come on. Get on your feet. Mrs So-and-So’s out of bed. You should be’. They
tended to treat us all the same and we were a bit ratty about that. It’s back to this, they’re not treating you
as individuals . . . I didn’t want to keep going. I was in a lot of pain.
Beth
You just had to be organised [about going back home] and this is the one thing that they did impress, better
organisation is how you feel better when you’re discharged.
Cathy
I’m slightly apprehensive [about going home] from the point of view that I’ve got to manage a very large
shopping bag and a walking stick. I am just a little concerned and I’ve said to myself, ‘Leave it [Susan]. Wait till
we get there and see what happens’.
Susan
BOX 5 Inpatient experiences illustrative quotations (continued)
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Inconsistencies in information
The majority of participants felt that they had been fully informed about what to expect during their
inpatient stay and that, as a result, there were ‘no surprises’ (see Box 5). However, some participants
identified inconsistencies between preoperative information and subsequent information, which they
found unsettling.
Early postoperative mobilisation
Patients were surprised about being able to get up and walk so quickly after surgery (see Box 5).
There was a sense of pride in being able to fulfil what they thought was required of them and they
benchmarked their success against the content of the information that they had received before
surgery, as well as feedback from health-care professionals. Positive affirmation was important to
encourage patients to meet ERAS goals. Participants emphasised the importance of participating in
exercises and working towards their own recovery, engaging in the emotional and physical work
required of them as ‘active’ patients.
Most felt that mobilisation after their operation moved at an appropriate pace. When patients could
not mobilise quickly, particularly older patients or those with complications, they felt that staff largely
listened to their concerns. Likewise, a younger patient was satisfied that staff helped her to mobilise
more quickly than anticipated. In this way, care was negotiated and plans were amended to meet
patient needs.
However, other participants described how they had felt under pressure to mobilise and ‘conform’ to
the demands of the programme. Such patients thought that health-care professionals did not listen
to their concerns or respond to their individual needs. Others experienced a tension between giving
their bodies time to ‘heal’ and the need to become active, expressing a concern that activity might
be ‘damaging’. When expectations of patients and health-care professionals differed, this created
frustrations for patients. A small number of participants thought that such tension undermined their
right to autonomy and choice about their care.
Discharge
Most participants reported feeling ‘ready’ to return home by the time that discharge happened
(see Box 5). They thought that it was better to go home than to remain in hospital. Feeling ‘prepared’
contributed to a feeling of confidence about discharge and return home. Participants valued the help
and guidance that they had received before admission about how to prepare for discharge. Such
preparations included reorganising the home, acquiring assistive devices and ensuring that family and
friends were available to help. Participants at Towerton thought that assessing patients’ needs before
admission and providing appropriate assistive devices were useful. Information empowered patients
and instilled confidence. Those being discharged felt more reassured when they understood their
recovery trajectories, how to perform post-discharge exercises and what they could and could not do.
Part of the ERAS process is mobilisation (i.e. standing and walking) and participants said that their
desire to go home motivates them to mobilise. Discharge delays due to staffing issues were a source of
frustration and patients sometimes received conflicting information about which day they were being
discharged, which made them feel unsettled.
By contrast, other participants reported that they felt under pressure to be discharged before they felt
well enough. This was linked to their concerns that they were being made to mobilise too quickly. A
small number of participants attributed this to a demand for beds. Among those who were concerned,
worries about going home were wide-ranging and included not knowing what to expect, fear of falling
and a lack of ability to sleep and perform everyday tasks. Those who lacked family support, particularly
those who lived alone, were more anxious.
Postoperative
Post-discharge experiences illustrative quotations are provided in Box 6.
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BOX 6 Post-discharge experiences illustrative quotations
It would be useful [for the health-care professionals] to actually say what you might experience. It’s nice to
know that what you’re feeling isn’t actually unusual or anything to worry about. You know, I was worried that
I was pulling the pin out of the thigh or something when it started really, really aching. I wondered if I’d done
something wrong.
Noura
Speaking to other people who’ve had hip replacements and who know of those who haven’t bothered with the
physio after a week or two, because to be honest, who wants to put yourself through that three times a day
when it hurts? But I came home and my husband would help me. He was good in that respect and he could
see within a week the difference it was making, but it was hard.
Rachel
When I came home and I was doing my exercises and I didn’t I couldn’t quite do some. I was sort of, you
know, what do I do? Do I walk more? Do I do the exercises more? Do I push through the pain? The physio said
to push through the pain but at the joint school they said not to push through the pain.
Penny
You just wonder how much that you should do because I’m that sort of person you know, ‘did I overdo it? Should I
have rested more with my leg up?’ and then you worry about developing problems and things if you don’t mobilise.
Linda
I’ve been on pain relief up until yesterday, when I got fed up with it all. And I’ve been gradually cutting down
of my own accord and today I’ve not had a single anything. I know what my body needs. And it’s my body
and I’ll do what I like with it.
Elizabeth
I took myself off everything and then the last couple of weeks I’ve actually had some problems with sort of
swelling and things ‘cause I think I did it too quickly. There’s been no support from the GP, which might be
quite nice. I suppose I could make those appointments myself but if it was more protocol that that’s what
happened, you would feel more supported.
Penny
It’s difficult when you get home a few days later. I just felt I needed a bit more reassurance and you know I’m even
nursing myself, but it depends on your family. You know people aren’t medically minded or haven’t got a clue about
looking after somebody when you come out of hospital. So you do rely on professional people around you.
Noura
It was nice to be back home again after the hospital and I found it, with the help of my wife, she’d be there when I
was doing these exercises, you know, in case I sort of toppled over or something. She was right behind me, literally.
Kevin
Realistically, I would like to think [in the future] I would suffer from no real noticeable pain in my left knee
and hopefully the right knee once it’s operated on and I think, given what I’ve been able to do, most of it is
going to work out in that I should be able to go for a nice long walk with family and friends.
Steven
I think [ERAS] is called a rapid recovery but I’ve seen that as just the normal.
Andrew
When you use the words enhanced recovery programme, what comes to my mind is get them recovered, get
them out, save money, so they’re not bed blocking.
Geoff
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Participants said that their initial recovery at home after discharge from hospital was the most challenging
period of their journey through joint replacement. Physical challenges included postoperative bruising,
high pain levels and ‘unfamiliar sensations’ that they had not anticipated. Participants facing such
challenges explained that they were unsure what was ‘normal’. Although many were relieved to be back
in their home environment, participants described unexpected practical challenges, such as bathing and
going to the toilet. Participants said that adaptive devices were useful, but also found that ones that they
needed were not necessarily available.
Physiotherapy exercises
Participants emphasised the importance of actively participating in their care by carrying out exercises
that the physiotherapy team had provided. However, several were unsure if they were performing the
exercise in keeping with the guidance they had received. Again, there was a reported tension between
being active and allowing their bodies time to heal. Some felt uncertain about how far to ‘push themselves’.
Participants also said that they were not always certain about whether or not some daily activities were
safe to carry out, for instance whether or not they should be sleeping on their side.
Pain relief
Many participants were satisfied with the pain relief medicines that they had been given on discharge.
These included medicines to take home with them. However, if things were not going well then managing
pain after discharge could be a source of worry. One participant described feeling ‘alone’ and ‘abandoned’
when experiencing severe pain 1 week after discharge, and not knowing who to contact for support.
Most participants described feeling confident in reducing their pain medications without clinical input.
However, one thought that her decision to do this too quickly had caused her pain to return.
Post-discharge support
Although patients were expected to be independent in their recovery after discharge, many struggled
to maintain their role as active participants without clinical input. Among those experiencing challenges,
there was a desire for more support to provide ‘reassurance’. This included guidance from professionals
in secondary care and their own GPs. The provision of contact details on discharge helped provide a
feeling of security. Knowledge that they were receiving a follow-up appointment was also a source of
reassurance and participants saw this as a key point in their recovery.
Family
The importance of family and friends as a source of practical and emotional support during this period
was repeatedly emphasised. When this was not possible, a small number of participants had help from
community services, which they also valued.
The future
Despite some of the challenges encountered, participants were largely optimistic about moving forwards
and they enjoyed reflecting on progress. Many discussed how their joint replacement would enable them
to participate more fully in everyday life. Expectations included having ‘pain-free joints’ and ‘going for
short walks’, and participants emphasised the importance of having ‘realistic’ expectations. For some,
discussions of the future were dominated by the prospect of future joint replacements. Others remained
uncertain about what to expect.
Discussion
Overview of findings
Seventeen of the 31 CFIR constructs influenced the implementation of ERAS across all five domains.
As described in Intervention characteristics, participants felt that ERAS afforded advantages over
alternative solutions. Support was higher when ERAS was seen to have been developed internally
rather than externally. Guidance was flexible and could be adapted to meet the demands of individual
hospital services. In the ‘outer setting’, participants thought that ERAS should be tailored to patient
needs and that education could empower them in their recovery.
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There were concerns about a lack of post-discharge support and tensions between primary and
secondary care. In the ‘inner setting’, one of the key elements of success was effective multidisciplinary
collaboration. This was achieved by transferring knowledge about patients along the care pathway,
through multidisciplinary team meetings and paperwork. ERAS was a ‘message’ that had to be
communicated to all staff, but there were concerns about funding constraints, staffing levels and large
numbers of patients. Access to information about the intervention was variable. The characteristics
of individuals had an impact on implementation, and staff were reluctant to change working practices
when ERAS was seen as being incompatible with professional judgements. Formal and informal
targets were used to inform service delivery. Within ‘process’, protocols were used to streamline care,
although these had to be flexible to meet individual needs. Participants thought that ‘top-down’
encouragement, monitoring and regular meetings helped to ensure team engagement. Involving strong
opinion leaders in its development, and ‘champions’ who drove through implementation and acted as a
point of contact, helped facilitate implementation. Reviewing outcomes data, informal communication
to discuss progress and patient feedback helped to develop ERAS over time.
Findings on patients’ experiences of ERAS showed that time to surgery varied and cancellations were
emotionally difficult. Patients valued preoperative education, but timings meant that not all patients
were offered educational classes. Participants wanted more information on expected progress, along
with emotional support. There were different experiences of being offered a choice of anaesthesia.
For some, this was explained in advance of admission, and others were consulted on the day of surgery,
which caused anxiety and prevented them from making an informed choice. Some participants identified
inconsistencies in information between their preoperative education and inpatient care, which they
found troubling. Most were enthusiastic about mobilising quickly after surgery, although others felt
under pressure and wanted to leave their bodies time to ‘heal’. Most participants reported feeling
‘ready’ to return home, and this was enhanced by discharge preparation before admission and the
support of family. However, a small number felt that they were under pressure to be discharged before
they were well enough. Postoperative recovery was often most challenging in the first few weeks, and
some were unsure how to perform exercises and daily tasks, or were worried about unfamiliar bodily
sensations. They wanted more post-discharge input to provide ‘reassurance’. Follow-up appointments
were therefore considered key points in recovery.
How findings relate to current literature
Findings characterise differences in how ERAS services for hip and knee replacement are delivered by
identifying barriers to and enablers of their successful implementation. This may help to account for
variation in health outcomes for these surgeries.13 For instance, meeting patient needs may help them
to work more successfully towards their own recovery. Findings reflect those from previous studies
that have explored processes that influence implementation of ERAS for other conditions.88,96,97 These
found that multidisciplinary collaboration was essential and that this could be threatened by the need
to co-ordinate working practices across different departments.98 Likewise, components of ERAS were
seen as incompatible with working practices of some members of the multidisciplinary team; this
meant that some staff were resistant to change.99 A need to engage staff was emphasised, and ERAS
‘champions’ were seen as a means of achieving this goal.26,96 The importance of providing education
and information to patients, and providing realistic expectations of their recovery, was discussed.28,88
Temporality or strategies to embed ERAS over time were discussed in a small number of studies.59
Studies have been synthesised in a recent systematic review.87 Our study contributed to this literature
by emphasising the importance of meeting patient needs in service design and for effective collaboration
between primary and secondary care services.
Previous work has highlighted the value of preoperative education as a way of helping patients to
prepare emotionally and practically for colorectal surgery.100 In other surgeries, inconsistencies
between preoperative education and inpatient experiences in colorectal and colonic surgeries have also
been previously identified and our findings accord with these.25,101 Patients undergoing colorectal surgery
expressed enthusiasm about working towards their own recovery,100 a finding reflected in our work.
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In addition, some colorectal patients echoed the tension we identified between meeting the demands
of the programme and allowing themselves time to recover.102 Several of these also worried that they
were being discharged too early.24,25 A recent review of patient experiences of ERAS for a range of
surgeries reflects one of the core findings of our study about the importance of post-discharge support.24,103
Other issues identified in our study relate to challenges in the wider health-care system, such as the
cancellation of elective surgeries owing to funding constraints104 and discharge delays.27
Our study identified issues that may relate specifically to ERAS as delivered in hip and knee replacement.
For instance, some patients felt unable to make an informed choice about anaesthesia, although both
local and general anaesthesia may be used.105 Challenges were identified in the postoperative period,
particularly around difficulties in performing physiotherapy exercises that are a crucial component of
rehabilitation17 and a desire for more assistive devices.
Patient experiences of ERAS for hip and knee replacement can be understood using Mol’s work,
which explores how health-care professionals interact with patients and negotiate processes of care.86
Processes of negotiation became apparent when patients began engaging in efforts to mobilise post
surgery. In the immediate post-discharge period, most patients were enthusiastic about working towards
their recovery or reported how decisions were taken in collaboration with health-care professionals
who ‘tinkered’ with their care to address individual needs. However, others reported tensions between
the expectations of health-care professionals and their own preferences, and expressed a desire for a
greater element of control. Issues were echoed in discussions around timing of discharge. In contrast,
once they had been discharged, patients struggled with their autonomy and wanted more support to
guide their rehabilitation. The study also highlights the physical and emotional work that patients did
as ‘active’ participants in their recovery.86
Strengths and weaknesses
Using ethnographic research methods involved spending extended periods of time at study sites, using
multiple research methods that provided a rounded account of practice. Analysis included information
about what people did, as well as what they said, and their reasons for their actions and decisions.106
Different numbers of participants were drawn from each of the study sites, meaning that experiences
at some hospital sites may be over-represented in the analysis. This was mitigated by analysing data
from each hospital as a discrete data set and then comparing and contrasting findings. We conducted
recruitment of patients through busy health-care professionals working within services, and we did not
ask them to keep records of those who were approached but who did not take part out of respect for
the professionals’ busy workloads. This means that there is the chance that those who participated may
not represent the experiences of all patients accessing services. However, inclusion of four hospitals,
the relatively large sample size of health-care professionals (n = 38) and patients (n = 37) with diverse
characteristics, achievement of data saturation92 and robust analysis provide confidence that findings
may be transferable to other settings.107 In addition, interviewed patients were either in hospital
awaiting discharge or already at home.
Discussions around preoperative and inpatient experiences represent the views of all patients who
participated in the study (n = 37). We found that experiences in both groups were broadly similar and
therefore we do not make a distinction between them in the analysis. Postoperative accounts relate
only to those who had been discharged from hospital at the time of interview (n = 15).
The CFIR provided a theoretical basis to our analysis. We used CFIR because of its emphasis on meeting
patients’ needs in service design. Our study highlighted that meeting patients’ needs was central to the
successful implementation of ERAS into everyday practice. By using inductive coding and transposing
themes onto the theory that we thought was the best ‘fit’ for the data, we ensured that data were not
forced into predefined constructs. A challenge that we encountered in analysis was how best to make
decisions about where themes fitted best, particularly when it was possible that these could be mapped
against more than one construct. When this was the case, themes were mapped onto the construct that
was considered to be the best ‘fit’ or coded into more than one construct.
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Future research
Study participants reflected on the role of primary care in delivering components of ERAS, including
processes of referral and post-discharge support. Further research could explore how primary care
interacts with ERAS protocols, providing a more comprehensive understanding of the delivery of ERAS.
In addition, further research should explore patient experiences of referral from primary to secondary
care services, to provide a more comprehensive account of experiences through the care pathway.
Conclusions
Our qualitative research with health-care professionals as participants demonstrates that successful
implementation of ERAS services for THR and TKR depends on several aspects, such as the extent to
which services have been adapted to meet individual needs, effective communication between staff
and planning processes.
Our qualitative research with patients highlights the perceived value of preoperative education and
information to empower patients to become active participants in their care. Our findings also show
some tensions between the need to mobilise early and the desire to have time to ‘heal’ after surgery.
There are also challenges after discharge, including how to access support when needed. This study
highlights how patients might value more information and support from health-care professionals,
particularly in the post-discharge period, to enable them to work more effectively towards their
own recovery.
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Chapter 7 Health economics of enhanced
recovery and joint replacement
Background
Following the findings that the introduction of a national ERAS programme maintained improvement on
patient outcomes but did not alter the rate of change already under way (see Chapter 6), we do not report
the results of the cost-effectiveness model as it predicts no differences in outcomes following the
implementation of the programme. Hence, we review the literature on the cost-effectiveness of enhanced
recovery from hip and knee replacement. Previous systematic reviews have considered joint replacement
compared with conservative management87,108 and specific components of enhanced recovery, such as
thromboprophylaxis.88,89 However, there are no reviews considering the cost-effectiveness of a complete
ERP, or of most of the components. In addition, there is limited evidence about the primary care and
hospital costs of primary elective joint replacement in the subsequent years after surgery. It is important to
have up-to-date and robust data on the costs of joint replacement and its drivers, to inform decisions
about changes in health service delivery and produce good practice guidelines.68 Investment and
disinvestment decisions regarding new osteoarthritis and joint replacement interventions are driven by
cost-effectiveness evidence,72 in which resource use and costs are a key input.
Aims
l To assess the evidence from cost–utility analyses of ERPs for patients having joint replacement for
osteoarthritis, report on the quality of these studies and identify research gaps for future work.
l To assess the primary care and hospital costs for NHS England of primary joint replacement up to
2 years post surgery, contrast resource use and costs by operation types, and estimate the main
predictors of 1-year hospital costs following joint replacement.
Methods of the systematic review of the cost-effectiveness of enhanced
recovery following hip and knee replacement
The methods of the systematic review were registered with the International Prospective Register
of Systematic Reviews number CRD42017059473. We defined the search strategies and database
selection with assistance from an information specialist, and by comparing our search terms with
those from previous reviews and review protocols of economic evaluations of joint replacement.
We searched Ovid MEDLINE, EMBASE, the NHS Economic Evaluation Database (via The Cochrane
Library) and the American Economic Association’s electronic bibliography (EconLit) (via ProQuest) for
English-language peer-reviewed papers published between 1 January 2000 and 1 March 2017 that
included a cost–utility analysis of an ERP or components of one, compared with usual care, in patients
having hip or knee replacement (the complete search strategy is presented in Report Supplementary
Material 7). Abstracts or conference presentations were excluded, as results are not presented in
sufficient detail to allow critical appraisal of the economic evaluations.
We included studies with participants undergoing joint replacement for osteoarthritis and excluded
populations with other indications for surgery, such as avascular necrosis, inflammatory arthropathy,
previous/failed surgery, cancer, congenital conditions or infection, as well as studies looking at
emergency procedures (e.g. due to trauma). We assumed that studies without details of the indication
for surgery were representative of a population with osteoarthritis, and therefore included these
studies. We also excluded evaluations of surgical technique or choice of implant.
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Economic evaluations of any preoperative, perioperative or postoperative intervention within the joint
replacement ERP were included, in addition to studies considering ERPs as a whole. Interventions had
to be those that form part of the usual pathway of care (with or without enhanced recovery) for joint
replacement. We included model-based evaluation and randomised controlled trials/cohort-based
economic evaluation, and restricted the analysis to cost–utility analyses [i.e. reporting costs per
quality-adjusted life-year (QALY) gained], as this is the preferred approach to inform decisions.90
The search strategy and inclusion and exclusion criteria were piloted by two reviewers. For the latter,
the search was run and inclusion and exclusion criteria were applied to 10% of the search results to
check consistency between reviewers. Studies were then independently screened based on their titles
and abstracts by three reviewers. EndNote X7 (Clarivate Analytics, Philadelphia, PA, USA) was used to
manage the references. Full texts were obtained for studies chosen for inclusion by any reviewer. As
an amendment to the protocol, evaluations of thromboprophylaxis were excluded at the full-text stage
because of a recent comprehensive systematic review in this area.88 Data extraction was performed
by three reviewers, with disagreements resolved by a fourth reviewer, using a standardised form
(presented in Report Supplementary Material 8).
The quality of reporting and risk of bias of the economic evaluations were assessed using the Consensus
on Health Economic Criteria (CHEC) list,91 the International Society for Pharmacoeconomics and
Outcomes Research (ISPOR) questionnaire for modelling studies92 and the Assessment of the Validation
Status of Health-Economic decision models (AdViSHE) tool.93 Items in the checklists were marked as yes,
no, unknown or not applicable for each study, and a final assessment of the risk of bias was made by
the reviewer. We added the Cochrane Collaboration’s tool96 to the original protocol to assess risk of
bias in trial-based studies, referring to the original reports of trial outcomes when necessary.
The principal outcomes reported in this review were a point estimate of cost-effectiveness, in terms of
incremental cost per QALY gained, and the probability of an intervention being cost-effective according
to the willingness-to-pay threshold used by the authors of each study.
Results of the systematic review
We identified 11,060 studies and one additional study was found from other sources. After excluding
duplicates, we screened 6221 titles and abstracts. We excluded 6072 papers based on their abstracts
and 136 following review of their full texts (reasons for exclusion are given in Figure 22). We therefore
included 13 papers in this review.86,97–106,109,110
Table 14 summarises the characteristics of the 13 studies. Five studies included both hip and knee
replacement patients,97–99,101,109 five included only hip replacement patients100,102–104,106 and three
included only knee replacement patients.86,105,110 Two papers evaluated an entire ERP98,109 and the
remainder evaluated components of a pathway, such as optimisation of comorbidities (specifically morbid
obesity),110 measures to reduce allogenic blood transfusion,99,100 local infiltration of anaesthetic,101
prophylactic antibiotics and other infection prevention measures,97,102–104 and physical therapy.86,105 The
final study106 concerned the optimal timing of follow-up post surgery.
The results of the 13 studies are summarised in Table 15. The types of costs, populations and tools
used for eliciting utilities and additional results for each study are reported in Report Supplementary
Material 7.
Whole enhanced recovery pathway
Larsen et al.109 report an economic analysis alongside a randomised trial, with 56 hip replacement and
31 knee replacement participants in Denmark. The pathway used in the treatment arm (‘accelerated care’)
was not different to that of the control group (‘conventional rehabilitation’) in terms of intraoperative
management, analgesia, nausea control or bowel regulation. Differences in the treatment protocols
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• EMBASE, n = 5860
• MEDLINE, n = 4889
• NHS EED, n = 272
• EconLit, n = 39
• Not reporting cost per QALY, n = 53
• Not enhanced recovery, n = 42
• Thromboprophylaxis, n = 34
• Published as abstract only, n = 3
• Not osteoarthritis, n = 2
• Non-English language, n = 1
• Duplicate publication, n = 1
FIGURE 22 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of studies
included in this review. EconLit, American Economic Association’s electronic bibliography; NHS EED, NHS Economic
Evaluation Database.
TABLE 14 Summary of studies included in the review
First author (year) Comparison Joint Study type Country
ERP
Brunenberg (2005)98 Joint recovery programme (pre assessment and
intensive rehabilitation) vs. conventional care
Hip and knee Trial based The Netherlands
Larsen (2009)109 Accelerated perioperative care and
rehabilitation vs. conventional care
Hip and knee Trial based Denmark
Preoperative
McLawhorn (2016)110 Bariatric surgery followed by TKA 2 years later
vs. immediate TKA
Knee Markov model USA
Courville (2012)97 Preoperative nasal screening for S. aureus
colonisation followed by mupirocin treatment
for patients with positive cultures vs. empirical
treatment of all preoperative patients with
mupirocin vs. standard infection prevention
measures without S. aureus screening or
mupirocin decolonisation
Hip and knee Decision tree
model
USA
continued
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TABLE 14 Summary of studies included in the review (continued )
First author (year) Comparison Joint Study type Country
Intraoperative
Jackson (2000)99 Postoperative erythrocyte recovery and
transfusion vs. usual transfusion practice
Hip and knee Markov model USA
Sonnenberg (2002)100 Autologous blood donation and transfusion vs.
usual practice without autologous donation
Hip Markov model USA
Marques (2015)101 Intraoperative local anaesthetic wound
infiltration administered before wound closure
in addition to standard anaesthesia vs.
standard anaesthesia
Hip and knee Trial based UK
Cummins (2009)103 Antibiotic-impregnated bone cement vs.
conventional cement
Hip Markov model USA
Graves (2016)102 Nine arms, comparing combinations of
prophylactic systemic antibiotics, antibiotic-
impregnated cement, laminar airflow and body
exhaust suits
Hip Markov model UK
Merollini (2013)104 No antibiotic prophylaxis, antibiotic prophylaxis
and antibiotic-impregnated cement, and
antibiotic prophylaxis and laminar airflow, each
compared with a baseline strategy of routine
antibiotic prophylaxis
Hip Markov model Australia
Postoperative
Fusco (2016)105 10 face-to-face rehabilitation sessions
plus 10 telesessions vs. 20 face-to-face
rehabilitation sessions
Knee Markov model Italy
Kauppila (2011)86 Multidisciplinary biopsychosocial outpatient
rehabilitation programme vs. conventional
orthopaedic care
Knee Trial based Finland
Bolz (2010)106 2-yearly routine follow-up vs. follow-up at
3 months and 1 or 2 years vs. no follow-up
Hip Markov model Australia
TKA, total knee arthroplasty.
TABLE 15 Summary of findings from studies included in this analysis
First author; country Population Strategy Cost-effective?
ERP
Brunenberg;98 The Netherlands THA and TKA Conventional care
Joint recovery programme (pre
assessment and intensive
rehabilitation)
Yes, more effective and
less costly
Larsen;109 Denmark THA Conventional care
Accelerated perioperative care and
rehabilitation
Yes, more effective and
less costly
TKA Conventional care
Accelerated perioperative care and
rehabilitation
Yes, less effective but
less costly
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TABLE 15 Summary of findings from studies included in this analysis (continued )
First author; country Population Strategy Cost-effective?
Preoperative
McLawhorn;110 USA Morbid obese TKA Immediate TKA
Bariatric surgery, followed by TKA
2 years later
Yes
Courville;97 USA THA and TKA Standard infection prevention
measures without S. aureus screening
or mupirocin decolonisation, or
preoperative nasal screening for
S. aureus followed by mupirocin
treatment for patients with positive
cultures
Empirical treatment of all
preoperative patients with mupirocin
Yes, more effective and
less costly
Intraoperative
Jackson;99 USA THA and TKA Usual transfusion practice
Postoperative erythrocyte recovery
and transfusion
No
Sonnenberg;100 USA THA Usual practice without autologous
donation
Autologous blood donation and
transfusion
Yes
Marques;101 UK THA and TKA Standard anaesthesia
Intraoperative local anaesthetic
wound infiltration administered before
wound closure in addition to standard
anaesthesia
Yes, more effective and
less costly
Cummins;103 USA THA Conventional cement
Antibiotic-impregnated bone cement Yes, more effective and
less costly
Graves;102 UK THA No systemic antibiotics, plain cement
and conventional ventilation
Systemic antibiotics, antibiotic-
impregnated cement and conventional
ventilation
Yes, more effective and
less costly
Merollini;104 Australia THA No antibiotic prophylaxis, or antibiotic
prophylaxis, or antibiotic prophylaxis
and laminar airflow
Antibiotic prophylaxis and antibiotic-
impregnated cement
Yes, more effective and
less costly
Postoperative
Fusco;105 Italy TKA 20 face-to-face rehabilitation sessions
10 face-to-face rehabilitation sessions
plus 10 telesessions
Yes, same effectiveness
but less costly
Kauppila;86 Finland TKA Conventional orthopaedic care
Multidisciplinary biopsychosocial
outpatient rehabilitation programme
No
Bolz;106 Australia THA 2-yearly routine follow-up, or follow-up
at 3 months and 1 or 2 years
No follow-up Yes
THA, total hip arthroplasty; TKA, total knee arthroplasty.
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between the two arms involved patient education, nutrition, admission times, staffing and mobilisation
(described in Report Supplementary Material 7). The accelerated care pathway was less costly and more
effective than the control, both overall and in the subgroup of hip replacement participants. For knee
replacement patients, the authors reported the accelerated care pathway to be cost-saving but less effective
than the control, albeit the difference was not statistically significant. They reported a cost saving of
618,075 Danish krone per QALY lost with accelerated care compared with conventional rehabilitation,
which made it cost-effective (threshold of 160,000 krone per QALY in Denmark).
Brunenberg et al.98 report an economic evaluation of a before-and-after trial with 98 hip and 62 knee
replacement participants in the Netherlands. The intervention (‘joint recovery programme’) consisted
of a 20-minute pre-assessment screening 6 weeks before the operation, for physical assessment and
analysis of the home situation to aid discharge planning, patient education sessions 1–2 weeks before
surgery, group rehabilitation sessions and supervision by physical therapists and nurses (described in
Report Supplementary Material 7). Patients in the ‘usual care’ group underwent conventional physiotherapy
for 1 hour daily, did not receive pre-assessment screening or information sessions, and discharge
arrangements were addressed during admission to hospital. The joint recovery programme intervention
was less costly and more effective than the control for both hip and knee replacement, resulting in a
cost saving of US$1261 per patient for hip replacement and US$3336 per patient for knee replacement,
albeit with no statistically significant difference in QALYs. The probability that the joint recovery programme
was the most cost-effective option was > 80% for willingness-to-pay thresholds up to US$45,000.
Preoperative components of the enhanced recovery pathway
McLawhorn et al.110 used a Markov model to assess the cost-effectiveness of bariatric surgery 2 years
before total knee arthroplasty for morbidly obese (BMI ≥ 35 kg/m2) patients who were candidates for both
operations because of end-stage knee osteoarthritis and failed non-operative weight loss interventions.
The strategy including bariatric surgery was cost-effective at the stated willingness-to-pay threshold of
US$100,000 per QALY in 98.8% of probabilistic simulations.
Courville et al.97 compared three strategies of screening for and treating S. aureus colonisation to prevent
deep surgical site infections following total knee arthroplasty and total hip arthroplasty. Courville et al.97
found that decolonisation of all preoperative patients with mupirocin, without testing for S. aureus, was
the dominant strategy (cheaper and more effective) when compared with treating only patients testing
positive for S. aureus, or no screening or decolonisation for S. aureus.
Intraoperative components of the enhanced recovery pathway
Two studies investigated strategies to reduce allogenic blood transfusions: collecting autologous blood
prior to surgery100 or aseptic collection of wound drainage.99 Autologous blood prior to surgery was
found to be cost-effective, at US$2750 per QALY gained, whereas aseptic collection of wound drainage
was not, at a cost of US$5.7M per QALY gained.
Marques et al.101 conducted economic evaluations alongside two randomised controlled trials of adding
local wound infiltration with bupivacaine to usual anaesthetic care for total hip arthroplasty and total
knee arthroplasty.101 The infiltration of local anaesthetic was found to be less costly and more effective
than standard anaesthesia in both hip and knee replacement patients. Three studies used Markov
models to investigate measures to reduce surgical site infection in the USA,103 UK102 and Australia.104 The
cheapest and most effective measure in all three included use of antibiotic-impregnated cement. The two
studies that looked at other factors102,104 each found the use of prophylactic systemic antibiotics to be
less costly and more effective than non-use, and the use of conventional ventilation in operating
theatres to be less costly and more effective than laminar airflow ventilation. Graves et al.102 considered
use of body exhaust suits and found them to be dominated by strategies that did not include use of
these suits.
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Postoperative components of the enhanced recovery pathway
Fusco and Turchetti105 used a Markov model to evaluate a strategy of 10 face-to-face rehabilitation
sessions followed by 10 telerehabilitation sessions after knee replacement, compared with 20 face-to-face
sessions. They found the strategy including telerehabilitation to be cost-saving and to improve range of
movement (knee flexion). However, they found no utility data for patients following a telerehabilitation
programme, so for their base case assumed it to be non-inferior to face-to-face rehabilitation. In a
sensitivity analysis, if telerehabilitation conferred an improvement in quality of life of at least 2.5%, the
strategy’s probability of being cost-effective was 1 (at a willingness-to-pay threshold of €30,000/QALY).
Kauppila et al.86 performed an economic evaluation of a 10-day outpatient rehabilitation course
between 2 and 4 months after knee replacement, which included clinical assessments, physical activity,
sessions with a psychologist, and lectures from an orthopaedic surgeon, nutritionist and social
worker.107 They found that patients who completed this course had higher costs and slightly worse
quality-of-life outcomes over the 1 year of follow-up (albeit not statistically significant) than those
receiving conventional orthopaedic care.
Bolz et al.106 compared three follow-up strategies: 2-yearly routine follow-up, follow-up twice (at 3 months,
and between 1 and 2 years after surgery) or no follow-up. The model assumed that no revisions would
be delayed in either strategy that included follow-up and the outcomes for these two strategies were
identical in each analysis. The no follow-up strategy was dominant for any assumed rate of delayed
revision between 1% and 50%.
Assessment of study quality and reporting quality
Using the CHEC list, the quality of the studies was generally good (Figure 23a). However, the time horizons
in the four trial-based studies (1 year86,98,101,109) and two model-based studies (1 year97 and 7 years106)
were too short to capture all relevant outcomes or costs. Furthermore, most studies did not report
whether or not they had conflicts of interest.
Using the Cochrane Collaboration’s tool (see Figure 23b), the risk of bias of the trial-based studies
was rated as being low for items such as incomplete outcome data and selective reporting, but high
or uncertain for the remainder. Three trial-based studies stated that participants were allocated at
random;79,101,107 the fourth was a before-and-after trial whereby patients were recruited consecutively
from a waiting list for hip and knee replacement.98 Larsen et al.79 discussed stratification and Kauppila
et al.107 reported a computer-generated sequence. The risk of bias could not be assessed accurately, as the
random sequence generation was not described precisely in any of the studies. The staff administering the
interventions were not blinded to allocation in any trial, and in three trials98,101,107 outcomes were assessed
by researchers aware of the treatment allocation.
Using the ISPOR questionnaire, the quality of the model-based studies was generally good (see Figure 23c).
However, none of the model-based studies reported a detailed process for internal and external validation.
Three studies99,100,105 were based on previously published models.111–113 Of these, only Briggs et al.111
(the basis for Fusco and Turchetti’s model105) provided details of model validation. Further limitations in
model validation were highlighted with the AdViSHE tool (see Figure 23d).93
Methods of estimating costs of joint replacement
Setting and data sources
We used an incidence-based approach to estimate the primary and hospital care costs. Individuals
undergoing an elective admission for joint replacement were identified and followed up retrospectively
using data from three sources: the NJR, HES and CPRD GOLD (see Chapter 2).
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FIGURE 23 Assessments of study quality based on tools from (a) CHEC; (b) ISPOR questionnaire; (c) AdViSHE tool; and
(d) the Cochrane Collaboration. (continued )
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Study participants
To estimate hospitalisation costs, we included only individuals identified in the NJR, HES and PROMs
linked data set with a planned surgery for joint replacement between April 2008 and January 2017
(observation period). Patients without a concordant date of replacement between NJR and HES
databases were excluded from the analysis. If an individual had a primary joint replacement and a
contralateral joint replacement during the observation period, we counted the costs from the primary
joint replacement and included the patient only once in the analysis. To estimate outpatient and
primary care costs, we included only patients in the CPRD GOLD data set with a first ever clinical or
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FIGURE 23 Assessments of study quality based on tools from (a) CHEC; (b) ISPOR questionnaire; (c) AdViSHE tool; and
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referral record of planned joint replacement occurring from 1 April 2008 until 31 December 2016.
For further detail on cost methodology, see Report Supplementary Material 9.
Death, complications and revisions at 1 year
All-cause mortality was estimated at 30 days and 1 year from the day of planned admission for joint
replacement and using the date of death from the ONS mortality database.
For hospitalisation costs, we defined postoperative complications as one or more events happening up
to 1 year after joint replacement. We also identified revisions occurring up to 1 year following joint
replacement from revisions declared to the NJR registry by the surgeons and revisions reported to HES.
Costs
Hospitalisation costs were estimated by converting the diagnosis and operational codes for each
finished consultant episode in a hospital admission into a HRG via the 2016/17 case mix grouper
software (HRG4+ 2016/17 Local Payment Grouper, NHS Digital, UK).36 HRGs are standard groups of
clinically similar treatments that consume a common set of health-care resources. HRGs for each
finished consultant episode were then valued using NHS Reference Costs 2016–17114 and appropriate
methodology,115 and summed to produce the total cost per hospital admission.
Primary care contacts included GP consultations in clinic or surgery, telephone contacts and out-of-office
visits. These also included nurse face-to-face and non-face-to-face contacts and contacts with other
community health-care professionals (e.g. health visitor or physiotherapist). Primary care contacts and
tests were costed using 2016/17 unit costs from national cost databases.116 Pharmaceuticals were costed
by matching each prescribed medication to a British National Formulary code and valuing these using
2016/17 cost data from NHS Digital Prescription Cost Analysis.117 See Report Supplementary Material 9 for
more details on the cost methodology. Total costs per patient were aggregated into monthly and annual
amounts for the purposes of the analysis.
Statistical analysis
We report total hospital inpatient costs for patients with complete follow-up data at years 1 and 2
following joint replacement, and for the whole sample after adjusting for censoring using the
methodology developed by Lin et al.118 Costs are reported as means together with their 95% CIs,
obtained from 1000 bootstrap estimates. We estimated the total annual joint replacement costs in the
UK by multiplying the NHS primary and hospital costs in the year of surgery by the number of primary
joint replacements in 2017 (96,717 hip replacements and 106,334 knee replacements).
Predictors of hospitalisation costs of joint replacement were estimated using a generalised linear
model (GLM). After reviewing the literature, we examined the following predictors of costs in the year
of the joint replacement: age, sex, EuroQol-5 Dimensions, three-level version/OHS/OKS before surgery
and change at 6 months, complications and revision up to 1 year after surgery, social deprivation index;
Charlson Comorbidity Index score, BMI prior to surgery, type of joint replacement (unicondylar, total
and patellofemoral for knee; resurfacing or total for hip), surgical variables, ASA grade before surgery,
thrombolysis agents used (low-molecular-weight heparin, none, aspirin and other), type of anaesthesia
(general, epidural, spinal and nerve block), death and year of surgery.
We used t-test and Pearson’s chi-squared test to evaluate the missingness for the potential predictors
of costs (e.g. BMI, EQ-5D/OHS/OKS before surgery and change at 6 months) in terms of age, sex,
hospitalisation costs, LOS, Charlson Comorbidity Index score and type of joint replacement. We also
performed multiple imputation of the missing data using a chained model with 20 iterations regressed on
complete variables to inform the prediction models (see Report Supplementary Material 9 for more details).
The choice of the GLM family and link functions was informed by the modified Park test and the
Box–Cox test, respectively. We applied stepwise backward selection (at a p-value of < 0.05) per 300
bootstrap samples to identify variables that were consistently selected for at least 50% of the analyses
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and to inform the final models. A two-tailed t-test with α = 0.01 (to account for the large sample size)
was used to determine whether or not each coefficient was statistically significantly different from
zero, and their selection as predictors of costs was informed using Akaike’s information criterion,
mean square error and likelihood test. All analyses were performed using Stata.
Results of costs of joint replacement
We identified 397,119 and 457,747 patients as having had a primary THR or TKR, respectively, in the
NJR, HES and PROMs linked data set. Table 16 reports the baseline characteristics of the two cohorts.
There was a lower proportion of women in the THR cohort than in the TKR cohort (40.4% vs. 57.0%).
More younger individuals (69.1 years vs. 69.5 years) with lower BMI (28.8 kg/m2 vs. 30.7 kg/m2)
underwent THR than TKR. Furthermore, the Oxford and EQ-5D scores were slightly lower in the THR
cohort than in the TKR cohort (17.4 vs. 18.2 for OHS/OKS and 0.33 vs. 0.37 for EQ-5D).
Hospitalisation costs
The follow-up for the THR and TKR cohorts was 3.9 years (SD 2.5 years) (Table 17). In the first year
after the joint replacement, 1.2% (4071/344,721) and 0.8% (2965/394,118) of individuals died in the
hip and knee cohorts, respectively. An improvement at 6 months was reported for both cohorts using
the EQ-5D and OHS/OKS instruments.
Hospitalisation costs associated with index admission were £6208 (median £5824, SD £969) for THR
compared with £6122 (median £5692, SD £967) for TKR. The mean LOS in the index admission was
4.82 [median 4, SD 3.8, interquartile range (IQR) 3–6] days and 4.77 (median 4, SD 3.5, IQR 3–5) days
for THR and TKR, respectively. These costs and LOS represent averages across the whole observation
period. However, we found no clear trend in costs over the observation period when resource use was
valued using the recommended NHS Reference Costs 2016–17114 (Table 18).
The mean 1-year hospitalisation costs were estimated to be £7817 (median £6258, SD £4618) and £7784
(median £6226, SD £4520) for THR and TKR, respectively, of which the index admission accounted for
79.4% and 78.5% of the total. Hospitalisation costs and LOS within 1 year were highly correlated for
both types of joint replacement (Spearman’s correlation coefficient 0.84). Comparing 1-year costs over
the observation period, we found that joint replacements decreased in each year relative to the previous
year (see Table 18). In 2015, TKR and THR 1-year costs were, respectively, £194 (95% CI £136 to £252)
and £253 (95% CI £191 to £315) lower than in 2008, adjusting for other covariates.
TABLE 16 Patient characteristics of study cohorts at primary joint replacement
Characteristic
Primary joint replacement
Hip (N= 397,119) Knee (N= 457,747)
Age (years), mean (SD) 69.1 (10.8) 69.5 (9.5)
Female, % 40.4 57.0
White ethnicity, %a 86.1 82.4
Index of Multiple Social Deprivation, mean (SD)b 18.0 (13.2) 19.4 (14.0)
BMI (kg/m2), mean (SD)c 28.8 (5.2) 30.7 (5.4)
Underweight (< 18.5 kg/m2), % 0.7 0.2
Normal (18.5–25 kg/m2), % 19.4 9.7
Overweight (25–30 kg/m2), % 39.8 34.4
Class I obese (30–35 kg/m2), % 26.6 32.8
Class II obese (35–40 kg/m2), % 10.1 16.4
Class III obese (≥ 40 kg/m2), % 3.4 6.7
OHS/OKS before surgery, mean (SD)d 17.4 (8.2) 18.2 (7.8)
continued
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TABLE 16 Patient characteristics of study cohorts at primary joint replacement (continued )
Characteristic
Primary joint replacement
Hip (N= 397,119) Knee (N= 457,747)
EQ-5D-3L score before surgery, mean (SD)e 0.33 (0.32) 0.37 (0.32)
Location, %f
Urban 71.3 74.7
Town and fringe 12.8 11.8
Village/isolated 15.9 13.5
Charlson Comorbidity Index score
Mean (SD) 0.37 (0.75) 0.4 (0.8)
Median (IQR) 0 (0–1) 0 (0–1)
ASA grade, %
Fit and healthy (1) 13.8 10.2
Mild disease not incapacitating (2) 70.3 73.7
Incapacitating systemic disease (3) 15.5 15.9
Life-threatening disease or expected to die within 24 hours (4 and 5) 0.4 0.3
Indication, %
Osteoarthritis 96.8 98.8
Osteoarthritis and other 3.2 1.2
Operation type, n (%)g
Total joint replacement 381,145 (98.1) 418,510 (92.4)
Partial joint replacement 34,299 (7.8)
Patellofemoral joint replacement 4939 (1.1)
MoM resurfacing 7271 (1.9)
Implant type, %h
Bicondylar 92.0
MoM 4.6
Non-MoM 95.4
Anaesthesia, %i
General 38.9 35.4
Epidural 4.6 4.6
Nerve block 8.0 15.3
Spinal 71.0 68.5
Thromboprophylaxis for joint replacement, %
None 3.1 3.7
Aspirin only 5.1 5.6
LMWH (with or without other) 66.0 72.3
Other (no LMWH) 25.8 18.4
EQ-5D-3L, EuroQol-5 Dimensions, three-level version; IQR, interquartile range; LMWH, low-molecular-weight heparin;
MoM, metal on metal.
a 1.5% and 1.3% missing in hip and knee, respectively.
b 1.1% and 1.0% missing in hip and knee, respectively.
c 29.0% and 29.1% missing in hip and knee, respectively.
d 41.2% and 45.3% missing in hip and knee, respectively.
e 41.9% and 45.9% missing in hip and knee, respectively.
f 0.3% missing in each cohort.
g 2.2% missing in each cohort.
h 1.3% missing in each cohort.
i 0.5% missing in both cohorts.
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Musculoskeletal diagnosis (ICD-10 chapter 1335) accounted for 32–35% of readmission costs within the
first year of joint replacement, followed by injury diagnosis (ICD-10 chapter 19:35 21%) and circulatory
system diagnosis (ICD-10 chapter 9:35 8–9%) (Table 19).
Individuals undergoing partial knee replacement had, on average, lower 1-year costs and LOS [mean
£6897 (SD £3263) and 4.4 (SD 5.9) days, n = 29,066] than individuals undergoing patellofemoral joint
replacement [£7381 (SD £3892) and 5.4 (SD 7.7) days, n = 4370] and TKR [£7860 (SD £4606) and
7.5 (SD 11.5) days, n = 360,682]. Individuals undergoing metal-on-metal (MoM) resurfacing had, on
TABLE 17 Patient outcomes and hospitalisation costs
Patient outcome/hospitalisation cost
Joint replacement
Hip Knee
Follow-up time (years), mean (SD) 3.9 (2.5) 3.9 (2.5)
Mortality, n (%)
Within 30 daysa 514 (0.1) 0 (0)
Within 1 yearb 4,071 (1.2) 2,965 (0.8)
Initial hospitalisation (index admission to discharge),c mean (SD)
Hospital LOS (days) 4.8 (3.8) 4.8 (3.5)
Hospitalisation costs (£) 6208 (969) 6122 (967)
OHS/OKS change at 6 monthsd 20.1 (10.2) 15.3 (10.0)
EQ-5D-3L score change at 6 monthse 0.40 (0.34) 0.29 (0.33)
Hospitalisation costs (£) within 1 year of replacement,b mean (SD)
Index hospitalisation 6, 07 (990) 6110 (979)
Emergency hospitalisations after discharge 648 (2880) 606 (2730)
Planned hospitalisations after discharge 963 (2825) 1067 (2850)
Total 7817 (4618) 7784 (4520)
Total length of hospital stay (days) within 1 year of replacement,b mean (SD)
Index hospitalisation 4.9 (3.8) 4.8 (3.5)
Emergency hospitalisations after discharge 1.4 (7.4) 1.4 (7.2)
Planned hospitalisations after discharge 0.9 (5.3) 1.0 (5.5)
Total 7.3 (11.2) 7.2 (11.2)
Hospitalisation costs within year 2 after joint replacement,f mean (SD)
Emergency hospitalisations (£) 524 (2598) 549 (2692)
Planned hospitalisations (£) 908 (2841) 1090 (3020)
Total costs (£) 1432 (4169) 1639 (4353)
Total length of hospital stay (days) within year 2 after joint replacement,f
mean (SD)
1.9 (9.1) 2.1 (9.5)
EQ-5D-3L, EuroQol-5 Dimensions, three-level version.
a 393,869 and 453,561 individuals with 30-day follow-up in hip and knee cohorts, respectively.
b 344,721 and 394,118 individuals with complete follow-up, including those who died in that year, in the hip and knee
cohorts, respectively.
c 397,119 and 457,747 individuals in the hip and knee replacement cohorts, respectively.
d 202,761 and 216,322 individuals with pre-surgery and 6-month OHSs/OKSs in the hip and knee replacement
cohorts, respectively.
e 187,636 and 201,077 individuals with pre-surgery and 6-month EQ-5D scores in the hip and knee replacement
cohorts, respectively.
f 293,618 and 333,123 individuals with complete follow-up, including those who died within 2 years of hip and knee
replacement, respectively.
DOI: 10.3310/hsdr08040 Health Services and Delivery Research 2020 Vol. 8 No. 4
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Judge et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
109
average, lower 1-year costs and LOS [mean £6553 (SD £2900) and 4.8 (SD 5.8) days, n = 7000] than
individuals undergoing THR [£7842 (SD £4643) and 7.4 (SD 11.3) days, n = 337,721].
After adjusting for censoring, the mean 1-year costs were similar to the complete-case analysis, at £7827
(95% CI £7813 to £7842) and £7805 (95% CI £7790 to £7818) for THR and TKR, respectively. For THR,
the mean cost in the first 2 years following joint replacement (2-year) adjusted for censoring was £9258
TABLE 18 Hospitalisation costs between 2008 and 2016
Year
Joint replacement, mean cost (95% CI)
Hip Knee
Initial hospitalisation costs (£) (index admission to discharge)a
2008 Reference Reference
2009 –3 (–20 to 15) 6 (–10 to 23)
2010 8 (–11 to 25) 29 (12 to 46)
2011 –27 (–43 to –11) 10 (–6 to 25)
2012 –42 (–59 to –26) 1 (–14 to 17)
2013 –63 (–79 to –47) –7 (–22 to 9)
2014 –67 (–83 to –51) 16 (1 to 31)
2015 –56 (–72 to –40) 43 (28 to 58)
2016 –52 (–68 to –36) 66 (51 to 81)
Hospitalisation costs within 1 year of joint replacementb
2008 Reference Reference
2009 –35 (–102 to 30) –35 (–98 to 29)
2010 –78 (–144 to –12) –80 (–141 to –19)
2011 –161 (–225 to –98) –92 (–152 to –31)
2012 –201 (–264 to –139) –138 (–198 to –79)
2013 –236 (–298 to –174) –147 (–207 to –88)
2014 –279 (–340 to –218) –211 (–269 to –152)
2015 –253 (–315 to –191) –194 (–252 to –136)
Hospitalisation costs within 2 years after joint replacementc
2008 Reference Reference
2009 –37 (–132 to 59) –53 (–150 to 44)
2010 –116 (–210 to –22) –160 (–253 to –66)
2011 –197 (–289 to –105) –194 (–287 to –102)
2012 –224 (–315 to –131) –234 (–326 to –142)
2013 –302 (–394 to –210) –283 (–375 to –193)
2014 –323 (–413 to –233) –373 (–463 to –283)
a 394,124 and 454,010 individuals in hip and knee cohorts, respectively.
b 340,753 and 389,429 individuals with complete follow-up in hip and knee cohorts, respectively, including those who
died in that year.
c 288,850 and 327,904 individuals with complete follow-up in hip and knee cohorts, respectively, including those who
died within 2 years of hip and knee replacement.
Notes
Adjusted for variables with complete data at baseline using GLM (gamma family and identity link): sex (binary), age in
year of costs (continuous), Charlson Comorbidity Index (continuous), consultant (binary), ASA grade (categorical),
surgeon volume and unit volume. Costs concerns all joint replacement and are not adjusted for hip replacement
(resurfacing and total) or knee replacement (total, partial and patellofemoral).
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(95% CI £9233 to £9280), compared with £9277 (SD £6927) using only the complete cases (n = 293,618).
For TKR, the cost in the first 2 years following joint replacement (2-year) adjusted for censoring was
£9452 (95% CI £9430 to £9475), similar to £9446 using only complete cases (n = 333,123). Comparing
2-year costs over the observation period, we found that joint replacements decreased each year relative
to the previous year (see Table 18). In 2014, TKR and THR costs were £373 (95% CI £283 to £463) and
£323 (95% CI £233 to £413) lower than in 2008, respectively, adjusting for other covariates.
Predictors of hospitalisation costs in the first year following joint replacement
Data were missing for 50% and 70% of patients concerning Oxford and EQ-5D scores (before surgery
and at 6 months), BMI or other predefined variables to inform the prediction of hospitalisation costs
for hip and knee replacement, respectively. The cohorts with incomplete data had a lower proportion
of total joint replacements, higher mortality rates at 1 year, higher hospitalisation costs and higher LOS
than complete cases. Following multiple imputation, the predictors of hospitalisation costs for THR and
TKR are shown in Tables 20 and 21, respectively. A GLM with gamma family and identity link function
was appropriate and had a good fit.
Holding all else constant, conventional THR was more expensive, on average, than MoM resurfacing
(£451; p < 0.001). Women had higher mean hospitalisation costs than men (£167; p < 0.001) and
increasing age was associated with higher costs (£28 per additional year). Individuals with higher
quality-of-life values (EQ-5D and OHS) at baseline and reporting improvements at 6 months were
associated with lower hospitalisation costs. Larger femur head size was associated with higher costs,
with additional costs of up to £226 for head sizes of > 53 mm compared with the cost for head sizes
of ≤ 28 mm. We found significant variation in hospitalisation costs concerning bearing surfaces with
strong evidence (p < 0.01) that ceramic-on-ceramic, ceramic-on-metal and metal-on-ceramic bearings
were associated with lower mean 1-year hospitalisation costs than metal-on-polythene bearings (the
most common bearing type in the cohort). Costs were lower in recent years (–£31/year; p < 0.001),
holding all else constant. Complications and revisions within the year were significantly associated
with higher mean costs, with an additional £6601 (p < 0.001) and £11,255 (p < 0.001), respectively.
TABLE 19 Top five diagnosis groups for hospitalisation costs following joint replacement by ICD-10 code and year
Hip replacement Knee replacement
ICD-10 Description Mean cost (£) ICD-10 Description Mean cost (£)
Year 1
13 Musculoskeletal 506 13 Musculoskeletal 573
19 Injury 333 19 Injury 348
9 Circulatory 139 9 Circulatory 133
2 Neoplasms 119 18 Symptoms 112
18 Symptoms 111 2 Neoplasms 106
NA All others 259 NA All others 263
Year 2
13 Musculoskeletal 401 13 Musculoskeletal 508
19 Injury 213 19 Injury 274
2 Neoplasms 163 2 Neoplasms 157
9 Circulatory 154 9 Circulatory 155
11 Digestive 107 11 Digestive 117
NA All others 297 NA All others 312
NA, not applicable.
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TABLE 20 Predictors of 1-year hospitalisation costs following hip replacement (n = 330,765)
Predictor
Proportion/mean
in study cohort
Mean additional
cost (£) 95% CI (£) p-value
Type of joint replacement
THR 97.9% Reference
MoM resurfacing 2.1% –451 –556 to –347 p < 0.001
Age (years) at replacement (centred at
69 years)
69.1 28 27 to 30 p < 0.001
Age (years) at replacement squared 0.9 0.8 to 0.9 p < 0.001
Sex
Male 59.5% Reference
Female 40.5% 167 147 to 188 p < 0.001
Charlson Comorbidity Index score 0.36 380 362 to 399 p < 0.001
BMI (kg/m2) at hip replacement 28.8 –4 –6 to –1 p = 0.002
EQ-5D score at baseline (per 0.10 units) 0.32 –105 –113 to –96 p < 0.001
EQ-5D score change at 6 months
(per 0.10 units)
0.41 –97 –104 to –89 p < 0.001
OHS at baseline 17.4 –30 –32 to –27 p < 0.001
OHS change at 6 months 20.1 –17 –19 to –14 p < 0.001
Calendar year of replacement
(centred at 2012)
–31 –35 to –26 p < 0.001
ASA grade
Fit and healthy (1) 13.9% –150 –174 to –126 p < 0.001
Mild disease not incapacitating (2) 70.4% Reference
Incapacitating systemic disease (3) 15.3% 637 600 to 675 p < 0.001
Life-threatening disease or expected
to die within 24 hours (4 and 5)
0.4% 2112 1772 to 2452 p < 0.001
Head size (mm)
≤ 28 42.2% Reference
29–35 31.4% 45 22 to 69 p < 0.001
36–42 23.4% 56 27 to 85 p < 0.001
43–48 1.4% 29 –72 to 129 p = 0.579
49–52 1.2% 66 –59 to 191 p = 0.300
≥ 53 0.4% 226 60 to 392 p = 0.008
Bearing surfaces
MoP 61.9% Reference
MoM 4.3% –29 –105 to 47 p = 0.450
CoC 16.9% –40 –69 to –10 p = 0.009
CoP 16.6% –24 –51 to 4 p = 0.094
Other (ceramic on metal or metal
on ceramic)
0.4% –194 –324 to –64 p = 0.003
Surgeon volume of hip procedures
(per 100)
97.4 –16 –28 to –4 p = 0.007
Complications within 1 year 6.0% 6601 6472 to 6731 p < 0.001
Revision within 1 year 0.9% 11,255 10,800 to 11,709 p < 0.001
Death 1.0% 4682 4374 to 4991 p < 0.001
Constant 8600 8500 to 8700 p < 0.001
CoC, ceramic on ceramic; CoP, ceramic on polyethylene; MoP, metal on polyethylene.
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TABLE 21 Predictors of 1-year hospitalisation costs following knee replacement (n = 391,691)
Predictor
Proportion/mean
in study cohort
Mean additional
cost (£) 95% CI (£) p-value
Type of joint replacement
TKR 92.5% Reference p < 0.001
Unicondylar knee replacement 7.4% –391 –429 to –353 p < 0.001
Patellofemoral replacement 0.1% –96 –194 to 3 p = 0.057
Age (years) at replacement (centred at
69 years)
31 30 to 32 p < 0.001
Age (years) at replacement squared 1.1 1.0 to 1.2 p < 0.001
Sex
Male 56.8% Reference
Female 43.2% 248 227 to 269 p < 0.001
Charlson Comorbidity Index score 0.39 365 350 to 381 p < 0.001
Year of surgery (centred in 2012) –10 –15 to –6
IMD score (divided by 100) 0.19 –247 –320 to –174 p < 0.001
EQ-5D score at baseline (per 0.10 units) 0.37 –96 –104 to –88 p < 0.001
EQ-5D score change at 6 months
(per 0.10 units)
0.30 –92 –99 to –85 p < 0.001
OKS at baseline 18.2 –26 –32 to –25 p < 0.001
OKS change at 6 months 15.2 –8 –12 to –7 p < 0.001
ASA grade
Mild disease not incapacitating (2) 73.7% Reference
Fit and healthy (1) 10.2% –153 –184 to –122 p < 0.001
Incapacitating systemic disease (3) 15.7% 622 590 to 653 p < 0.001
Life-threatening disease or expected
to die within 24 hours (4 and 5)
0.3% 1579 1324 to 1834 p < 0.001
Deformity
< 10 65.2% Reference
10–30 33.7% 62 39 to 85 p < 0.001
> 30 1.1% 496 386 to 606 p < 0.001
Range of flexion
91–110 45.3% Reference
< 70 2.1% 86 10 to 163 p = 0.027
70–90 19.7% 54 24 to 84 p < 0.001
> 110 32.9% –15 –40 to 10 p = 0.238
Type of surgeon
Consultant 78.5% Reference
Other 21.5% 51 26 to 75 p < 0.001
continued
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Holding all else constant, TKR was significantly associated with higher 1-year hospitalisation costs than
unicondylar knee replacement (£391; p < 0.001).Women had higher mean hospitalisation costs than men
(£248; p < 0.001) and costs were positively associated with age (£31 per additional year; p < 0.001) and
higher deprivation, with individuals living in more deprived areas having higher costs. Individuals with
higher quality-of-life values (EQ-5D and OKS) at baseline and those reporting improvements at 6 months
had lower hospitalisation costs. Higher deformity and lower range of flexion were also significantly
associated with higher costs. Costs were lower in recent years (–£10/year; p < 0.001), holding all else
constant. Complications and revisions within the first year were significantly associated with higher costs,
with an additional £6075 (p < 0.001) and £7753 (p < 0.001), respectively.
The mean 1-year hospitalisation costs were higher for patients who died (an additional £4682 for THR
and £4597 for TKR), mostly as a result of higher LOS than those who survived the first year (mean of
30.4 days vs. 7.0 days for hip patients who did/did not die and 30.0 days vs. 7.0 days for knee patients
who did/did not die).
Costs before and after joint replacement
Adding primary, outpatient and inpatient hospitalisation costs, the mean NHS costs associated with THR
amounted to £9295 in the year of surgery (Figure 24) compared with £9483 following TKR (Figure 25).
Using the annual number of UK primary joint replacements in 2017, the NHS primary and hospital care
costs were estimated at £897M (n = 96,717) and £1007M (n = 106,334) in the year of the THR and
TKR, respectively.
Hospitalisation costs accounted for the highest proportion of the total 1-year cost for both THR and
TKR (82–84% of total costs in the year of joint replacement), followed by primary care (10–11% of
total costs) and outpatient care (6–7% of total costs). In the second year after joint replacement, total
costs decreased to £3095 for knee and £2692 for hip cohorts, with inpatient costs again being the
largest component (53% for both knee and hip).
TABLE 21 Predictors of 1-year hospitalisation costs following knee replacement (n= 391,691) (continued )
Predictor
Proportion/mean
in study cohort
Mean additional
cost (£) 95% CI (£) p-value
Approach
Medial parapatellar 93.0% Reference
Lateral parapatellar 1.0% 180 77 to 282 p = 0.001
Mid-vastus 3.1% 29 –27 to 86 p = 0.306
Subvastus 1.2% 119 25 to 212 p = 0.013
Other 1.7% –15 –90 to 60 p = 0.686
Type of fixation
Cemented 95.0% Reference
Uncemented 4.2% –66 –114 to –18 p = 0.007
Hybrid 0.7% 44 –75 to 163 p = 0.468
General anaesthesia 36.5% 74 53 to 95 p < 0.001
Complications within 1 year 6.0% 6075 5994 to 6155 p < 0.001
Revision within 1 year 1.1% 7753 7528 to 7978 p < 0.001
Death 0.8% 4597 4368 to 4826 p < 0.001
Constant 8068 8010 to 8126 p < 0.001
IMD, Index of Multiple Deprivation.
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Figure 26 reports the hospitalisation costs in the months before and after joint replacement. The annual
hospitalisation costs in the year of joint replacement were £6753 (95% CI £6732 to £6774) and £6563
(95% CI £6544 to £6583) higher for THR and TKR, respectively, than those of the previous year (Table 22).
However, hospitalisation costs decreased in the 5 months prior to surgery, reflecting lower hospital
admissions leading up to the elective admission. In the year of joint replacement, about 81–83% of
hospitalisation costs occurred in the first month post joint replacement. Costs in the second year after joint
replacement were £389 (95% CI £370 to £407) and £349 (95% CI £329 to £368) higher than costs in the
year prior to surgery for knee and hip replacement, respectively.
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A similar pattern was observed with outpatient and primary care costs (Figures 27 and 28). Primary
care costs in the year of the surgery were higher than in the previous year, at £64 (95% CI £37 to
£91) and £5 (95% CI –£17 to £26) for TKR and THR, respectively (Table 23). The highest costs
occurred in the first month after joint replacement. Outpatient costs were also higher in the year of
surgery than in the previous year, with an additional £80 (95% CI £53 to £107) and £15 (95% CI –£31
to £61) for TKR and THR, respectively, with the highest costs occurring in the second month (Table 24).
However, outpatient costs in the second year after surgery were significantly lower than in the year
preceding the surgery for both types of joint replacement [–£105 (95% CI –£78 to –£133) and –£126
(95% CI –£109 to –£143) for knee and hip, respectively]. In contrast, primary care costs were lower
in the second year after surgery for THR (by –£53), but higher for TKR (by £37) than in the year
preceding surgery.
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TABLE 22 Hospitalisation costs in the years before and after joint replacement
Joint replacement
Time point
Year before Year 1 Year 2
Knee (£)a 1240 7803 1628
Difference vs. year before (£) (95% CI) 6563 (6544 to 6583) 389 (370 to 407)
n 297,794 297,794 297,794
Hip (£)a 1085 7838 1434
Difference vs. year before (£) (95% CI) 6753 (6732 to 6774) 349 (329 to 368)
n 257,563 257,563 257,563
a Complete cases, including those who died in that year.
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TABLE 23 Primary care costs in the years before and after joint replacement
Joint replacement
Time point
Year before Year 1 Year 2
Knee (£)a 960 1024 997
Difference vs. year before (£) (95% CI) 64 (37 to 91) 37 (9 to 64)
n 23,601 23,601 23,601
Hip (£)a 919 923 866
Difference vs. year before (£) (95% CI) 5 (–17 to 26) –53 (–74 to –32)
n 24,509 24,509 24,509
a Complete cases, including those who died in that year.
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Discussion
The systematic review of cost-effectiveness evidence of enhanced recovery identified two studies
evaluating an entire pathway.98,109 This is consistent with reviews of cost-effectiveness of enhanced
recovery programmes for other surgical sites,119–121 which have found few studies reporting the effect
on quality of life and none presenting cost-effectiveness results using QALYs. The ERP was found to be
associated with reduced costs for all patients and the incremental cost-effectiveness estimate favoured
the enhanced recovery protocol, with a high probability of it being the most cost-effective option.
Furthermore, we were able to examine the hospitalisation costs of different types of joint replacement
through their identification in the NJR data set and linkage to hospital records. We found partial knee
replacement to have lower 1-year costs than TKR, even after adjusting for potential confounders.
Previous studies have examined the costs of joint replacement, but consisted of smaller samples and
without linkage to NJR data.74,122
Cost-effectiveness of enhanced recovery
We identified 11 studies presenting cost–utility data for components of an ERP.86,97,99–106,110 However,
these cover only a few of the potential ERP components and the available evidence was mostly based
on single studies. These studies covered a variety of interventions, across different health-care systems,
and used different cost perspectives. The studies identified in this review were generally of good
quality, according to the CHEC list,91 with a short time horizon identified as a key limitation in six
studies.86,97,98,101,106,109 When the models were assessed against the ISPOR questionnaire,123 there were
concerns about the lack of model validation work, potentially questioning the reliability of 9 of the 13
studies identified.97,99,100,102–106,110 The trials were generally of good quality.
Our review had some limitations. We may have missed relevant evidence by limiting our search to
reports published in the English language and excluding studies that did not report QALYs. Of the
studies excluded because they did not report QALYs, one investigated a complete ERP.124 This was a
retrospective review of total knee arthroplasty patients in Turkey who followed either a rapid-recovery
protocol or a standard care protocol. The rapid-recovery protocol was found to be cost-saving and
associated with statistically significant differences in knee flexion and extension at 6 months.
Costs of joint replacement
Consistent with Chapter 5, we found 1- and 2-year hospitalisation costs to decrease over recent
years. However, we found no clear trend concerning the costs of the elective surgery itself, despite a
significant decrease in LOS between 2008 and 2016. This can be explained by the nature of costing in
the NHS, which is based on HRGs for hospital episodes rather than days in hospital. Therefore, it is key
to note that such a costing approach was shown here not to be sensitive to capture what we would
expect to be a decrease in costs.
TABLE 24 Outpatient care costs in the years before and after joint replacement
Joint replacement
Time point
Year before Year 1 Year 2
Knee (£)a 576 656 470
Difference vs. year before (£) (95% CI) 80 (53 to 107) –105 (–78 to –133)
n 13,793 13,793 13,793
Hip (£)a 518 533 392
Difference vs. year before (£) (95% CI) 15 (–31 to 61) –126 (–109 to –143)
n 13,708 13,708 13,708
a Complete cases, including those who died in that year.
HEALTH ECONOMICS OF ENHANCED RECOVERY AND JOINT REPLACEMENT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
118
We identified a reduction in hospitalisation costs in the 5 months prior to surgery for both types of
joint replacement, reflecting fewer hospitalisations leading up to the elective admission. This suggests
that the selection of patients for joint replacement takes into account their recent history of hospital
admissions. Furthermore, primary care costs were slightly lower in the second year after surgery for
THR, but slightly higher for TKR, than in the year preceding surgery, possibly reflecting differences in
recovery times between the two procedures.
The main predictors of costs were similar for THR and TKR. As in previous work,122 we found
preoperative quality of life to be associated with hospitalisation costs: 1-year costs were higher for
individuals with worse preoperative quality of life, even after adjusting for other covariates. In addition,
1-year costs were lower for individuals reporting improvements in quality of life at 6 months.
Having a revision or complication was found to be associated with very high additional costs in the
first year after surgery, after adjusting for other covariates. Given the high annual primary care and
hospital costs of £897M and £1007M for THR and TKR, respectively, there is a considerable economic
incentive to fund research aimed at identifying cost-effective ways of improving the quality of life of
patients following joint replacement and reducing the risk of revisions and complications.
Our study had some limitations. NJR data were obtained for individuals undergoing joint replacement,
with osteoarthritis as an indication for surgery. Hence, individuals without osteoarthritis as one of the
indications were not available for analysis (e.g. rheumatoid arthritis or hip fracture). A large proportion
of the cohort had missing data for one or more key covariates of the hospitalisation costs, in particular
EQ-5D or OHS responses and BMI, which necessitated the use of missing data methods, specifically
multiple imputation. A key assumption whenever multiple imputation is utilised is that the missing data
may be classified as missing at random. This assumption is always untestable, but owing to the large
number of relevant covariates in our linked data we judged it to be reasonable in this case.
Conclusion
Our systematic review found limited cost–utility evidence, either for an entire ERP or for individual
components of a pathway, for patients having THR or TKR. Our findings support the use of ERPs as a
whole, prophylactic systemic antibiotics, antibiotic-impregnated cement and conventional ventilation.
However, there is ample scope for future cost-effectiveness studies into enhanced recovery for total
hip arthroplasty and total knee arthroplasty patients. Furthermore, our study reports the costs of joint
replacement and shows these to have decreased in recent years. We highlight the significant costs
associated with revisions and complications following joint replacement and the incentive to reduce
these in the patient population. We also identified significant differences between types of operation in
TKR and THR that warrant further research. A key advantage of this study is the use of large numbers
of primary care and hospital care data collected routinely in the NHS, meaning that the data are
representative of the range of individuals undergoing joint replacement. Therefore, the results are
generalisable for use in other studies in the UK setting. Our results can be used as inputs in future
work assessing the cost and cost-effectiveness of joint replacement and, in particular, to explore
heterogeneity between patient subgroups.
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Chapter 8 Patient and public involvement
Second forum results: Tuesday 7 November 2017
The group discussed the results of the statistical analyses in general. The group was encouraged to see
that the preliminary results showed that the ERP had not had a negative impact on patient outcomes.
Members of the group requested that the results be broken down for different age groups and different
comorbidities. The group discussed the presentation of the charts and thought that some of the diagrams
were unclear.
One member commented that ‘it was hard to see the results proportionally and they wanted the scale
to be easier to read’. It was also noted that members were worried that some of the charts might be
upsetting to patients. They want guidance rather than scaremongering. The group were interested in
hospital-acquired infection and LOS. The group wanted to know if it would it be possible to look at
patients who are living alone and how it affects their outcomes.
Final forum results: Tuesday 4 September 2018
Prior to the final meeting, the group members were given a brief plain English summary of the last
meeting and a reminder of the project aims. The meeting began by refreshing the group on the
research project and discussing the previous meeting outcomes. The group thought that the patient
outcomes listed could also be described as ‘getting it right’ for the patient. It was agreed that the four
top outcomes were still the most important.
The group was then asked to discuss some preliminary diagrams that had been created to map the top four
different patient outcomes for both THR and TKR. One group member thought that it would be useful to
compare the information in the maps with data on health and well-being, for example people who live in
deprived areas. The group discussed whether or not the maps properly reflected if, in certain areas, patients
might arrive in hospital with a higher score in the OHS and OKS but still had the replacement operation,
and how that would affect the measure of outcomes. One group member commented that ‘If you lived in
one of these areas that did not score well, you would then be questioning why’.
It was suggested that the colours for the different maps should be consistent. For example, dark blue is
positive for the pain and function map, but displayed as negative on the complications map.
The group then moved on to discuss who this information should be given to. It was agreed that the
information is most important for CCGs to look at and see what are they doing wrong, rather than for
a patient. The group was then asked whether or not the maps would be helpful for patients. It was
thought that not all patients would have the mental capacity or well-being to make the decision to
choose a better-scoring hospital. It was agreed that most people would want to go to the local hospital
particularly in order to help with travel before and after the operation and for family visiting. Waiting
times would help to make a decision. For example, the hospital with the shortest waiting time would
be preferable. It was agreed that the maps would be too ‘bewildering’ if they were just handed to
patients, as they are already bombarded with information before operation. The PEP-R group agreed that
the information would be useful for the CCGs, rather than for patients. It was agreed that it would be
overwhelming for patients to see this information before an operation, as some areas are marked as good
for pain but bad for complications. The group agreed that it was difficult to make decisions based on CCG
area, as individual hospitals have their own results. It was thought that amalgamating all the results to get
one score on one map would be helpful. One group member commented that ‘the information shown on
the map is quite high level, but as a patient your choice is on a much smaller scale’.
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Chapter 9 Final conclusions
Geographical variation
There are a number of factors that are predictive of whether or not a patient achieves a successful
outcome following primary hip or knee replacement surgery. Consistent with the existing literature, we
identified a number of patient and surgical factors that predicted outcome, in addition to some hospital
organisational factors. In respect of patient case-mix factors, we found that patients achieving the best
outcomes in respect of absolute change (improvement) in symptoms of patient self-reported pain and
function, before and 6 months after surgery, were older age, people living in affluent areas and those
with no comorbidities.
This is as expected and such case-mix factors are known within the literature. Surgical factors we
identified included bigger femoral head size (≥ 44 mm). None of the hospital organisational factors we
explored predicted pain and functional outcomes. As expected, patient case-mix factors were also
predictors of complications and LOS. A number of the surgical and hospital organisational factors were
found to predict these other outcomes. For example, hospitals with more beds available overnight for
trauma and orthopaedics and those with units performing fewer THRs per year were associated with
longer stays for patients undergoing primary THR.
The findings above tell us about predictors of outcomes of surgery at a population level. However,
outcomes of surgery are likely to vary at the small area level, such as between individual hospitals
and across health areas (e.g. CCGs). A strength of using large national data from the NJR is that we
had the statistical power, and coverage, to explore geographical variation at the small area level. This
allowed us to first describe variation in outcomes across health areas, and second to try to identify
factors that could explain why such variation exists. In our study, we observed substantial evidence of
variation in patient outcome across the 207 CCGs. A key point is that this variation is seen after a
national ERAS programme has been rolled out. The absolute change in OKS varied from 11.2 to 19.1
(and in OHS from 17.5 to 24.9), 6-month complication rate of TKR varied from 1.5% to 8.4% (and for
THR from 2.0% to 8.6%), mean LOS for TKR varied from 2.7 to 6.6 days (and for THR from 2.5 to 6.2 days)
and bed-day costs varied from £4564 to £8901 (and for THR from £4322 to £8566). Accounting for
patient case-mix factors did not explain the observed variation across health areas. Neither did further
adjustment for surgical and hospital organisational factors. Hence, even though these factors do predict
differences in outcome between patients, they do not explain the observed variation in outcome across
health areas.
This is an important finding, as a CCG cannot use patient case mix as a justification for why it has
worse outcomes than others. However, there is still the potential for residual confounding, due to other
measures of patient case mix not fully accounted for in our models (e.g. the type of work that patients
are returning to, levels of depression, assumptions about weighting in the Charlson Comorbidity Index
that may not reflect the relative weight of different comorbidities’ influence over THR/TKR outcomes).
This is, however, to the best of our knowledge, the most thorough attempt yet to adjust for patient,
surgical and hospital factors, and, given the magnitude of variation that remains, there would have to be
really very strong residual confounding to fully explain the remaining variability. It was disappointing not
to be able to find any variables captured in routine health data that could explain these observed variations.
The potential explanation is that this variation is down to historical local hospital organisational contexts,
and specific to local care process and care pathways, that cannot be captured and adjusted for in routine
health data. Nevertheless, the information we present is important in highlighting that this variation exists,
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such that local hospitals and CCGs can be aware of how they are performing and take the necessary action
and local audit to attempt to tackle the problem. It is also informative to patients in making a decision in
deciding where to have elective surgery, such as THR/TKR, as this is not emergency surgery and patients
have a choice through the Patient Choice Agenda.
Enhanced recovery care pathway
Natural experimental study
Our data show that outcomes of primary THR and TKR have been gradually improving over time, with a
decrease in LOS, reduction in estimated average inpatient bed-day cost, improvement in patient-reported
outcomes of pain and function, decrease in complications and reduction in 5-year revision risk. These
trends of improving outcomes were seen across all age groups, and in those with and without comorbidity.
These findings are positive, in highlighting that reductions in LOS have been achieved without adversely
affecting patient outcomes. However, these trends of improving outcomes had begun prior to the formal
roll-out of ERPs through the national NHS ERAS implementation programme and were not temporally
associated with the national ERAS programme. It is of note that when we looked at the effect of
individual hospitals in a region of England, a significant impact of ERAS on LOS was seen at Southampton
and the Isle of Wight, where, prior to implementing ERAS, LOS was stable and not changing, and, after
ERAS implementation, LOS declined substantially. However, in many hospitals, formalising ERAS
implementation saw no improvements in LOS, predominantly as mean LOS had already been declining,
with little further reductions in LOS once ERAS was formally implemented.
Health economics
We found limited cost–utility evidence, either for an entire ERP or for individual components of a
pathway, for patients having THR or TKR. There are also concerns regarding the ability of short time
horizons in trials in this area to capture relevant outcomes, and regarding a general lack of reporting
of model validation. However, our findings support the use of ERPs as a whole, prophylactic systemic
antibiotics, antibiotic-impregnated cement and conventional ventilation.
We estimated the hospitalisation costs associated with index admission for THR to be £6208,
compared with £6122 for TKR. Within 1 year of the joint replacement, the total hospitalisation costs
were estimated to be £7827 and £7805 for THR and TKR, respectively, of which the index admission
accounted for 79.4% and 78.5% of the total. Although complications, revision and reoperation are
uncommon following surgery, they are associated with high costs. For THR, complications and revisions
were significantly associated with higher costs, at £6601 and £11,255, respectively. Given that there
are > 200,000 patients receiving THR and TKR each year in the UK, the costs associated with these
operations are high, and remain higher in subsequent years after the operation. However, THR and
TKR are the most cost-effective options in individuals with osteoarthritis. There is then a strong
economic incentive to further improve the quality of life of individuals following joint replacement and
reduce revision surgery and complications of surgery.
Process evaluation (qualitative research)
The ethnographic study of health professionals involved in the delivery of enhanced recovery services
found that support for the care pathway was higher when the pathway was developed internally rather
than externally. Guidance was flexible and could be adapted to meet the demands of individual hospital
services. There were concerns about a lack of post-discharge support and tensions between primary
and secondary care. One of the key elements of success was effective multidisciplinary collaboration,
achieved through multidisciplinary team meetings and paperwork. Involving strong opinion leaders in
its development and ‘champions’ who drove through implementation and acted as a point of contact
helped facilitate implementation. The study highlighted the importance of ensuring that protocols are
sufficiently flexible to meet individual patient needs. Services should also prioritise strategies to empower
patients in their recovery through education.
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The study of patients’ experiences of the ERP found that hip and knee schools (classes) for patients
undergoing the surgeries were highly valued. Patients felt that they helped prepare them for surgery
and provided ‘confidence’ in the care they would receive. They were enthusiastic about the potential
for early discharge and invested in their recovery, preparing them to take on the role of ‘active’
participants in their care. Most thought that it was useful to practise exercises to prepare them for
postoperative mobilisation. Most participants were presented with the option of local or general
anaesthesia, although they had different experiences of this. Although some were given this option
during hip or knee schools or at their preoperative assessment, others were asked on the day of
surgery, meaning that they felt unable to make an informed choice. Patients were surprised about
being able to mobilise so quickly after surgery. There was a sense of pride in being able to fulfil what
they thought was required of them and they benchmarked their success against their preoperative
education and feedback from health-care professionals. Participants emphasised the importance of
participating in exercises and working towards their own recovery, engaging in the emotional and
physical work required of them as ‘active’ patients. Most of those interviewed reported feeling ‘ready’
to return home and considered it preferable to remaining in hospital. Some participants reported
feeling under pressure to be discharged before they felt well enough and this was linked to concerns
that they were being made to mobilise too quickly. A small number of participants attributed this to
a demand for beds. Those who lacked family support, particularly those who lived alone, were more
anxious. The study highlights how patients might value more information and support from health-care
professionals, particularly in the post-discharge period, to enable them to work more effectively
towards their own recovery.
Research in context
Although at a national level we did not observe any impact of the ERAS pathway on changing trends in
outcomes of surgery, hospitals will have implemented this at different time points, and may be early
adopters having already implemented many of the ERP components before the national programme
had begun. We therefore looked at the effect within individual hospitals within a region of England,
and conducted the statistical interrupted time series analysis within these individual hospitals, focusing
on the outcomes of pain/function and LOS. Three of these NHS hospitals were part of the qualitative
process evaluation, allowing us to set the findings of the statistical analysis in context of what we
observe from the qualitative data.
For all three of these hospitals, it is clear that there is no impact of the date they implemented ERAS
on the OHS and OKS pain and functional outcome scores, these generally being continuations of
existing trends. However, all three hospitals observed reductions in LOS over the study period.
In Shinebury, LOS for THR and TKR was already declining prior to the official ERAS start date, and it
continued to decline over the study duration. This hospital was an early adopter and innovator and
hence the official start date of 2009 from the NHS England planned care programme just reflects that
ERAS was already implemented prior to the official national programme. Enhanced recovery and early
discharge started as a research project for a hip arthroplasty database that the trust had been running
since 1998. ERAS was piloted in 2000, and was originally initiated by a key consultant surgeon and a
lead physiotherapist who has since moved on. Physiotherapists gradually took on more ERAS duties, in
the form of 2- and 6-week joint review clinics from about 2002, and then hip school from about 2004.
Digital versatile discs (DVDs) were first recored in 2005 and became available about 2006. Joint review
clinics originally included both hips and knees, but, as the number of patients increased, two separate
clinics were introduced (circa 2008). There were two nurses (sisters) who were the ‘main kind of driving
force behind the clinic’, and were also central points of contact for doctors and consultants. The hospital
won an innovation award in 2006 for implementing the DVD, booklet and clinic.
Fitness for surgery is evaluated at pre-assessment and includes full medical checks, and patients
sometimes attend hip/knee school on that same day as well. Follow-up takes place at the joint review
clinic at 2, 6 and 52 weeks; this takes place with the same team and in the same place as knee/hip
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school. If there are extra difficulties, the patient is seen by the consultant as an outpatient. All patients
have to attend hip/knee school and they receive a booklet and a DVD as part of this: ‘they are as
educated as they could possibly be’. The DVD includes consultants talking about THR surgery and
previous patients talking about their experiences, while demonstrating some of the exercises. Hip
and knee patients follow identical care pathways. Patients see OTs at pre-assessment and complete
questionnaires (home environment sheet) about their home environment, to assess the level of
support that will be needed post discharge. OTs have a printed list every week of joint patients coming
to pre-assessment, so that they know in advance who they are expecting and when. Patients do not
necessarily see an anaesthetist at pre-assessment, unless requested by the surgeon. For complex
patients, notes are given to the anaesthetist in between pre-assessment and surgery. Patients are seen
by physiotherapists and mobilised on day 1 after surgery. Joint review clinics are run by the lead
physiotherapist, OTs and specialised orthopaedic nurses.
What is surprising is that, although an ERAS service had been in place for many years, LOS for this
hospital trust (Shinebury) was still high at the start of the study in 2008, and was still able to decline
so much. This may partly reflect coding of hospitals in the HES database (see Appendix 1, Figure 29).
Shinebury Hospitals NHS Foundation Trust came into being in January 2012 as a result of the
integration of two different NHS trusts, which achieved foundation trust status in 2006. Separating
these sites out, we can see that LOS was already very low for THR at this site, whereas for TKR LOS
was much higher in both hospital sites.
In Towerton Hospital, LOS for both THR and TKR was relatively high, with a stable trend prior to the ERAS
start date; however, after the start date there was a significant reduction and decline in mean LOS (TKR:
5.6 days in April 2008 declining to 4.3 days in December 2016; THR: 6.2 days in April 2008 declining to
4.7 days in December 2016). In this hospital setting, there is a clear impact of ERAS on reducing LOS.
The process evaluation shows that Towerton Hospital had a very strong and comprehensive ERAS service.
There was a ‘nurse champion’ who, along with the matron, ran multidisciplinary team groups to decide how
to implement ERAS at the hospital, and ran education classes for staff. The surgical pre-assessment involves
a clinical assessment to establish patients’ fitness for surgery, taking next of kin details and who to call post
operation. Pre-assessment includes looking at patients’ social history and current living arrangements, and
home measurement forms are given to patients for them to complete and bring to hip/knee school, where
a physiotherapist or OT can pick them up. Patients see OTs one to one at the end of the hip/knee school
sessions if they are eligible for help (i.e. if they live in a certain postcode area). Equipment can be delivered
to eligible patients’ homes preoperatively. Physiotherapists see patients on the ward as soon as possible
post operation (sometimes day zero if appropriate, but no later than day 1 after surgery). Postoperative,
OTs do a washing/dressing and kitchen assessment, to see whether or not extra support from social
services is required. An ERAS nurse champion attends ward round meetings every morning, as do all
multidisciplinary team staff. The hospital uses a ‘step-down’ ward (part of a maternity unit at a nearby
hospital) for patients who are not quite ready to go home but are ‘too good’ to stay on the elective
ward. Follow-up knee classes are held in the outpatient department, which is at another local hospital.
Hip patients are not routinely scheduled for outpatient physiotherapy, unless they need it for a particular
reason. The hospital provides education sessions and a ‘rolling education programme’, so ERAS is an
ongoing and evolving concept.
In Elmfield Hospital, a different pattern was observed for THR and TKR. For THR, LOS was already
declining. However, after the ERAS start date, there was no further decline and, if anything, LOS started
to increase afterwards. For TKR, LOS was in decline and continued on the existing downwards trend
after the official ERAS start date. From the information obtained about the service, there does not
appear to be an officially running ERAS programme; rather, ERAS methods are used to reduce waiting
times for hip replacement but not for knee replacement. There are separate care pathways for hip
and knee patients. The initial implementation of ERAS for hips was through funding for a specialist
physiotherapist, and involved streaming patients to include those considered appropriate for it. This was
decided on the basis of a pro forma completed by patients, giving details of medical and social ‘fitness
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for it’. Patients whom Elmfield identified as suitable were flagged at the time they were first seen as
outpatients. However, this funding for the physiotherapist was lost after about 18 months. Currently,
it has a twice-monthly hip arthritis clinic set up to reduce waiting time, and a same-day assessment
clinic so patients attend only once for all preoperative assessments. The anaesthetists introduced an
anaesthetic protocol that included preoperative, perioperative and postoperative pain control and
management. There is a hip school that is run twice weekly. There is not a formal ERAS for knees, but
they do day-case UKR, and knee patients are also streamed according to comorbidities and analgesic
requirements, but there is no knee school. There is nothing in the patient pre-assessment clinic paperwork
to indicate that patients have been streamed to ERAS. At the beginning of ERAS implementation, home
visits were undertaken as standard; this no longer happens. OTs used to see patients in pre-admission,
but, since same-day assessment was introduced, they now see patients at a pre-admission clinic only if a
‘trigger’ has been flagged during the assessment; otherwise OTs do not see patients until hip school or
post operation. It is ‘not the norm’ for patients to be specially referred to an OT.
Final conclusions
Our data show that outcomes of primary THR and TKR have been gradually improving over time,
with a decrease in LOS, reduction in estimated average inpatient bed-day cost, improvement in
patient-reported outcomes of pain and function, decrease in complications and reduction in 5-year
revision risk. These trends of improving outcomes were seen across all age groups, and in those with
and without comorbidity. However, trends of improving outcomes had begun prior to the introduction
of the formal NHS ERAS roll-out and, hence, were not temporally associated with the national ERAS
programme. These findings are positive, in highlighting that reductions in LOS have been achieved
without adversely affecting patient outcomes.
Even though patient outcomes have been improving over time, analysis of the most recent years of
data identified potentially unwarranted variations in patient outcomes of THR and TKR. This variation
cannot be explained by differences in patient case mix, surgical factors or hospital organisational
factors. This information is informative to commissioners in monitoring variations in outcomes
of surgery.
The qualitative study of patients’ experiences of enhanced recovery illustrates how processes of care
were negotiated between patients and health-care professionals, along with the emotional and physical
work that patients did as ‘active’ participants in their recovery. Interviews with patients included
discussion around preoperative educational needs, tensions between mobilising and giving themselves
time to ‘heal’ after surgery, and challenges post discharge. The study also demonstrates that ‘good care’
remains an aspiration, particularly in the post-discharge period.
The ethnographic study, using observations and interviews of staff involved in delivery of ERAS,
demonstrates that successful implementation of ERAS services for hip and knee replacement depends
on several aspects, such as the extent to which services have been adapted to meet individual needs,
effective communication between staff and planning processes. Doing so provides information to
health-care providers on how best to organise and deliver these services in the future. The study may
also be of use to clinicians and researchers in helping to understand service delivery for ERAS in
other surgeries.
Implications for practice
There is variation in patient outcomes of primary THR and TKR. The determinants of this variation
remain unknown and cannot be explained by a hospital treating healthier or fitter patients. In those
hospitals with poorer outcomes, there is a need for hospital mangers and clinicians to understand why
their outcomes are worse than others and take action to address this.
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Reductions in LOS can be achieved without having a negative impact on patient outcomes. ERAS services
are valued by both patients and health professionals involved in running these services. Patients valued
hip and knee schools, feeling that they helped to prepare them for surgery and provided ‘confidence’
in the care they would receive. Patients emphasised the importance of participating in exercises and
working towards their own recovery, engaging in the emotional and physical work required of them as
‘active’ patients. Although we found no observed impact of the national implementation of ERAS on
patient outcomes, this probably reflects early adopters and innovators having already introduced ERAS
components into their service, with the continuing decline in LOS nationally reflecting additional hospitals
introducing ERAS. Exploring the effect of ERAS in individual hospitals, we can see that in sites that are
implementing ERAS for the first time (those with a relatively high and stable LOS prior to implementation
date), the introduction of ERAS can have an impact, with subsequent trends of reducing LOS. Those
hospitals that are still observed to have a high LOS in our current years of registry data would probably
see benefit from implementing ERAS principles.
Scope for future work
l Although national trends towards improved patient outcome are encouraging, there is still
substantial variation in outcome between hospital trusts and CCGs, so there is work to be done to
understand why these potentially unwarranted variations in patient outcome exist, particularly
those with consistently worse outcomes over time.
l Further research should explore patient experiences of referral from primary to secondary care
services, to provide a more comprehensive account of experiences through the care pathway. In
addition, future research may also consider GPs’ views and experiences of ERAS, particularly at the
points of referral and discharge. This would provide a ‘system-wide’ understanding of the delivery
of ERAS.
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Appendix 1 Additional tables and figures
TABLE 25 Descriptive statistics of variables included in the hip and knee models (data from 2014 to 2016)
Variable
Model
Hip replacements
(N= 173,107)
TKRs/UKRs
(N= 210,725)
Patient factors
Calendar year, n (%)
2014 57,156 (33.0) 69,001 (32.7)
2015 57,535 (33.2) 69,999 (33.2)
2016 58,416 (33.8) 71,725 (34.0)
Age (years), n (%)
< 50 7907 (4.6) 4180 (2.0)
50–59 22,887 (13.2) 26,789 (12.7)
60–69 51,097 (29.5) 68,970 (32.7)
70–79 61,994 (35.8) 79,241 (37.6)
80–84 19,426 (11.2) 21,753 (10.3)
≥ 85 9,796 (5.7) 9,792 (4.7)
Women, n (%) 103,860 (60.0) 119,436 (56.7)
BMI (kg/m2), mean (SD) 28.9 (5.2) 31.1 (5.5)
Preoperative ASA physical function score, n (%)
Fit and healthy (grade 1) 22,195 (12.8) 18,909 (9.0)
Mild disease not incapacitating (grade 2) 121,255 (70.1) 155,093 (73.6)
Incapacitating systemic disease (grade 3) 28,945 (16.7) 36,171 (17.2)
Life-threatening disease or expected to die within 24 hours
(grades 4 and 5)
712 (0.4) 552 (0.3)
IMD (quintile groupings), n (%)
Least deprived (20%) 42,058 (24.3) 46,435 (22.0)
Former less deprived (20–40%) 43,001 (24.8) 49,019 (23.3)
Current less deprived (40–60%) 31,200 (18.0) 40,216 (19.1)
More deprived (20–40%) 29,289 (16.9) 38,292 (18.2)
Most deprived (20%) 27,559 (15.9) 36,763 (17.5)
Rural/urban indicator, n (%)
Urban (≥ 10,000) 123,862 (71.6) 157,758 (74.9)
Town and fringe 22,223 (12.8) 25,083 (11.9)
Village/isolated 27,022 (15.6) 27,884 (13.2)
Primary indication, n (%)
Osteoarthritis 167,686 (96.9) 208,333 (98.9)
Osteoarthritis and other 5421 (3.1) 2392 (1.1)
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TABLE 25 Descriptive statistics of variables included in the hip and knee models (data from 2014 to 2016) (continued )
Variable
Model
Hip replacements
(N= 173,107)
TKRs/UKRs
(N= 210,725)
Charlson Comorbidity Index score, n (%)
0 (no comorbidity) 122,047 (70.5) 140,711 (66.8)
1 (mild comorbidity) 32,926 (19.0) 46,984 (22.3)
2 (moderate comorbidity) 11,870 (6.9) 15,341 (7.3)
≥ 3 (severe comorbidity) 6264 (3.6) 7689 (3.7)
Baseline OHS/OKS, median (IQR) 17 (11–23) 18 (12–23)
EQ-5D-3L (quintile groupings), n (%)
Lowest quintile 21,265 (12.3) 40,798 (19.4)
Second quintile 47,303 (27.3) 29,601 (14.1)
Third quintile 35,237 (20.4) 54,583 (25.9)
Fourth quintile 32,083 (18.5) 20,352 (9.7)
Highest quintile 37,219 (21.5) 65,391 (31.0)
Surgical factors
Lead surgeon experience, n (%)
Consultant 143,417 (82.9) 172,183 (81.7)
Other 29,690 (17.2) 38,542 (18.3)
Surgical volume per lead surgeon (surgeries per year), n (%)
≤ 10 3013 (1.4) 3109 (1.8)
11–50 45,279 (21.5) 37,816 (21.9)
51–75 41,610 (19.8) 30,651 (17.7)
76–100 38,898 (18.5) 30,979 (17.9)
101–150 45,056 (21.4) 36,610 (21.2)
> 150 36,869 (17.5) 33,942 (19.6)
Surgical volume per unit (surgeries per year), n (%)
≤ 200 45,319 (26.2) 31,321 (14.9)
200–299 47,040 (27.2) 51,335 (24.4)
300–399 37,984 (21.9) 50,346 (23.9)
400–499 10,159 (5.9) 32,782 (15.6)
≥ 500 32,605 (18.8) 44,941 (21.3)
Minimally invasive surgery, n (%) 7076 (4.1) 9332 (4.4)
Thromboprophylaxis, n (%)
None 1598 (0.9) 2049 (1.0)
Aspirin only 5219 (3.0) 7111 (3.4)
LMWH (± other) 109,443 (63.2) 152,836 (72.5)
Other (no LMWH) 56,847 (32.8) 48,729 (23.1)
Mechanical prophylaxis 167,638 (96.8) 204,642 (97.1)
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TABLE 25 Descriptive statistics of variables included in the hip and knee models (data from 2014 to 2016) (continued )
Variable
Model
Hip replacements
(N= 173,107)
TKRs/UKRs
(N= 210,725)
Anaesthetic type, n (%)
General 56,951 (32.9) 62,447 (29.6)
Regional: epidural 5230 (3.0) 6841 (3.3)
Regional: nerve block 8824 (5.1) 21,619 (10.3)
Regional: spinal (intrathecal) 131,627 (76.0) 157,123 (74.6)
Type of approach, n (%)
Anterior, anterolateral, Hardinge, lateral, trochanteric osteotomy, other 55,100 (31.8)
Posterior 118,007 (68.2)
Lateral parapatellar 1907 (0.9)
Medial parapatellar 197,718 (93.8)
Mid-vastus 5942 (2.8)
Subvastus 2302 (1.1)
Other approaches in knee surgery 2856 (1.4)
Bone grafts, n (%)
Femoral 921 (0.5) 2225 (1.1)
Cup 5669 (3.3)
Tibia 705 (0.3)
Primary cup fixation, n (%)
Cementless cup 110,862 (64.4)
Cemented cup 61,415 (35.7)
Type of primary stem fixation, n (%)
Cementless THR stem 72,509 (42.4)
Cemented THR stem 98,607 (57.6)
Primary femoral fixation, n (%)
Cementless 9461 (4.5)
Cemented 200,741 (95.5)
Tibial fixation, n (%)
Cementless 8855 (4.2)
Cemented 201,226 (95.8)
Bearing surface (type of hip implant), n (%)
MoM 991 (0.6)
MoP 106,548 (62.1)
CoC 20,821 (12.1)
CoP 43,138 (25.2)
CoM or MoC or unknown 23 (< 0.1)
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TABLE 25 Descriptive statistics of variables included in the hip and knee models (data from 2014 to 2016) (continued )
Variable
Model
Hip replacements
(N= 173,107)
TKRs/UKRs
(N= 210,725)
Femoral head size (mm) (type of hip implant), n (%)
≤ 28 55,652 (32.4)
32 75,536 (44.0)
36–42 39,556 (23.0)
≥ 44 1141 (0.7)
Type of knee implant, n (%)
Bicondylar 16,409 (7.8)
Unicondylar or hinged or linked or custom or preassembled 194,201 (92.2)
Hospital organisation factors
Unit type, n (%)
Public hospital 123,481 (71.3) 148,758 (70.6)
Independent sector: hospital 40,842 (23.6) 50,739 (24.1)
Independent sector: treatment centre 8784 (5.1) 11,228 (5.3)
FTE of specialty groups on trauma and orthopaedic surgery, n (%)
0–24 20,558 (11.9) 63,415 (30.1)
25–29 17,541 (10.1) 29,416 (14.0)
30–39 32,725 (18.9) 47,334 (22.5)
40–49 32,528 (18.8) 28,572 (13.6)
≥ 50 69,755 (40.3) 41,988 (19.9)
Consultant FTE, n (%)
0–24 40,108 (23.2) 92,154 (43.7)
25–29 15,788 (9.1) 21,437 (10.2)
30–39 32,530 (18.8) 33,396 (15.9)
40–49 23,966 (13.8) 25,209 (12.0)
≥ 50 60,715 (35.1) 38,529 (18.3)
Middle-grade doctor FTE, n (%)
0–24 97,397 (56.3) 151,270 (71.8)
25–29 18,900 (10.9) 17,590 (8.4)
30–39 21,667 (12.5) 19,425 (9.2)
40–49 14,362 (8.3) 9,306 (4.4)
≥ 50 20,781 (12.0) 13,134 (6.2)
Early-career doctor FTE, n (%)
0–24 168,646 (97.4) 208,405 (98.9)
25–29 3757 (2.2) 2055 (1.0)
30–39 704 (0.4) 265 (0.1)
40–49 0 (0.0) 0 (0.0)
≥ 50 0 (0.0) 0 (0.0)
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TABLE 25 Descriptive statistics of variables included in the hip and knee models (data from 2014 to 2016) (continued )
Variable
Model
Hip replacements
(N= 173,107)
TKRs/UKRs
(N= 210,725)
Total beds available overnight, n (%)
0–349 15,186 (8.8) 41,447 (19.7)
350–499 18,469 (10.7) 40,887 (19.4)
500–699 34,541 (20.0) 51,403 (24.4)
700–999 51,891 (30.0) 41,415 (19.7)
≥ 1000 53,020 (30.6) 35,573 (16.9)
Total beds available overnight for trauma and orthopaedic surgery, n (%)
0–34 15,873 (9.2) 59,732 (28.4)
35–49 26,118 (15.1) 46,946 (22.3)
50–69 47,209 (27.3) 53,577 (25.4)
70–99 52,178 (30.1) 32,574 (15.5)
≥ 100 31,729 (18.3) 17,896 (8.5)
Total beds available overnight for rehabilitation, n (%)
0 74,465 (57.8) 59,793 (54.5)
> 0–10 9605 (7.5) 8695 (7.9)
11–20 16,923 (13.1) 15,651 (14.3)
≥ 20 27,754 (21.6) 25,655 (23.4)
Operating theatres, n (%)
< 10 11,278 (6.5) 53,927 (25.6)
10–14 26,830 (15.5) 45,205 (21.5)
15–19 38,320 (22.1) 42,661 (20.2)
20–24 27,414 (15.8) 22,226 (10.6)
≥ 25 69,265 (40.0) 46,706 (22.2)
Dedicated day-case operating theatres, n (%)
0 24,951 (14.4) 39,251 (18.6)
1–2 32,531 (18.8) 51,685 (24.5)
3–4 37,891 (21.9) 47,745 (22.7)
5–6 42,126 (24.3) 27,857 (13.2)
≥ 7 35,608 (20.6) 44,187 (21.0)
CoC, ceramic on ceramic; CoM, ceramic on metal; CoP, ceramic on polyethylene; EQ-5D-3L, EuroQol-5 Dimensions,
three-level version; IMD, Index of Multiple Deprivation; LMWH, low-molecular-weight heparin; MoC, metal on ceramic;
MoP, metal on polyethylene.
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TABLE 26 Poisson multilevel models of LOS for patients who underwent planned primary hip replacement
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Intercept 1.16 1.13 to 1.20 < 0.01 1.17 1.14 to 1.21 < 0.01 1.13 1.09 to 1.17 < 0.01
Patient factors
Calendar year (reference: 2014)
2015 0.09 0.08 to 0.09 < 0.01 0.08 0.07 to 0.08 < 0.01 0.07 0.06 to 0.07 < 0.01
2016 0.05 0.04 to 0.05 < 0.01 0.04 0.03 to 0.04 < 0.01 0.03 0.03 to 0.04 < 0.01
Age (years) (reference: < 50 years)
50–59 0.01 < 0.01 to 0.03 0.12 0.01 –0.01 to 0.02 0.29 0.02 0.01 to 0.04 < 0.01
60–69 0.06 0.05 to 0.07 < 0.01 0.05 0.03 to 0.06 < 0.01 0.07 0.05 to 0.08 < 0.01
70–79 0.20 0.19 to 0.22 < 0.01 0.17 0.16 to 0.19 < 0.01 0.19 0.18 to 0.21 < 0.01
80–84 0.42 0.41 to 0.44 < 0.01 0.38 0.37 to 0.40 < 0.01 0.39 0.38 to 0.41 < 0.01
≥ 85 0.63 0.61 to 0.64 < 0.01 0.59 0.57 to 0.60 < 0.01 0.59 0.57 to 0.61 < 0.01
Sex (reference: female)
Male –0.09 –0.09 to –0.08 < 0.01 –0.09 –0.09 to –0.08 < 0.01 –0.09 –0.10 to –0.08 < 0.01
BMI (kg/m2) < 0.01 < 0.01 to < 0.01 < 0.01 < 0.01 < 0.01 to < 0.01 < 0.01 < 0.01 < 0.01 to < 0.01 < 0.01
Preoperative ASA physical function score (reference: mild disease not incapacitating, grade 2)
Fit and healthy (grade 1) –0.06 –0.07 to –0.05 < 0.01 –0.05 –0.06 to –0.05 < 0.01 –0.05 –0.06 to –0.04 < 0.01
Incapacitating systemic disease
(grade 3)
0.22 0.21 to 0.22 < 0.01 0.20 0.20 to 0.21 < 0.01 0.17 0.17 to 0.18 < 0.01
Life-threatening disease or expected to
die within 24 hours (grades 4 and 5)
0.43 0.40 to 0.46 < 0.01 0.41 0.38 to 0.44 < 0.01 0.36 0.33 to 0.39 < 0.01
IMD (reference: most deprived 20%)
Least deprived (20%) –0.04 –0.05 to –0.03 < 0.01 –0.03 –0.05 to –0.02 < 0.01 –0.02 –0.04 to –0.01 < 0.01
Former less deprived (20–40%) –0.03 –0.04 to –0.02 < 0.01 –0.03 –0.04 to –0.01 < 0.01 –0.02 –0.03 to –0.01 < 0.01
Current less deprived (40–60%) –0.02 –0.03 to –0.01 < 0.01 –0.02 –0.03 to –0.01 < 0.01 –0.02 –0.03 to –0.01 < 0.01
More deprived (20–40%) –0.01 –0.02 to < 0.01 0.07 –0.01 –0.02 to < 0.01 0.06 –0.01 –0.02 to < 0.01 0.11
A
P
P
E
N
D
IX
1
N
IH
R
Jo
u
rn
als
Lib
rary
w
w
w
.jo
u
rn
alslib
rary.n
ih
r.ac.u
k
1
4
8
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Rural/urban indicator (reference: urban ≥ 10,000 habitants)
Town and fringe –0.01 –0.02 to < 0.01 0.08 –0.01 –0.02 to < 0.01 0.14 < 0.01 –0.02 to 0.01 0.44
Village/isolated –0.02 –0.03 to –0.01 < 0.01 –0.02 –0.03 to –0.01 < 0.01 –0.01 –0.02 to < 0.01 0.04
Primary indication (reference: osteoarthritis)
Osteoarthritis and other 0.18 0.17 to 0.20 < 0.01 0.17 0.16 to 0.19 < 0.01 0.14 0.13 to 0.15 < 0.01
Charlson score (reference: none, 0)
Mild (1) 0.08 0.07 to 0.08 < 0.01 0.08 0.07 to 0.08 < 0.01 0.07 0.06 to 0.07 < 0.01
Moderate (2) 0.19 0.18 to 0.19 < 0.01 0.18 0.17 to 0.19 < 0.01 0.16 0.15 to 0.17 < 0.01
Severe (≥ 3) 0.34 0.33 to 0.35 < 0.01 0.33 0.32 to 0.34 < 0.01 0.30 0.29 to 0.32 < 0.01
EQ-5D-3L (reference: highest quintile)
Lowest quintile –0.13 –0.14 to –0.12 < 0.01 –0.13 –0.14 to –0.12 < 0.01 –0.12 –0.13 to –0.12 < 0.01
Second quintile –0.17 –0.18 to –0.16 < 0.01 –0.16 –0.17 to –0.16 < 0.01 –0.16 –0.17 to –0.15 < 0.01
Third quintile –0.20 –0.21 to –0.19 < 0.01 –0.19 0.20 to –0.18 < 0.01 –0.18 –0.19 to –0.17 < 0.01
Fourth quintile –0.24 –0.25 to –0.23 < 0.01 –0.23 –0.24 to –0.22 < 0.01 –0.22 –0.23 to –0.21 < 0.01
Surgical factors
Lead surgeon experience (reference: consultant)
Other 0.09 0.08 to 0.10 < 0.01 0.02 0.01 to 0.03 < 0.01
Surgical volume per lead surgeon (reference: > 150 surgeries per year)
≤ 10 0.11 0.09 to 0.13 < 0.01 0.04 0.03 to 0.06 < 0.01
11–50 0.08 0.07 to 0.09 < 0.01 0.02 0.02 to 0.03 < 0.01
51–75 0.05 0.04 to 0.06 < 0.01 0.01 < 0.01 to 0.02 0.01
76–100 0.03 0.02 to 0.04 < 0.01 < 0.01 –0.01 to 0.01 0.96
101–150 0.03 0.02 to 0.04 < 0.01 0.01 < 0.01 to 0.02 0.08
continued
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TABLE 26 Poisson multilevel models of LOS for patients who underwent planned primary hip replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Surgical volume per unit (reference: surgeries per year, ≥ 500)
≤ 200 0.05 0.04 to 0.06 < 0.01 0.14 0.13 to 0.15 < 0.01
200–299 < 0.01 –0.01 to 0.01 0.56 0.06 0.05 to 0.07 < 0.01
300–399 –0.04 –0.06 to –0.03 < 0.01 0.01 < 0.01 to 0.03 0.02
400–499 –0.04 –0.06 to –0.03 < 0.01 0.05 0.04 to 0.07 < 0.01
Minimally invasive surgery (reference: no)
Yes –0.05 –0.07 to –0.04 < 0.01 –0.03 –0.05 to –0.02 < 0.01
Thromboprophylaxis (reference: LMWH± other)
None < 0.01 –0.02 to 0.03 0.91 0.03 < 0.01 to 0.05 0.04
Aspirin only –0.03 –0.05 to –0.02 < 0.01 –0.02 –0.04 to –0.01 0.01
Other (no LMWH) –0.02 –0.03 to –0.02 < 0.01 < 0.01 < 0.01 to 0.01 0.42
Mechanical prophylaxis (reference: any)
None 0.08 0.06 to 0.09 < 0.01 0.03 0.01 to 0.04 < 0.01
General anaesthesia (reference: no)
Yes 0.04 0.03 to 0.05 < 0.01 0.04 0.03 to 0.04 < 0.01
Regional: epidural anaesthesia (reference: no)
Yes
Regional: nerve block anaesthesia (reference: no)
Yes 0.05 0.04 to 0.06 < 0.01 0.04 0.03 to 0.05 < 0.01
Regional: spinal anaesthesia (reference: no)
Yes –0.03 –0.04 to –0.03 < 0.01 –0.03 –0.04 to –0.02 < 0.01
Type of approach (reference: posterior)
Anterior, anterolateral, Hardinge, lateral,
trochanteric osteotomy, other
0.06 0.05 to 0.07 < 0.01 0.06 0.06 to 0.07 < 0.01
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Femoral bone graft (reference: no)
Yes 0.06 0.03 to 0.10 < 0.01 0.06 0.03 to 0.10 < 0.01
Cup bone graft (reference: no)
Yes 0.07 0.06 to 0.08 0.68 0.05 0.04 to 0.07 < 0.01
Primary cup fixation (reference: cementless)
Cemented –0.01 –0.02 to –0.01 < 0.01 –0.01 –0.02 to < 0.01 < 0.01
Type of primary stem fixation (reference: cemented THR stem)
Not available or resurfacing 0.01 –0.03 to 0.04 0.89 0.03 –0.01 to 0.06 0.13
Cementless THR stem –0.07 –0.08 to –0.07 1.00 –0.04 –0.05 to –0.04 < 0.01
Bearing surface (reference: MoP)
MoM –0.01 –0.10 to 0.09 < 0.01 –0.07 –0.17 to 0.02 0.14
CoC < 0.01 –0.01 to 0.01 < 0.01 –0.03 –0.04 to –0.02 < 0.01
CoP –0.02 –0.03 to –0.01 0.84 –0.04 –0.04 to –0.03 < 0.01
CoM or MoC or unknown 0.10 0.08 to 0.13 < 0.01 0.08 0.06 to 0.10 < 0.01
Femoral head size (mm) (reference: ≤ 28mm)
32 < 0.01 –0.01 to 0.01 0.51 –0.01 –0.01 to < 0.01 0.10
36–42 0.03 0.02 to 0.04 < 0.01 0.02 0.01 to 0.03 < 0.01
≥ 44 –0.03 –0.11 to 0.06 < 0.01 –0.04 –0.12 to 0.05 0.37
Hospital organisation factors
Unit type (reference: public hospital)
Independent sector: hospital –0.22 –0.23 to –0.21 < 0.01
Independent sector: treatment centre –0.40 –0.41 to –0.38 < 0.01
continued
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TABLE 26 Poisson multilevel models of LOS for patients who underwent planned primary hip replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
FTE of specialty groups on trauma and orthopaedic surgery (reference: 0–24 FTEs)
25–29 0.01 –0.01 to 0.02 0.40
30–39 0.03 0.02 to 0.04 < 0.01
40–49 0.03 0.01 to 0.04 < 0.01
> 50 0.04 0.03 to 0.05 < 0.01
Consultant FTE (reference: 0–24 FTEs)
25–29 0.03 0.02 to 0.04 < 0.01
30–39 0.04 0.03 to 0.05 < 0.01
40–49 0.03 0.01 to 0.04 < 0.01
> 50 0.04 0.02 to 0.06 < 0.01
Middle-grade doctor FTE (reference: 0–24 FTEs)
25–29 0.01 < 0.01 to 0.02 0.15
30–39 < 0.01 –0.01 to 0.01 0.77
40–49 0.01 < 0.01 to 0.02 0.10
> 50 0.04 0.03 to 0.05 < 0.01
Early-career doctor FTE (reference: 0–24 FTEs)
25–29 –0.01 –0.03 to 0.01 0.39
30–39 –0.05 –0.09 to –0.01 0.01
Total beds available overnight (reference: 0–349)
350–499 –0.04 –0.05 to –0.02 < 0.01
500–699 –0.03 –0.04 to –0.01 < 0.01
700–999 –0.05 –0.06 to –0.03 < 0.01
≥ 1000 –0.09 –0.11 to –0.07 < 0.01
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Total beds available overnight for trauma and orthopaedic surgery (reference: 0–34)
35–49 0.02 0.01 to 0.03 < 0.01
50–69 0.06 0.05 to 0.07 < 0.01
70–99 0.11 0.09 to 0.12 < 0.01
≥ 100 0.16 0.14 to 0.17 < 0.01
Total beds available overnight for rehabilitation (reference: 0)
> 0–10 0.01 –0.01 to 0.02 0.38
11–20 0.01 < 0.01 to 0.03 0.02
≥ 20 0.07 0.06 to 0.08 < 0.01
Operating theatres (reference: < 10)
10–14 0.01 –0.01 to 0.02 0.27
15–19 –0.02 –0.04 to < 0.01 0.01
20–24 –0.09 –0.11 to –0.07 < 0.01
≥ 25 –0.06 –0.08 to –0.04 < 0.01
Dedicated day-case operating theatres (reference: ≥ 7)
0 0.09 0.08 to 0.10 < 0.01
1–2 0.06 0.05 to 0.07 < 0.01
3–4 0.07 0.06 to 0.08 < 0.01
5–6 0.04 0.03 to 0.05 < 0.01
CoC, ceramic on ceramic; CoM, ceramic on metal; CoP, ceramic on polyethylene; EQ-5D-3L, EuroQol-5 Dimensions, three-level version; IMD, Index of Multiple Deprivation;
LMWH, low-molecular-weight heparin; MoC, metal on ceramic; MoP, metal on polyethylene.
D
O
I:
1
0
.3
3
1
0
/h
sd
r0
8
0
4
0
H
ealth
Services
an
d
D
elivery
R
esearch
2
0
2
0
V
o
l.8
N
o
.4
©
Q
u
een
’s
P
rin
ter
an
d
C
o
n
tro
ller
o
f
H
M
SO
2
0
2
0
.T
h
is
w
o
rk
w
as
pro
d
u
ced
b
y
Ju
d
ge
et
al.u
n
d
er
th
e
term
s
o
f
a
co
m
m
issio
n
in
g
co
n
tract
issu
ed
b
y
th
e
Secretary
o
f
State
fo
r
H
ealth
an
d
So
cial
C
are.T
h
is
issu
e
m
ay
b
e
freely
repro
d
u
ced
fo
r
th
e
pu
rpo
ses
o
f
private
research
an
d
stu
d
y
an
d
extracts
(o
r
in
d
eed
,
th
e
fu
ll
repo
rt)
m
ay
b
e
in
clu
d
ed
in
pro
fessio
n
al
jo
u
rn
als
pro
vid
ed
th
at
su
itab
le
ackn
o
w
led
gem
en
t
is
m
ad
e
an
d
th
e
repro
d
u
ctio
n
is
n
o
t
asso
ciated
w
ith
an
y
fo
rm
o
f
ad
vertisin
g.
A
pplicatio
n
s
fo
r
co
m
m
ercial
repro
d
u
ctio
n
sh
o
u
ld
b
e
ad
d
ressed
to
:
N
IH
R
Jo
u
rn
als
Lib
rary,
N
atio
n
al
In
stitu
te
fo
r
H
ealth
R
esearch
,
E
valu
atio
n
,
Trials
an
d
Stu
d
ies
C
o
o
rd
in
atin
g
C
en
tre,
A
lph
a
H
o
u
se,
U
n
iversity
o
f
So
u
th
am
pto
n
Scien
ce
P
ark,So
u
th
am
pto
n
SO
1
6
7
N
S,U
K
.
1
5
3
TABLE 27 Poisson multilevel models of LOS for patients who underwent planned primary knee replacement
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Intercept 1.08 1.05 to 1.12 < 0.01 1.09 1.05 to 1.13 < 0.01 1.26 1.22 to 1.30 < 0.01
Patient factors
Calendar year (reference: 2016)
2015 0.08 0.08 to 0.09 < 0.01 0.08 0.07 to 0.08 < 0.01 0.07 0.06 to 0.08 < 0.01
2016 0.04 0.04 to 0.05 < 0.01 0.04 0.03 to 0.04 < 0.01 0.03 0.03 to 0.04 < 0.01
Age (years) (reference: < 50 years)
50–59 –0.01 –0.03 to < 0.01 0.11 –0.04 –0.06 to –0.02 < 0.01 –0.03 –0.05 to –0.01 < 0.01
60–69 0.04 0.02 to 0.06 < 0.01 –0.01 –0.02 to 0.01 0.56 0.01 –0.01 to 0.03 0.20
70–79 0.17 0.15 to 0.19 < 0.01 0.11 0.10 to 0.13 < 0.01 0.13 0.11 to 0.15 < 0.01
80–84 0.38 0.36 to 0.40 < 0.01 0.32 0.30 to 0.33 < 0.01 0.32 0.31 to 034 < 0.01
≥ 85 0.56 0.54 to 0.58 < 0.01 0.50 0.48 to 0.52 < 0.01 0.49 0.47 to 0.51 < 0.01
Sex (reference: female)
Male –0.05 –0.05 to –0.04 < 0.01 –0.04 –0.05 to –0.04 < 0.01 –0.04 –0.05 to –0.04 < 0.01
BMI (kg/m2) < 0.01 < 0.01 to < 0.01 < 0.01 < 0.01 < 0.01 to < 0.01 < 0.01 < 0.01 < 0.01 to < 0.01 < 0.01
Preoperative ASA physical function score (reference: mild disease not incapacitating, grade 2)
Fit and healthy (grade 1) –0.06 –0.07 to –0.05 < 0.01 –0.05 –0.06 to –0.04 < 0.01 –0.03 –0.04 to –0.03 < 0.01
Incapacitating systemic disease (grade 3) 0.20 0.19 to 0.20 < 0.01 0.18 0.18 to 0.19 < 0.01 0.15 0.15 to 0.16 < 0.01
Life-threatening disease or expected to
die within 24 hours (grades 4 and 5)
0.39 0.36 to 0.42 < 0.01 0.37 0.34 to 0.40 < 0.01 0.32 0.29 to 0.35 < 0.01
IMD (reference: most deprived 20%)
Least deprived (20%) –0.03 –0.04 to –0.02 < 0.01 –0.02 –0.03 to –0.01 < 0.01 –0.01 –0.02 to < 0.01 0.03
Former less deprived (20–40%) –0.01 –0.02 to < 0.01 0.02 –0.01 –0.02 to < 0.01 0.15 < 0.01 –0.01 to 0.01 0.98
Current less deprived (40–60%) –0.01 –0.02 to < 0.01 0.22 < 0.01 –0.01 to 0.01 0.40 < 0.01 –0.01 to 0.01 0.53
More deprived (20–40%) < 0.01 –0.01 to 0.01 0.85 < 0.01 –0.01 to 0.01 0.89 < 0.01 –0.01 to 0.01 0.75
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Rural/urban indicator (reference: urban ≥ 10,000 habitants)
Town and fringe –0.01 –0.02 to < 0.01 0.20 –0.01 –0.02 to < 0.01 0.18 < 0.01 –0.01 to 0.01 0.38
Village/isolated –0.02 –0.03 to –0.01 < 0.01 –0.02 –0.03 to –0.01 < 0.01 –0.01 –0.02 to < 0.01 0.02
Primary indication (reference: osteoarthritis)
Osteoarthritis and other 0.16 0.15 to 0.18 < 0.01 0.15 0.13 to 0.16 < 0.01 0.11 0.09 to 0.13 < 0.01
Charlson score (reference: none, 0)
Mild (1) 0.07 0.07 to 0.08 < 0.01 0.08 0.07 to 0.08 < 0.01 0.07 0.06 to 0.07 < 0.01
Moderate (2) 0.18 0.17 to 0.19 < 0.01 0.18 0.17 to 0.18 < 0.01 0.16 0.15 to 0.16 < 0.01
Severe (≥ 3) 0.31 0.30 to 0.32 < 0.01 0.31 0.30 to 0.32 < 0.01 0.28 0.27 to 0.29 < 0.01
EQ-5D-3L (reference: lowest quintile)
Second quintile –0.10 –0.11 to –0.10 < 0.01 –0.10 –0.11 to –0.09 < 0.01 –0.10 –0.10 to –0.09 < 0.01
Third quintile –0.13 –0.14 to –0.13 < 0.01 –0.13 –0.14 to –0.12 < 0.01 –0.12 –0.13 to –0.12 < 0.01
Fourth quintile –0.16 –0.17 to –0.15 < 0.01 –0.15 –0.16 to –0.14 < 0.01 –0.14 –0.15 to –0.13 < 0.01
Highest quintile –0.20 –0.21 to –0.19 < 0.01 –0.19 –0.20 to –0.19 < 0.01 –0.18 –0.19 to –0.18 < 0.01
Surgical factors
Lead surgeon experience (reference: consultant)
Other 0.09 0.08 to 0.09 < 0.01 0.01 < 0.01 to 0.02 < 0.01
Surgical volume per lead surgeon (reference: > 150 surgeries per year)
≤ 10 0.10 0.08 to 0.12 < 0.01 0.03 0.01 to 0.04 0.01
11–50 0.08 0.07 to 0.09 < 0.01 0.01 0.01 to 0.02 < 0.01
51–75 0.07 0.06 to 0.08 < 0.01 0.02 0.01 to 0.03 < 0.01
76–100 0.05 0.05 to 0.06 < 0.01 0.01 0.01 to 0.02 < 0.01
101–150 0.03 0.02 to 0.04 < 0.01 < 0.01 –0.01 to 0.01 0.67
continued
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TABLE 27 Poisson multilevel models of LOS for patients who underwent planned primary knee replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Surgical volume per unit (reference: surgeries per year, ≥ 500)
≤ 200 0.06 0.05 to 0.07 < 0.01 0.10 0.09 to 0.11 < 0.01
200–299 0.01 < 0.01 to 0.01 0.23 0.01 0.01 to 0.02 < 0.01
300–399 –0.03 –0.04 to –0.02 < 0.01 –0.02 –0.03 to –0.01 < 0.01
400–499 –0.03 –0.04 to –0.02 < 0.01 –0.02 –0.03 to –0.01 < 0.01
Minimally invasive surgery (reference: no)
Yes –0.07 –0.08 to –0.05 < 0.01 –0.05 –0.07 to –0.04 < 0.01
Thromboprophylaxis (reference: LMWH± other)
None –0.05 –0.07 to –0.03 < 0.01 –0.02 –0.04 to 0.01 0.21
Aspirin only –0.02 –0.04 to –0.01 0.01 –0.02 –0.03 to < 0.01 0.01
Other (no LMWH) –0.01 –0.02 to –0.01 < 0.01 0.01 < 0.01 to 0.02 < 0.01
Mechanical prophylaxis (reference: any)
None 0.08 0.06 to 0.09 < 0.01 0.02 < 0.01 to 0.03 0.01
General anaesthesia (reference: no)
Yes 0.05 0.05 to 0.06 < 0.01 0.05 0.05 to 0.06 < 0.01
Regional: epidural anaesthesia (reference: no)
Yes 0.04 0.03 to 0.05 < 0.01 0.02 0.01 to 0.03 < 0.01
Regional: nerve block anaesthesia (reference: no)
Yes 0.05 0.04 to 0.05 < 0.01 0.03 0.02 to 0.04 < 0.01
Regional: spinal anaesthesia (reference: no)
Yes
Type of approach (reference: medial parapatellar)
Lateral parapatellar 0.08 0.06 to 0.11 < 0.01 0.07 0.04 to 0.09 < 0.01
Mid-vastus –0.06 –0.07 to –0.05 < 0.01 –0.07 –0.08 to –0.05 < 0.01
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Subvastus –0.04 –0.07 to –0.02 < 0.01 –0.03 –0.05 to < 0.01 0.02
Other 0.04 0.02 to 0.06 < 0.01 0.04 0.02 to 0.06 < 0.01
Femoral bone graft (reference: no)
Yes 0.02 < 0.01 to 0.04 0.04 0.03 0.01 to 0.05 0.02
Tibia bone graft (reference: no)
Yes 0.10 0.07 to 0.14 < 0.01 0.09 0.05 to 0.13 < 0.01
Primary femoral fixation (reference: cemented)
Cementless
Primary tibial fixation (reference: cemented)
Cementless
Type of knee implant (reference: bicondylar)
Unicondylar, hinged, linked, custom or
preassembled
–0.24 –0.25 to –0.22 < 0.01 –0.25 –0.26 to –0.24 < 0.01
Hospital organisation factors
Unit type (reference: public hospital)
Independent sector: hospital –0.26 –0.27 to –0.26 < 0.01
Independent sector: treatment centre –0.44 –0.45 to –0.42 < 0.01
FTE of specialty groups on trauma and orthopaedic surgery (reference: 0–24 FTEs)
25–29 0.02 0.01 to 0.03 < 0.01
30–39 0.02 0.02 to 0.03 < 0.01
40–49 0.05 0.04 to 0.06 < 0.01
> 50 0.06 0.05 to 0.07 < 0.01
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TABLE 27 Poisson multilevel models of LOS for patients who underwent planned primary knee replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Consultant FTE (reference: 0–24 FTEs)
25–29 0.02 0.01 to 0.03 < 0.01
30–39 0.01 < 0.0 to –0.02 0.02
40–49 0.02 0.01 to 0.03 < 0.01
> 50 0.04 0.02 to 0.05 < 0.01
Middle-grade doctor FTE (reference: 0–24 FTEs)
25–29 0.01 < 0.01 to 0.02 0.01
30–39 0.04 0.03 to 0.05 < 0.01
40–49 0.03 0.02 to 0.05 < 0.01
> 50 0.04 0.02 to 0.06 < 0.01
Early-career doctor FTE (reference: 0–24 FTEs)
25–29
30–39
Total beds available overnight (reference: 0–349)
350–499 –0.03 –0.04 to –0.02 < 0.01
500–699 –0.06 –0.07 to –0.05 < 0.01
700–999 –0.08 –0.09 to –0.07 < 0.01
≥ 1000 –0.10 –0.12 to –0.08 < 0.01
Total beds available overnight for trauma and orthopaedic surgery (reference: 0–34)
35–49 0.02 0.01 to 0.03 < 0.01
50–69 0.03 0.03 to 0.04 < 0.01
70–99 0.04 0.02 to 0.05 < 0.01
≥ 100 0.05 0.03 to 0.07 < 0.01
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Total beds available overnight for rehabilitation (reference: 0)
> 0–10 < 0.01 –0.02 to 0.01 0.93
11–20 < 0.01 –0.02 to 0.01 0.62
≥ 20 0.03 0.02 to 0.04 < 0.01
Operating theatres (reference: < 10)
10–14 –0.02 –0.03 to –0.01 < 0.01
15–19 –0.01 –0.02 to < 0.01 0.20
20–24 –0.04 –0.06 to –0.03 < 0.01
≥ 25 –0.06 –0.08 to –0.04 < 0.01
Dedicated day-case operating theatres (reference: ≥ 7)
0 < 0.01 < 0.01 to 0.01 0.35
1–2 0.01 < 0.01 to 0.01 0.23
3–4 < 0.01 –0.01 to 0.01 0.49
5–6 0.01 < 0.01 to 0.02 0.01
EQ-5D-3L, EuroQol-5 Dimensions, three-level version; IMD, Index of Multiple Deprivation; LMWH, low-molecular-weight heparin.
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TABLE 28 Continuous multilevel models of OHS for patients who underwent planned primary hip replacement
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Intercept 35.1 34.3 to 35.8 < 0.01 36.3 35.4 to 37.1 < 0.01 35.9 35.1 to 36.8 < 0.01
Patient factors
Calendar year (reference: 2014)
2015 –0.4 –0.5 to –0.2 < 0.01 –0.2 –0.4 to –0.1 0.01 –0.2 –0.4 to –0.1 0.01
2016 –0.1 –0.3 to 0.1 0.23 0.0 –0.2 to 0.1 0.65 0.0 –0.2 to 0.1 0.67
Age (years) (reference: < 50 years)
50–59 0.5 0.2 to 0.9 < 0.01 0.6 0.3 to 1.0 < 0.01 0.6 0.3 to 0.9 < 0.01
60–69 0.8 0.5 to 1.1 < 0.01 1.1 0.7 to 1.4 < 0.01 1.0 0.7 to 1.3 < 0.01
70–79 < 0.1 –0.4 to 0.3 0.82 0.4 0.1 to 0.8 0.01 0.4 0.1 to 0.7 0.02
80–84 –1.0 –1.3 to –0.6 < 0.01 –0.4 –0.7 to 0.0 0.05 –0.4 –0.8 to < 0.1 0.03
≥ 85 –1.6 –2.0 to –1.2 < 0.01 –1.0 –1.4 to –0.5 < 0.01 –1.0 –1.4 to –0.6 < 0.01
Sex (reference: female)
Male 0.5 0.1 to 0.8 0.01 0.4 < 0.1 to 0.8 0.03 0.4 < 0.1 to 0.7 0.04
BMI (kg/m2) –0.1 –0.1 to –0.1 < 0.01 –0.1 –0.1 to –0.1 < 0.01 –0.1 –0.1 to –0.1 < 0.01
Preoperative ASA physical function score (reference: mild disease not incapacitating, grade 2)
Fit and healthy (grade 1) 1.0 0.8 to 1.2 < 0.01 1.0 0.8 to 1.1 < 0.01 0.9 0.8 to 1.1 < 0.01
Incapacitating systemic disease (grade 3) –1.6 –1.8 to –1.4 < 0.01 –1.5 –1.7 to –1.4 < 0.01 –1.4 –1.6 to –1.3 < 0.01
Life-threatening disease or expected to
die within 24 hours (grades 4 and 5)
–2.6 –3.6 to –1.5 < 0.01 –2.5 –3.6 to –1.5 < 0.01 –2.4 –3.4 to –1.3 < 0.01
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
IMD (reference: most deprived 20%)
Least deprived (20%) 1.6 1.4 to 1.8 < 0.01 1.5 1.3 to 1.7 < 0.01 1.5 1.3 to 1.7 < 0.01
Former less deprived (20–40%) 1.3 1.1 to 1.5 < 0.01 1.2 1.0 to 1.4 < 0.01 1.2 1.0 to 1.4 < 0.01
Current less deprived (40–60%) 0.6 0.4 to 0.8 < 0.01 0.6 0.4 to 0.8 < 0.01 0.6 0.4 to 0.8 < 0.01
More deprived (20–40%) 0.2 < 0.1 to 0.4 0.03 0.2 < 0.1 to 0.5 0.03 0.2 < 0.1 to 0.5 0.02
Rural/urban indicator (reference: urban ≥ 10,000 habitants)
Town and fringe 0.4 0.2 to 0.6 < 0.01 0.4 0.2 to 0.6 < 0.01 0.4 0.2 to 0.6 < 0.01
Village/isolated 0.8 0.6 to 0.9 < 0.01 0.8 0.6 to 0.9 < 0.01 0.7 0.5 to 0.9 < 0.01
Primary indication (reference: osteoarthritis)
Osteoarthritis and other
Charlson Comorbidity Index score (reference: none, 0)
Mild (1) –1.0 –1.1 to –0.8 < 0.01 –1.0 –1.1 to –0.8 < 0.01 –0.9 –1.1 to –0.8 < 0.01
Moderate (2) –1.2 –1.4 to –0.9 < 0.01 –1.1 –1.4 to –0.9 < 0.01 –1.1 –1.3 to –0.8 < 0.01
Severe (≥ 3) –1.1 –1.5 to –0.8 < 0.01 –1.1 –1.4 to –0.8 < 0.01 –1.0 –1.4 to –0.7 < 0.01
OHS baseline (points) –0.8 –0.8 to –0.8 < 0.01 –0.8 –0.8 to –0.8 < 0.01 –0.8 –0.8 to –0.8 < 0.01
EQ-5D-3L (reference: highest quintile)
Lowest quintile 2.3 2.0 to 2.5 < 0.01 2.3 2.0 to 2.5 < 0.01 2.3 2.0 to 2.5 < 0.01
Second quintile 3.3 3.1 to 3.6 < 0.01 3.3 3.0 to 3.6 < 0.01 3.3 3.0 to 3.5 < 0.01
Third quintile 3.2 2.9 to 3.5 < 0.01 3.2 2.9 to 3.5 < 0.01 3.2 2.9 to 3.4 < 0.01
Fourth quintile 3.9 3.6 to 4.2 < 0.01 3.9 3.6 to 4.2 < 0.01 3.9 3.6 to 4.2 < 0.01
Female × EQ-5D-3L (reference: highest quintile)
Female × lowest quintile 0.9 0.5 to 1.3 < 0.01 0.9 0.5 to 1.3 < 0.01 0.9 0.5 to 1.4 < 0.01
Female × second quintile 0.3 –0.1 to 0.7 0.17 0.3 –0.1 to 0.7 0.16 0.3 –0.1 to 0.8 0.13
Female × third quintile 0.7 0.3 to 1.1 < 0.01 0.7 0.3 to 1.1 < 0.01 0.7 0.3 to 1.2 < 0.01
Female × fourth quintile 0.5 0.1 to 0.9 0.03 0.5 0.1 to 0.9 0.03 0.5 0.1 to 0.9 0.02
continued
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TABLE 28 Continuous multilevel models of OHS for patients who underwent planned primary hip replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Surgical factors
Lead surgeon experience (reference: consultant)
Other –0.6 –0.7 to –0.4 < 0.01 –0.3 –0.4 to –0.1 < 0.01
Surgical volume per lead surgeon (reference: > 150 surgeries per year)
≤ 10 –1.2 –1.6 to –0.8 < 0.01 –1.0 –1.5 to –0.6 < 0.01
11–50 –0.7 –0.9 to –0.5 < 0.01 –0.6 –0.8 to –0.4 < 0.01
51–75 –0.5 –0.7 to –0.4 < 0.01 –0.5 –0.7 to –0.3 < 0.01
76–100 –0.5 –0.7 to –0.3 < 0.01 –0.4 –0.6 to –0.2 < 0.01
101–150 –0.3 –0.5 to –0.1 < 0.01 –0.3 –0.5 to –0.1 < 0.01
Surgical volume per unit (reference: surgeries per year, ≥ 500)
≤ 200 –0.2 –0.4 to < 0.1 0.13
200–299 –0.2 –0.4 to < 0.1 0.04
300–399 –0.1 –0.3 to 0.1 0.16
400–499 0.1 –0.2 to 0.4 0.53
Minimally invasive surgery (reference: no)
Yes
Thromboprophylaxis (reference: LMWH± other)
None
Aspirin only
Other (no LMWH)
Mechanical prophylaxis (reference: any)
None
General anaesthesia (reference: no)
Yes –0.3 –0.4 to –0.1 < 0.01 –0.3 –0.5 to –0.1 < 0.01
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Regional: epidural anaesthesia (reference: no)
Yes
Regional: nerve block anaesthesia (reference: no)
Yes
Regional: spinal anaesthesia (reference: no)
Yes 0.4 0.2 to 0.5 < 0.01 0.3 0.2 to 0.5 < 0.01
Type of approach (reference: posterior)
Anterior, anterolateral, Hardinge, lateral,
trochanteric osteotomy, other
–0.9 –1.0 to –0.8 < 0.01 –0.9 –1.0 to –0.7 < 0.01
Femoral bone graft (reference: no)
Yes –0.8 –1.6 to –0.1 0.03 –0.8 –1.5 to < 0.1 0.05
Cup bone graft (reference: no)
Yes 0.5 0.2 to 0.8 < 0.01 0.5 0.2 to 0.8 < 0.01
Primary cup fixation (reference: cementless)
Cemented –0.6 –0.8 to –0.5 < 0.01 –0.6 –0.7 to –0.4 < 0.01
Type of primary stem fixation (reference: cemented THR stem)
Not available or resurfacing < 0.1 –0.8 to 0.9 0.91
Cementless THR stem < 0.1 –0.1 to 0.1 0.94
Bearing surface (reference: MoP)
MoM –1.7 –3.9 to 0.4 0.11 –1.6 –3.6 to 0.3 0.10
CoC 0.2 < 0.1 to 0.5 0.03 0.3 0.1 to 0.6 < 0.01
CoP 0.2 0.1 to 0.4 < 0.01 0.3 0.1 to 0.4 < 0.01
CoM, MoC or unknown –0.5 –1.1 to 0.1 0.07 –0.4 –1.0 to 0.2 0.20
continued
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TABLE 28 Continuous multilevel models of OHS for patients who underwent planned primary hip replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Femoral head size (mm) (reference: ≤ 28mm)
32 0.1 –0.1 to 0.2 0.45 0.1 –0.1 to 0.2 0.32
36–42 < 0.1 –0.2 to 0.2 0.91 < 0.1 –0.2 to 0.2 0.64
≥ 44 2.0 0.2 to 3.8 0.03 2.1 0.3 to 3.9 0.02
Hospital organisation factors
Unit type (reference: public hospital)
Independent sector: hospital 0.8 0.6 to 0.9 < 0.01
Independent sector: treatment centre 1.0 0.7 to 1.3 < 0.01
FTE of specialty groups on trauma and orthopaedic surgery (reference: 0–24 FTEs)
25–29
30–39
40–49
> 50
Consultant FTE (reference: 0–24 FTEs)
25–29
30–39
40–49
> 50
Middle-grade doctor FTE (reference: 0–24 FTEs)
25–29
30–39
40–49
> 50
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Early-career doctor FTE (reference: 0–24 FTEs)
25–29
30–39
Total beds available overnight (reference: 0–349)
350–499 –0.5 –0.8 to –0.2 < 0.01
500–699 –0.7 –1.0 to –0.4 < 0.01
700–999 –0.7 –1.0 to –0.4 < 0.01
≥ 1000 –0.8 –1.1 to –0.4 < 0.01
Total beds available overnight for trauma and orthopaedic surgery (reference: 0–34)
35–49
50–69
70–99
≥ 100
Total beds available overnight for rehabilitation (reference: 0)
> 0–10
11–20
≥ 20
continued
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TABLE 28 Continuous multilevel models of OHS for patients who underwent planned primary hip replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Operating theatres (reference: < 10)
10–14 0.4 0.1 to 0.7 0.02
15–19 0.7 0.3 to 1.0 < 0.01
20–24 0.6 0.3 to 1.0 < 0.01
≥ 25 0.6 0.2 to 1.0 < 0.01
Dedicated day-case operating theatres (reference: ≥ 7)
0 –0.2 –0.4 to < 0.1 0.12
1–2 –0.3 –0.5 to < 0.1 0.02
3–4 < 0.1 –0.2 to 0.2 0.89
5–6 –0.1 –0.3 to 0.1 0.19
CoC, ceramic on ceramic; CoM, ceramic on metal; CoP, ceramic on polyethylene; EQ-5D-3L, EuroQol-5 Dimensions, three-level version; IMD, Index of Multiple Deprivation;
LMWH, low-molecular-weight heparin; MoC, metal on ceramic; MoP, metal on polyethylene.
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TABLE 29 Continuous multilevel models of OKS for patients who underwent planned primary knee replacement
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Intercept 25.62 24.89 to 26.35 < 0.01 25.96 25.18 to 26.73 < 0.01 25.61 24.84 to 26.38 < 0.01
Patient factors
Calendar year (reference: 2014)
2015 –0.74 –0.90 to –0.58 < 0.01 –0.71 –0.87 to –0.55 < 0.01 –0.69 –0.85 to –0.53 < 0.01
2016 –0.56 –0.72 to –0.40 < 0.01 –0.57 –0.73 to –0.41 < 0.01 –0.56 –0.72 to –0.40 < 0.01
Age (years) (reference: < 50 years)
50–59 1.30 0.76 to 1.85 < 0.01 1.30 0.76 to 1.85 < 0.01 1.26 0.71 to 1.81 < 0.01
60–69 2.57 2.04 to 3.10 < 0.01 2.56 2.03 to 3.09 < 0.01 2.51 1.98 to 3.03 < 0.01
70–79 2.92 2.39 to 3.45 < 0.01 2.92 2.39 to 3.45 < 0.01 2.86 2.33 to 3.39 < 0.01
80–84 2.54 1.99 to 3.09 < 0.01 2.53 1.98 to 3.08 < 0.01 2.48 1.93 to 3.03 < 0.01
≥ 85 2.23 1.64 to 2.82 < 0.01 2.21 1.62 to 2.80 < 0.01 2.18 1.59 to 2.77 < 0.01
Sex (reference: female)
Male 0.38 0.27 to 0.50 < 0.01 0.38 0.26 to 0.49 < 0.01 0.38 0.27 to 0.50 < 0.01
BMI (kg/m2) –0.08 –0.09 to –0.07 < 0.01 –0.08 –0.09 to –0.07 < 0.01 –0.07 –0.08 to –0.06 < 0.01
Preoperative ASA physical function score (reference: mild disease not incapacitating, grade 2)
Fit and healthy (grade 1) 0.80 0.60 to 1.01 < 0.01 0.81 0.60 to 1.01 < 0.01 0.77 0.57 to 0.98 < 0.01
Incapacitating systemic disease
(grade 3)
–1.16 –1.32 to –1.00 < 0.01 –1.13 –1.29 to –0.97 < 0.01 –1.05 –1.21 to –0.90 < 0.01
Life-threatening disease or expected to die
within 24 hours (reference: grades 4 and 5)
–3.11 –4.36 to –1.86 < 0.01 –3.07 –4.32 to –1.82 < 0.01 –2.94 –4.19 to –1.69 < 0.01
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TABLE 29 Continuous multilevel models of OKS for patients who underwent planned primary knee replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
IMD (reference: most deprived 20%)
Least deprived (20%) 1.31 1.10 to 1.52 < 0.01 1.30 1.09 to 1.50 < 0.01 1.28 1.07 to 1.49 < 0.01
Former less deprived (20–40%) 1.08 0.89 to 1.28 < 0.01 1.07 0.87 to 1.26 < 0.01 1.05 0.85 to 1.25 < 0.01
Current less deprived (40–60%) 0.45 0.25 to 0.65 < 0.01 0.44 0.23 to 0.64 < 0.01 0.44 0.23 to 0.64 < 0.01
More deprived (20–40%) 0.27 0.07 to 0.48 0.01 0.26 0.06 to 0.47 0.01 0.27 0.06 to 0.47 0.01
Rural/urban indicator (reference: urban ≥ 10,000 habitants)
Town and fringe 0.47 0.28 to 0.67 < 0.01 0.48 0.29 to 0.68 < 0.01 0.48 0.28 to 0.67 < 0.01
Village/isolated 0.84 0.65 to 1.03 < 0.01 0.85 0.66 to 1.04 < 0.01 0.83 0.64 to 1.02 < 0.01
Primary indication (reference: osteoarthritis)
Osteoarthritis and other
Charlson Comorbidity Index score (reference: none, 0)
Mild (1) –1.01 –1.15 to –0.88 < 0.01 –1.02 –1.15 to –0.88 < 0.01 –1.00 –1.13 to –0.86 < 0.01
Moderate (2) –0.97 –1.19 to –0.75 < 0.01 –0.96 –1.18 to –0.74 < 0.01 –0.91 –1.13 to –0.69 < 0.01
Severe (≥ 3) –1.28 –1.59 to –0.97 < 0.01 –1.27 –1.58 to –0.96 < 0.01 –1.22 –1.53 to –0.91 < 0.01
OKS baseline (points) –0.67 –0.68 to –0.66 < 0.01 –0.68 –0.69 to –0.67 < 0.01 –0.68 –0.69 to –0.67 < 0.01
EQ-5D-3L (reference: lowest quintile)
Second quintile 2.68 2.48 to 2.88 < 0.01 2.67 2.47 to 2.87 < 0.01 2.66 2.46 to 2.86 < 0.01
Third quintile 3.06 2.88 to 3.25 < 0.01 3.04 2.86 to 3.23 < 0.01 3.02 2.84 to 3.21 < 0.01
Fourth quintile 2.43 2.19 to 2.68 < 0.01 2.42 2.17 to 2.66 < 0.01 2.40 2.15 to 2.64 < 0.01
Highest quintile 3.81 3.60 to 4.01 < 0.01 3.78 3.57 to 3.99 < 0.01 3.77 3.56 to 3.98 < 0.01
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Surgical factors
Lead surgeon experience (reference: consultant)
Other –0.49 –0.63 to –0.34 < 0.01 –0.28 –0.43 to –0.12 < 0.01
Surgical volume per lead surgeon (reference: > 150 surgeries per year)
≤ 10 –0.54 –1.01 to –0.06 0.03
11–50 –0.33 –0.52 to –0.13 < 0.01
51–75 –0.23 –0.43 to –0.03 0.03
76–100 –0.08 –0.27 to 0.12 0.43
101–150 –0.16 –0.35 to 0.03 0.10
Surgical volume per unit (reference: surgeries per year, ≥ 500)
≤ 200 –0.19 0.42 to 0.03 0.10 –0.43 –0.66 to –0.20 < 0.01
200–299 –0.20 –0.40 to 0.01 0.06 –0.29 –0.50 to –0.08 0.01
300–399 –0.04 –0.23 to 0.16 0.71 –0.08 –0.28 to 0.11 0.40
400–499 –0.37 –0.59 to –0.15 < 0.01 –0.40 –0.62 to –0.19 < 0.01
Minimally invasive surgery (reference: no)
Yes
Thromboprophylaxis (reference: LMWH± other)
None
Aspirin only
Other (no LMWH)
Mechanical prophylaxis (reference: any)
None –0.37 –0.71 to –0.03 0.04
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TABLE 29 Continuous multilevel models of OKS for patients who underwent planned primary knee replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
General anaesthesia (reference: no)
Yes –0.41 –0.59 to –0.23 < 0.01 –0.46 –0.64 to –0.28 < 0.01
Regional: epidural anaesthesia (reference: no)
Yes
Regional: nerve block anaesthesia (reference: no)
Yes
Regional: spinal anaesthesia (reference: no)
Yes 0.29 0.10 to 0.48 < 0.01 0.25 0.07 to 0.44 0.01
Type of approach (reference: medial parapatellar)
Lateral parapatellar 0.40 –0.23 to 1.02 0.21 0.45 –0.17 to 1.08 0.16
Mid-vastus 0.17 –0.18 to 0.52 0.34 0.20 –0.15 to 0.56 0.26
Subvastus 0.67 0.11 to 1.24 0.02 0.63 0.07 to 1.19 0.03
Other –0.10 –0.59 to 0.39 0.70 –0.10 –0.59 to 0.39 0.70
Femoral bone graft (reference: no)
Yes
Tibia bone graft (reference: no)
Yes
Primary femoral fixation (reference: cemented)
Cementless
Primary tibial fixation (reference: cemented)
Cementless
Type of knee implant (reference: bicondylar)
Unicondylar, hinged, linked, custom or
preassembled
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Hospital organisation factors
Unit type (reference: public hospital)
Independent sector: hospital 0.73 0.57 to 0.88 < 0.01
Independent sector: treatment centre 0.57 0.28 to 0.85 < 0.01
FTE of specialty groups on trauma and orthopaedic surgery (reference: 0–24 FTEs)
25–29
30–39
40–49
> 50
Consultant FTE (reference: 0–24 FTEs)
25–29
30–39
40–49
> 50
Middle-grade doctor FTE (reference: 0–24 FTEs)
25–29
30–39
40–49
> 50
Early-career doctor FTE (reference: 0–24 FTEs)
25–29
30–39
continued
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TABLE 29 Continuous multilevel models of OKS for patients who underwent planned primary knee replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Total beds available overnight (reference: 0–349)
350–499
500–699
700–999
≥ 1000
Total beds available overnight for trauma and orthopaedic surgery (reference: 0–34)
35–49
50–69
70–99
≥ 100
Total beds available overnight for rehabilitation (reference: 0)
> 0–10
11–20
≥ 20
Operating theatres (reference: < 10)
10–14
15–19
20–24
≥ 25
Dedicated day-case operating theatres (reference: ≥ 7)
0
1–2
3–4
5–6
EQ-5D-3L, EuroQol-5 Dimensions, three-level version; IMD, Index of Multiple Deprivation.
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TABLE 30 Logistic multilevel models of complications at 6 months for patients who underwent planned primary hip replacement
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Intercept –4.95 –5.24 to –4.65 < 0.01 –4.85 –5.16 to –4.54 < 0.01 –4.84 –5.16 to –4.53 < 0.01
Patient factors
Calendar year (reference: 2014)
2015 0.10 0.04 to 0.16 < 0.01 0.08 0.02 to 0.14 0.01 0.08 0.02 to 0.14 0.01
2016 0.11 0.05 to 0.17 < 0.01 0.11 0.05 to 0.17 < 0.01 0.11 0.05 to 0.17 < 0.01
Age (years) (reference: < 50 years)
50–59 0.08 –0.10 to 0.25 0.38 0.07 –0.10 to 0.25 0.41 0.08 –0.10 to 0.25 0.40
60–69 0.22 0.06 to 0.39 0.01 0.20 0.04 to 0.37 0.02 0.21 0.04 to 0.37 0.02
70–79 0.55 0.39 to 0.71 < 0.01 0.50 0.33 to 0.67 < 0.01 0.50 0.33 to 0.67 < 0.01
80–84 0.86 0.69 to 1.03 < 0.01 0.81 0.63 to 0.99 < 0.01 0.81 0.63 to 0.99 < 0.01
≥ 85 1.16 0.98 to 1.33 < 0.01 1.11 0.92 to 1.29 < 0.01 1.10 0.91 to 1.28 < 0.01
Sex (reference: female)
Male 0.25 0.20 to 0.30 < 0.01 0.27 0.21 to 0.32 < 0.01 0.27 0.22 to 0.32 < 0.01
BMI (kg/m2) 0.01 0.01 to 0.02 < 0.01 0.01 0.01 to 0.02 < 0.01 0.01 0.01 to 0.02 < 0.01
Preoperative ASA physical function score (reference: mild disease not incapacitating, grade 2)
Fit and healthy (grade 1) –0.22 –0.32 to –0.12 < 0.01 –0.21 –0.31 to –0.11 < 0.01 –0.21 –0.31 to –0.10 < 0.01
Incapacitating systemic disease
(grade 3)
0.43 0.37 to 0.49 < 0.01 0.42 0.37 to 0.48 < 0.01 0.41 0.35 to 0.47 < 0.01
Life-threatening disease or expected to
die within 24 hours (grades 4 and 5)
0.85 0.63 to 1.08 < 0.01 0.83 0.61 to 1.06 < 0.01 0.82 0.59 to 1.04 < 0.01
continued
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TABLE 30 Logistic multilevel models of complications at 6 months for patients who underwent planned primary hip replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
IMD (reference: most deprived 20%)
Least deprived (20%) –0.04 –0.12 to 0.05 0.38 –0.02 –0.11 to 0.06 0.56 –0.02 –0.11 to 0.06 0.60
Former less deprived (20–40%) –0.05 –0.13 to 0.03 0.21 –0.04 –0.13 to 0.04 0.30 –0.04 –0.12 to 0.04 0.34
Current less deprived (40–60%) 0.08 –0.01 to 0.16 0.07 0.08 < 0.01 to 0.16 0.06 0.08 < 0.01 to 0.17 0.06
More deprived (20–40%) 0.09 0.01 to 0.18 0.03 0.10 0.01 to 0.18 0.03 0.10 0.01 to 0.18 0.03
Rural/urban indicator (reference: urban ≥ 10,000 habitants)
Town and fringe
Village/isolated
Primary indication (reference: osteoarthritis)
Osteoarthritis and other 0.36 0.23 to 0.49 < 0.01 0.35 0.23 to 0.48 < 0.01 0.35 0.22 to 0.47 < 0.01
Charlson Comorbidity Index score (reference: none, 0)
Mild (1) 0.33 0.27 to 0.39 < 0.01 0.33 0.27 to 0.39 < 0.01 0.33 0.27 to 0.39 < 0.01
Moderate (2) 0.50 0.41 to 0.58 < 0.01 0.50 0.41 to 0.58 < 0.01 0.49 0.41 to 0.57 < 0.01
Severe (≥ 3) 0.75 0.66 to 0.85 < 0.01 0.75 0.65 to 0.84 < 0.01 0.74 0.64 to 0.83 < 0.01
EQ-5D-3L (reference: highest quintile)
Lowest quintile –0.14 –0.21 to –0.06 < 0.01 –0.14 –0.21 to –0.06 < 0.01 –0.14 –0.21 to –0.06 < 0.01
Second quintile –0.28 –0.36 to –0.20 < 0.01 –0.28 –0.36 to –0.19 < 0.01 –0.27 –0.36 to –0.19 < 0.01
Third quintile –0.29 –0.37 to –0.20 < 0.01 –0.28 –0.37 to –0.19 < 0.01 –0.28 –0.36 to –0.19 < 0.01
Fourth quintile –0.36 –0.45 to –0.27 < 0.01 –0.35 –0.44 to –0.26 < 0.01 –0.35 –0.43 to –0.26 < 0.01
A
P
P
E
N
D
IX
1
N
IH
R
Jo
u
rn
als
Lib
rary
w
w
w
.jo
u
rn
alslib
rary.n
ih
r.ac.u
k
1
7
4
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Surgical factors
Lead surgeon experience (reference: consultant)
Other
Surgical volume per lead surgeon (reference: > 150 surgeries per year)
≤ 10
11–50
51–75
76–100
101–150
Surgical volume per unit (reference: surgeries per year, ≥ 500)
≤ 200 0.12 0.03 to 0.20 0.01 0.12 0.04 to 0.21 0.01
200–299 0.08 < 0.01 to 0.17 0.06 0.08 –0.01 to 0.17 0.07
300–399 0.07 –0.01 to 0.16 0.10 0.08 –0.01 to 0.17 0.09
400–499 0.05 –0.09 to 0.18 0.48 0.05 –0.09 to 0.18 0.48
Minimally invasive surgery (reference: no)
Yes –0.28 –0.43 to –0.13 < 0.01 –0.27 –0.43 to –0.12 < 0.01
Thromboprophylaxis (reference: LMWH± other)
None 0.14 –0.12 to 0.40 0.29 0.15 –0.10 to 0.41 0.25
Aspirin only 0.19 0.04 to 0.34 0.01 0.19 0.04 to 0.34 0.01
Other (no LMWH) –0.04 –0.10 to 0.02 0.15 –0.03 –0.09 to 0.03 0.28
Mechanical prophylaxis (reference: any)
None
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TABLE 30 Logistic multilevel models of complications at 6 months for patients who underwent planned primary hip replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
General anaesthesia (reference: no)
Yes
Regional: epidural anaesthesia (reference: no)
Yes
Regional: nerve block anaesthesia (reference: no)
Yes
Regional: spinal anaesthesia (reference: no)
Yes –0.08 –0.13 to –0.02 0.01 –0.07 –0.13 to –0.01 0.02
Type of approach (reference: posterior)
Anterior, anterolateral, Hardinge, lateral,
trochanteric osteotomy, other
Femoral bone graft (reference: no)
Yes
Cup bone graft (reference: no)
Yes
Primary cup fixation (reference: cementless)
Cemented
Type of primary stem fixation (reference: cemented THR stem)
Not available or resurfacing
Cementless THR stem
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Bearing surface (reference: MoP)
MoM –0.20 –1.17 to 0.77 0.69 –0.21 –1.17 to 0.76 0.68
CoC –0.04 –0.15 to 0.07 0.44 –0.05 –0.16 to 0.06 0.38
CoP –0.08 –0.15 to –0.01 0.03 –0.08 –0.16 to –0.01 0.02
CoM, MoC or unknown 0.13 –0.09 to 0.36 0.25 0.12 –0.10 to 0.35 0.28
Femoral head size (mm) (reference: ≤ 28mm)
32 –0.10 –0.16 to –0.04 < 0.01 –0.10 –0.16 to –0.04 < 0.01
36–42 –0.06 –0.13 to 0.02 0.17 –0.06 –0.14 to 0.02 0.14
≥ 44 –0.13 –0.98 to 0.73 0.77 –0.13 –0.99 to 0.73 0.77
Hospital organisation factors
Unit type (reference: public hospital)
Independent sector: hospital –0.08 –0.15 to –0.01 0.03
Independent sector: treatment centre –0.13 –0.27 to 0.01 0.06
FTE of specialty groups on trauma and orthopaedic surgery (reference: 0–24 FTEs)
25–29
30–39
40–49
> 50
Consultant FTE (reference: 0–24 FTEs)
25–29
30–39
40–49
> 50
continued
D
O
I:
1
0
.3
3
1
0
/h
sd
r0
8
0
4
0
H
ealth
Services
an
d
D
elivery
R
esearch
2
0
2
0
V
o
l.8
N
o
.4
©
Q
u
een
’s
P
rin
ter
an
d
C
o
n
tro
ller
o
f
H
M
SO
2
0
2
0
.T
h
is
w
o
rk
w
as
pro
d
u
ced
b
y
Ju
d
ge
et
al.u
n
d
er
th
e
term
s
o
f
a
co
m
m
issio
n
in
g
co
n
tract
issu
ed
b
y
th
e
Secretary
o
f
State
fo
r
H
ealth
an
d
So
cial
C
are.T
h
is
issu
e
m
ay
b
e
freely
repro
d
u
ced
fo
r
th
e
pu
rpo
ses
o
f
private
research
an
d
stu
d
y
an
d
extracts
(o
r
in
d
eed
,
th
e
fu
ll
repo
rt)
m
ay
b
e
in
clu
d
ed
in
pro
fessio
n
al
jo
u
rn
als
pro
vid
ed
th
at
su
itab
le
ackn
o
w
led
gem
en
t
is
m
ad
e
an
d
th
e
repro
d
u
ctio
n
is
n
o
t
asso
ciated
w
ith
an
y
fo
rm
o
f
ad
vertisin
g.
A
pplicatio
n
s
fo
r
co
m
m
ercial
repro
d
u
ctio
n
sh
o
u
ld
b
e
ad
d
ressed
to
:
N
IH
R
Jo
u
rn
als
Lib
rary,
N
atio
n
al
In
stitu
te
fo
r
H
ealth
R
esearch
,
E
valu
atio
n
,
Trials
an
d
Stu
d
ies
C
o
o
rd
in
atin
g
C
en
tre,
A
lph
a
H
o
u
se,
U
n
iversity
o
f
So
u
th
am
pto
n
Scien
ce
P
ark,So
u
th
am
pto
n
SO
1
6
7
N
S,U
K
.
1
7
7
TABLE 30 Logistic multilevel models of complications at 6 months for patients who underwent planned primary hip replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Middle-grade doctor FTE (reference: 0–24 FTEs)
25–29 0.09 < 0.01 to 0.17 0.04
30–39 0.05 –0.03 to 0.13 0.19
40–49 0.07 –0.03 to 0.16 0.17
> 50 0.03 –0.05 to 0.12 0.45
Early-career doctor FTE (reference: 0–24 FTEs)
25–29
30–39
Total beds available overnight (reference: 0–349)
350–499
500–699
700–999
≥ 1000
Total beds available overnight for trauma and orthopaedic surgery (reference: 0–34)
35–49
50–69
70–99
≥ 100
Total beds available overnight for rehabilitation (reference: 0)
> 0–10
11–20
≥ 20
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Operating theatres (reference: < 10)
10–14
15–19
20–24
≥ 25
Dedicated day-case operating theatres (reference: ≥ 7)
0
1–2
3–4
5–6
CoC, ceramic on ceramic; CoM, ceramic on metal; CoP, ceramic on polyethylene; EQ-5D-3L, EuroQol-5 Dimensions, three-level version; IMD, Index of Multiple Deprivation;
MoC, metal on ceramic; MoP, metal on polyethylene.
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TABLE 31 Logistic multilevel models of complications at 6 months for patients who underwent planned primary knee replacement
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Intercept –3.92 –4.20 to –3.65 < 0.01 –4.02 –4.30 to –3.73 < 0.01 –4.01 –4.30 to –3.72 < 0.01
Patient factors
Calendar year (reference: 2014)
2015 0.15 0.09 to 0.20 < 0.01 0.14 0.09 to 0.20 < 0.01 0.14 0.08 to 0.19 < 0.01
2016 0.15 0.09 to 0.20 < 0.01 0.14 0.08 to 0.20 < 0.01 0.14 0.08 to 0.19 < 0.01
Age (years) (reference: < 50 years)
50–59 –0.18 –0.35 to < 0.01 0.05 –0.19 –0.37 to –0.01 0.04 –0.18 –0.36 to < 0.01 0.04
60–69 –0.21 –0.38 to –0.04 0.01 –0.25 –0.42 to –0.08 < 0.01 –0.24 –0.42 to –0.07 0.01
70–79 –0.01 –0.18 to 0.16 0.94 –0.05 –0.22 to 0.12 0.55 –0.04 –0.22 to 0.13 0.61
80–84 0.25 0.08 to 0.43 0.01 0.21 0.03 to 0.38 0.02 0.21 0.03 to 0.39 0.02
≥ 85 0.61 0.43 to 0.80 < 0.01 0.57 0.38 to 0.75 < 0.01 0.57 0.38 to 0.75 < 0.01
Sex (reference: female)
Male 0.23 0.19 to 0.28 < 0.01 0.24 0.20 to 0.29 < 0.01 0.24 0.20 to 0.29 < 0.01
BMI (kg/m2)
Preoperative ASA physical function score (reference: mild disease not incapacitating, grade 2)
Fit and healthy (grade 1) –0.22 –0.32 to –0.12 < 0.01 –0.20 –0.30 to –0.10 < 0.01 –0.19 –0.29 to –0.09 < 0.01
Incapacitating systemic disease (grade 3) 0.42 0.36 to 0.47 < 0.01 0.41 0.35 to 0.46 < 0.01 0.39 0.34 to 0.45 < 0.01
Life-threatening disease or expected to
die within 24 hours (grades 4 and 5)
0.94 0.68 to 1.20 < 0.01 0.90 0.64 to 1.16 < 0.01 0.88 0.62 to 1.15 < 0.01
IMD (reference: most deprived 20%)
Least deprived (20%) –0.13 –0.20 to –0.05 < 0.01 –0.11 –0.19 to –0.03 < 0.01 –0.11 –0.18 to –0.03 0.01
Former less deprived (20–40%) –0.08 –0.15 to –0.01 0.03 –0.07 –0.14 to < 0.01 0.06 –0.07 –0.14 to 0.01 0.08
Current less deprived (40–60%) –0.03 –0.10 to 0.04 0.44 –0.03 –0.10 to 0.04 0.44 –0.03 –0.10 to 0.05 0.45
More deprived (20–40%) 0.03 –0.04 to 0.10 0.43 0.03 –0.04 to 0.10 0.43 0.03 –0.05 to 0.10 0.46
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Rural/urban indicator (reference: urban ≥ 10,000 habitants)
Town and fringe
Village/isolated
Primary indication (reference: osteoarthritis)
Osteoarthritis and other 0.26 0.07 to 0.44 0.01 0.25 0.06 to 0.44 0.01 0.24 0.05 to 0.42 0.01
Charlson Comorbidity Index score (reference: none, 0)
Mild (1) 0.28 0.22 to 0.33 < 0.01 0.28 0.23 to 0.33 < 0.01 0.28 0.22 to 0.33 < 0.01
Moderate (2) 0.41 0.34 to 0.49 < 0.01 0.42 0.34 to 0.49 < 0.01 0.41 0.33 to 0.48 < 0.01
Severe (≥ 3) 0.69 0.60 to 0.78 < 0.01 0.69 0.60 to 0.78 < 0.01 0.68 0.59 to 0.77 < 0.01
EQ-5D-3L (reference: lowest quintile)
Second quintile –0.08 –0.15 to < 0.01 0.04 –0.07 –0.15 to < 0.01 0.05 –0.07 –0.15 to < 0.01 0.06
Third quintile –0.18 –0.25 to –0.12 < 0.01 –0.18 –0.24 to –0.11 < 0.01 –0.17 –0.24 to –0.11 < 0.01
Fourth quintile –0.21 –0.29 to –0.12 < 0.01 –0.20 –0.29 to –0.11 < 0.01 –0.19 –0.28 to –0.10 < 0.01
Highest quintile –0.26 –0.33 to –0.20 < 0.01 –0.25 –0.32 to –0.19 < 0.01 –0.24 –0.31 to –0.18 < 0.01
Surgical factors
Lead surgeon experience (reference: consultant)
Other
Surgical volume per lead surgeon (reference: > 150 surgeries per year)
≤ 10 –0.10 –0.30 to 0.10 0.34
11–50 0.08 < 0.01 to 0.16 0.05
51–75 0.07 –0.01 to 0.15 0.08
76–100 0.06 –0.02 to 0.14 0.14
101–150 0.08 0.01 to 0.16 0.04
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TABLE 31 Logistic multilevel models of complications at 6 months for patients who underwent planned primary knee replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Surgical volume per unit (reference: surgeries per year, ≥ 500)
≤ 200 0.10 0.01 to 0.18 0.03 0.10 0.01 to 0.18 0.03
200–299 0.08 0.01 to 0.16 0.03 0.08 < 0.01 to 0.16 0.04
300–399 0.08 < 0.01 to 0.15 0.05 0.08 < 0.01 to 0.16 0.04
400–499 0.05 –0.03 to 0.14 0.23 0.05 –0.04 to 0.13 0.27
Minimally invasive surgery (reference: no)
Yes
Thromboprophylaxis (reference: LMWH± other)
None –0.27 –0.53 to < 0.01 0.05
Aspirin only –0.04 –0.19 to 0.10 0.55
Other (no LMWH) –0.03 –0.09 to 0.03 0.28
Mechanical prophylaxis (reference: any)
None 0.13 < 0.01 to 0.27 0.05
General anaesthesia (reference: no)
Yes 0.09 0.04 to 0.14 < 0.01 0.08 0.03 to 0.13 < 0.01
Regional: epidural anaesthesia (reference: no)
Yes
Regional: nerve block anaesthesia (reference: no)
Yes
Regional: spinal anaesthesia (reference: no)
Yes
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Type of approach (reference: medial parapatellar)
Lateral parapatellar
Mid-vastus
Subvastus
Other
Femoral bone graft (reference: no)
Yes
Tibia bone graft (reference: no)
Yes
Primary femoral fixation (reference: cemented)
Cementless
Primary tibial fixation (reference: cemented)
Cementless
Type of knee implant (reference: bicondylar)
Unicondylar, hinged, linked, custom or
preassembled
–0.38 –0.49 to –0.27 < 0.01 –0.38 –0.49 to –0.27 < 0.01
Hospital organisation factors
Unit type (reference: public hospital)
Independent sector: hospital –0.10 –0.16 to –0.04 < 0.01
Independent sector: treatment centre –0.30 –0.42 to –0.17 < 0.01
FTE of specialty groups on trauma and orthopaedic surgery (reference: 0–24 FTEs)
25–29
30–39
40–49
> 50
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TABLE 31 Logistic multilevel models of complications at 6 months for patients who underwent planned primary knee replacement (continued )
Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Consultant FTE (reference: 0–24 FTEs)
25–29
30–39
40–49
> 50
Middle-grade doctor FTE (reference: 0–24 FTEs)
25–29 –0.01 –0.10 to 0.07 0.77
30–39 0.02 –0.06 to 0.11 0.56
40–49 0.11 –0.01 to 0.22 0.07
> 50 0.10 < 0.01 to 0.21 0.05
Early-career doctor FTE (reference: 0–24 FTEs)
25–29
30–39
Total beds available overnight (reference: 0–349)
350–499
500–699
700–999
≥ 1000
Total beds available overnight for trauma and orthopaedic surgery (reference: 0–34)
35–49
50–69
70–99
≥ 100
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Category
Patient model Surgical model Hospital organisation model
Coefficient 95% CI p-value Coefficient 95% CI p-value Coefficient 95% CI p-value
Total beds available overnight for rehabilitation (reference: 0)
> 0–10
11–20
≥ 20
Operating theatres (reference: < 10)
10–14 0.13 0.05 to 0.21 < 0.01
15–19 0.06 –0.02 to 0.13 0.16
20–24 0.10 0.02 to 0.18 0.01
≥ 25 0.11 0.02 to 0.20 0.01
Dedicated day-case operating theatres (reference: ≥ 7)
0
1–2
3–4
5–6
EQ-5D-3L, EuroQol-5 Dimensions, three-level version; IMD, Index of Multiple Deprivation; LMWH, low-molecular-weight heparin.
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FIGURE 29 Trends in LOS and OHS and OKS at Hampshire Hospitals NHS Foundation Trust. (a) OHS LOS; (b) OHS
6 months – OHS baseline; (c) OKS LOS; and (d) OKS 6 months –OKS baseline. (continued )
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FIGURE 29 Trends in LOS and OHS and OKS at Hampshire Hospitals NHS Foundation Trust. (a) OHS LOS; (b) OHS
6 months – OHS baseline; (c) OKS LOS; and (d) OKS 6 months –OKS baseline.
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